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Abstract 
Nylon has been one of the most formative textiles in modern times. It's creation in the 
1940's proved the linear structure of polymers which led to the ability to design fabrics 
with robust and predictable properties. This caused a sensation in the hosiery industry and 
has since moved on to other markets such as the automotive industry, safety equipment 
and packaging to name a few. With the production being steady year-on-year at around 3.6 
megatonnes, a major concern has arisen over fears for the environmental impact of the 
chemical manufacturing process. Aside from the bulk disposal of salts and solvents, the 
amount of nitrous oxides produced in large scale manufacture is of great concern in efforts 
to reduce global warming. These molecules are over 300 times more powerful of a 
greenhouse gas than carbon dioxide and so any reduction will have a large impact.  
There is growing interest in the development of biological routes as a potential to 
circumvent these limitations of the traditional chemical routes. There are several reasons 
for this such as the fact that enzymatic routes rely on much lower temperatures, are 
typically solvent free processes and the emission of hazardous chemicals is avoided. With 
recent advances in synthetic biology, metabolic engineering offers the possibility of such a 
process.  
This thesis outlines one such biological route to manufacturing a Nylon 6 precursor, 6-
aminocaproic acid (6-ACA). By modifying a metabolic pathway from Acinetobacter 
calcoaceticus NCIMB 9871 and adding a Transaminase, a 5 gene operon has been 
assembled and expressed in E.coli BL21(DE3) which is capable of catalytically converting 
cyclohexanol into the Nylon 6 precursor in vivo. Five clonal variants were created and 
explored to identify the optimal producer.  The best producing clone, pQR1553 achieved a 
titre of 264.48 mg/L (2mM) from 10mM cyclohexanol when grown on 2xTY media and this 
was confirmed and quantified by GC-MS. This concentration represents one of the highest 
producing biological routes from an academic research group for 6-ACA in the published 
literature. However metabolite analysis showed a very clear bottleneck in the conversion of 
cyclohexanone to ε-caprolactone and attempts to resolve this were made.   
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Impact statement 
The body of work presented in this thesis could potentially have an impact on several 
levels. In an academic, and practical sense, the methods used to generate the successful 
clones i.e. CPEC and PCR based cloning could be used in future by researchers to create 
multi-gene expression cassettes. To the best of my knowledge, expressing 6 genes using a 
single plasmid hasn't been shown before in the department and certainly not using the 
assembly techniques used. This methodology could mean that larger metabolic pathways 
could be engineered, with minimal effort, to increase the speed of achieving results. 
Additionally it could lead to a larger interest in producing bulk chemicals from biological 
routes. The research presented here achieved good titres of 6-aminocaproic acid however 
with the implementation of design of experiments and further optimisations I believe it is 
capable of more. Looking at a wider scope of interest there is a necessity to replace 
petrochemical sources. This is due to a desperate need to reduce the human impact on the 
environment, conversion of traditional chemical routes into bio-production to eliminate 
these very harmful manufacturing processes would greatly help in the fight against global 
warming.  There is also scope to utilise this pathway and others to produce alternative 
products like methylated versions of monomers which are, by traditional chemistry, very 
difficult to achieve. By optimising these routes, a gap in the plastics market could be 
capitalised on which could accelerate the development of these plastics into the mass 
market. 
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Chapter 1: Introduction 
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1 Introduction to Nylon 
1.1 Nylon; a gamble in a recession 
 
Nylon is arguably the fabric which created an entirely new industry; it proved polymer 
properties could be both predicted and engineered. This opened the gates to the first 
viable commercial application of polymers. It was the fabric which revolutionised the 
hosiery industry in the 1940’s and has continued to provide a diverse portfolio of products 
ever since. Before its conception, a cellulose based material called Rayon was very popular 
however its properties of a low melting point and fading when exposed to light made it a 
difficult material. DuPont recognised the need for improvement and it was a scientist 
named Wallace Carothers who decided to focus on polymers. Initially he proved that 
polymers have a linear structure by reacting a diacid and a dialcohol however the resultant 
melting point was still too low. He then focused on polyamides since he believed these 
would have a higher melting point and eventually settled on Nylon 6,6; a polymer made 
from hexamethylene diamine and adipic acid, both of which were commonly and cheaply 
available (Wolfe, 2008). Manufacture was then rapidly scaled up and the total cost from 
R&D to full scale was $459 million in today’s value. Nylon has remained one of the most 
popular fabrics for 7 decades and production has remained steady at around 3.6 
megatonnes per annum (American Chemical Society, 1995), (World Nylon Fiber Report - 
Highlights, 2013).  
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1.1.1  The chemistry behind stocking 
The monomer building blocks can vary in size which therefore lead to many types of 
polymers exhibiting different properties e.g. 6,10; 6,12; 6,4 etc. However by far the two 
most popular are Nylon 6,6 and Nylon 6 (Antron, 2013). Therefore only these two will be 
discussed here.  
 
1.1.2 Nylon 6,6  
Both monomers (adipic acid and hexamethylene diamine) are manufactured from Benzene, 
an aromatic ring hydrocarbon commonly found in crude oil and coal. Initially adipic acid is 
produced from Benzene by using the following routes.  
1) Benzene is hydrogenated by passing hydrogen gas over liquid Benzene at 450K and 
40 atm of pressure with a nickel catalyst. This is then oxidised at 400K and 10atm of 
pressure with a cobalt salt catalyst to make KA oil (a mixture of cyclohexanone and 
cyclohexanol). This KA oil is then oxidised in liquid phase with 60% nitric acid using a copper 
and vanadium catalyst at 350K. This produces copious amounts of the greenhouse gas, 
Nitrogen Oxide (N2O) (The Essential Chemical Industry, 2013).  
2) Benzene is alkylated with propylene using an Aluminium trichloride catalyst (a 
Friedel Crafts catalyst) to produce Cumene. This is then oxidised to cumyl-hydroperoxide 
which is then acid cleaved into phenol and acetone. The phenol is then hydrogenated to KA 
oil (Bellussi & Perego, 2000). The KA oil is then oxidised in liquid phase with 60% nitric acid.  
3) Benzene is selectively hydrogenated to cyclohexene and subsequently hydrated to 
cyclohexanol. This isn’t as thermodynamically stable as it is to make cyclohexane and so a 
large proportion of this is also produced. However, by performing the reaction in an 
organic phase with a zinc-coated platinum catalyst yields significantly more cyclohexene.  
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Adipic acid is also further processed to produce hexamethylene diamine by firstly being 
converted into adiponitrile by ammoniation and then hydrogenated to 
hexamethylenediamine (Bellussi & Perego, 2000). Ammoniation is defined as being 
combined with or treated with ammonia.  
 
 
 
 
 
Finally, after the two monomers are manufactured they are mixed together in equimolar 
amounts at 550K under pressure in a reaction vessel and they undergo condensation 
polymerisation.  
Figure 1.1 Schematic of the pathways described from benzene to 
adipic acid. Grouped together in the box is KA oil (Cyclohexanol and 
cyclohenanone mix). Route 1 benzene is hydrogenated, route 2 
benzene is alkylated and route 3 benzene is selectively 
hydrogenated. 
 
Figure 1.2 The conversion of adipic acid to hexamethylene 
diamine. Adipic acid is converted to adiponitrile via 
ammoniation which is inturn hydrogenated to hexamethylene 
diamine.  
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1.1.3 Nylon 6   
Developed as a molecule which circumvented the patent DuPont held on Nylon6,6  Nylon 6 
(aka polycaprolactam) is a polymer of only one ringed monomer called caprolactam. The 
process for making caprolactam is similar to adipic acid. It begins with the alkylation of 
benzene with propylene using a Friedel-crafts catalyst (commonly Aluminium tricloride) to 
make cumene (or hydrogenated to cyclohexane as in Nylon 6,6 methodology 1 and then 
oxidised to KA oil). This is then oxidised to cumyl-hydroperoxide and acid cleaved to give 
phenol and acetone. The phenol is then hydrogenated to KA oil (mixture of cyclohexanone 
and cyclohexanol) (Bellussi & Perego, 2000). However, pure cyclohexanone is required to 
make Nylon 6 and so the cyclohexanol must firstly be dehydrated. This is achieved by 
heating the KA oil to 500K with a copper and chromium oxide catalyst (The Essential 
Chemical Industry, 2013). The cyclohexanone is then oximated with hydroxylammonium 
sulphate to cyclohexanone oxime. The final step involves the beckmann rearrangement of 
cyclohexanone oxime using sulphuric acid into caprolactam. Due to the low pH nature of 
this reaction, ammonia is added to nutralise this reaction creating a large quiatity of 
ammonium sulphate bi-product (Bellussi & Perego, 2000).  
In order to polymerise caprolactam by ring openning, it is heated to 533K for 12 hours with 
water, ethanoic acid and nitrogen gas. Due to the instability of caprolactam and the 
reactivity of its functional groups, the linear molecule reacts with ringed caprolactam and 
the polymerisation cycle starts again (The Essential Chemical Industry, 2013). 
 
 
 
 Figure 1.3 Truncated manufacturing routes to caprolactam from 
benzene 
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1.2 The environmental impact of Nylon production 
The traditional industrial chemical synthesis of Nylon requires harsh conditions which, as 
well as a high cost, are also detrimental to the environment. Firstly, the temperatures 
required in several steps are very high which places a large energy demand on the process. 
As the price of energy increases, it directly impacts the cost of goods of Nylon production 
which which leads to an increasing price for the consumer. Hazardous waste products are 
also produced in large quantities which is not only costly to dispose of, but are also directly 
harmful to the environment. For example, low pH steps in the process are often neutralised 
with ammonia producing ammonium sulphate which is commonly used as a fertiliser. An 
excess amount of the salt is produced per kilogram of product e.g. 2.8Kg/Kg of 
cyclohexanone oxime in the ammoximation of cyclohexanol alone (Bellussi and Perego, 
2000). However due to its high water solubility, a large proportion of the fertiliser simply 
runs off from the soil and into lakes and rivers (panap, 2010). This creates a twofold 
problem. Firstly, water with high nitrogen content nurtures algal growth which quickly 
stagnates water by metabolising dissolved oxygen and reducing light penetration to aquatic 
plants. Secondly ammonia, nitrite and nitrate are incredibly toxic to fish and a reduction in 
bacteria able to metabolise these leads to fatally poisoned fish (panap, 2010).  
Arguably the most environmentally detrimental impact of Nylon production is the emission 
of Nitrous oxides. Nitrous oxides are a powerful greenhouse gas which have an impact 300 
Figure 1.4 Breaking of the caprolactam ring into a linear monomer is self-
catalytic whereby the process generates a linear polymer in one reaction. 
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times that of CO2 (Ravishankara, Daniel and Portmann, 2009).  While the total nitrous 
production in the chemical industry only contributes 6% to the environmental emissions, 
owing to its potency, any reduction in production is a great improvement (epa.gov, 2017). 
In 2002, President Bush issued a policy which committed the US to reducing its greenhouse 
gas emissions and ever since there has been pressure on other western countries from the 
government to follow suit (Parker, 2009).  
 
1.3 The push towards greener chemistry 
During the past decade or so, chemical synthesis companies have begun to face pressure 
from governments and campaign groups about the effects of waste disposal, safety 
concerns and reliance on petrochemical feedstocks and their environmental impact 
(Poliakoff et al., 2002). The traditional chemical synthesis of commodity chemicals and the 
requirement for the use of finite resources, hazardous solvents, bi-product removal and 
waste disposal, expensive energy demands for high temperature and pressure steps and 
the removal of non-desired chiral molecules is placing added pressure on chemical 
companies. Biocatalysis and synthetic pathways on the contrary have several significant 
advantages over chemical synthesis. Enzymes, being biologically derived, operate in much 
milder conditions. They typically require much lower temperatures compared to chemical 
catalysts and additionally cannot tolerate harsh conditions or solvents. Furthermore many 
different types can be coupled together in cascades which enable the possibility to use very 
unstable intermediates because they are simply a substrate for the following enzyme, 
whereas in chemical synthesis it would prove problematic (Simon et al., 2014). 
Furthermore, enzymes offer the potential to produce 100% optically pure products 
therefore, in the case of Nylon 6,6, negating the requirement for chiral separation. It is 
clear therefore that if biocatalysis is adopted at scale, the potential for large cost savings is 
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apparent. However, interest from the chemical manufacturing industry has been slow for 
several reasons. Firstly the industry can be considered quiet conservative and innovative 
technologies are proving increasingly more difficult to convince company officials to adopt 
a change. Additionally, the method by which the enzymes are obtained is important since 
the cost of bulk scale quantities is substantial. Therefore it is probably that non-pure 
enzymes, for example whole cell catalysts or clarified lysates, are likely to play an important 
role in producing low-value commodity chemicals. At present benzene is cheap however 
dwindling oil reserves, political price hikes and reliance on suppliers from unstable 
countries is driving interest into more innovative, forward thinking technologies that will be 
required in the next few decades (Bart and Cavallaro, 2015). 
1.4 Metabolic engineering 
 
Genetic manipulation of microbial cells is a well-established process and something now 
common place in research. The term ‘’cell factory’’ was coined to describe and imply an 
engineered cell's ability to manufacture a useful product/function. The emergence of 
synthetic biology in recent years has in part been aimed at building multi-cascade 
enzymatic pathways in expression vectors, once a difficult process, is now made with 
relative ease. The premise of this subsidiary of synthetic biology is to be able to accomplish 
one of two problems (Bellussi and Perego, 2000); 1) to use relatively cheap feedstocks for 
engineered microbes and turn these into valuable commodity or fine chemicals or 2) 
reduce the process economics/the use of hazardous steps required in the chemical 
synthesis of such chemicals.  
 This design of such microbes requires knowledge of natural wild-type enzymes, their 
capabilities and how the product of one enzyme will be the substrate for the next. Whilst 
natural pathways exist in wild-type bacteria, whether a strain has the ability to produce the 
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product in industrially relevant quantities is always a concern and hence synthetic biology 
provides the tools with which to make it so. For example, by introducing an enzyme or a set 
of enzymes into an expression vector with a powerful promoter, growing the cells at a high 
density and optimising the growth conditions, a pathway which originates from a slow 
growing, complex bacterium then potentially operates at a much higher efficiency. 
Additionally the proteins may themselves be engineered to have an increased affinity for 
the substrate, to have an increased catalytic rate of reaction or indeed broaden its fidelity 
in order to make a wider substrate base with which to use as a feed for the pathway. 
Furthermore, the pathway may be entirely constructed from enzymes taken from several 
hosts and expressed in the same ‘’cell factory’’ in a combinatorial approach. Whatever the 
construct, yield is of pertinent importance when thinking about scale-up and industrial 
relevance.  
1.5 Efforts towards industrially relevant products 
In 2010, a study by Genomatica and the ICIS (International conference on Information 
systems) showed that 57% of executives in the chemical synthesis industry feel that a move 
away from petroleum based products is required however the process yields and therefore 
economics need to match (McGrew, 2010). The momentum in applied metabolic 
engineering has increased over the last decade which has led to an increase in the number 
of publications detailing researcher’s efforts in achieving high yields of commodity and fine 
chemicals. Several will be described here. Whilst early research focused on identifying 
natural producers of chemicals and increasing productivities by random mutagenesis and 
fermentation optimisation, metabolic engineering is now becoming a useful tool to 
broaden the scope of bioproduced chemicals (Lee et al., 2011). Akhtar et al ,constructed an 
enzymatic pathway in E.coli that conferred the ability to metabolise a broad range of fatty 
acids into fatty alcohols and alkanes. The pathway consisted of a carboxylic acid reductase, 
30 
 
an aldehyde reductase, a thioesterase and finally a lipase (Akhtar, Turner and Jones, 2013). 
Reported yields were only 350mg/L, however several parameters needed to be more 
controlled for instance, the flux through the pathways may need to be adjusted by 
controlling individual enzyme expression since the Kcat of the carboxylic acid reductase is 
low. Also the enzymes are competing with host variants and so the proportions of fatty 
alcohol’s, alkanes and aldehydes produced varied between batches (Akhtar, Turner and 
Jones, 2013). 
Yim et al’s demonstrated outstanding work for the production of 1,4-Butandiol (BDO) from 
E.coli. This compound is currently produced solely from oil and natural gases and is used 
also to produce polymers. Their approach was to engineer the natural TCA cycle of E.coli, 
and use it together with 4 genes from several different host organisms in order to produce 
BDO from cheap and renewable carbohydrate feedstocks. By using computer modelling to 
simulate and predict the metabolic pathway, they narrowed down potential routes based 
on bi-product formation, yields, pathway length and thermodynamic feasibility. After 
identifying which enzymes they were going to transform, they then found that in order to 
balance the pathway flux they needed to arrange the first two genes on a medium copy 
number plasmid and the last two into a high copy number plasmid. The aim of this being to 
minimise the burden placed on the cells and so not to disrupt growth characteristics. With 
this alone they achieved yields of 7.5g/L however they highlighted that bi-product 
formation was diverting metabolic intermediates away from the pathway. With this in mind 
they used the software OptKnock to identify target genome encoded host cell enzymes 
which could be deleted and therefore funnelling into the pathway. They removed 4 genes 
encoding the following proteins; Alcohol dehydrogenase, pyruvate formate lyse, lactate 
dehydrogenase and malate dehydrogenase and carbon tracing showed 95% of the glucose 
was being shunted down the designed pathway. This led to an increase in yield to 18 g/L. 
They finally recognised that if it was to become commercial, they required a 3-5 fold 
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increase in yields in order to make economic sense (Yim et al., 2011). However an article by 
Genomatica in 2010 stated that they have achieved yields of 80g/L BDO production in 
fermentations ranging from 30-3000L and say that their patented technology matches the 
economics of traditional chemistry for BDO production (McGrew, 2010).   
One hot topic is that of cell engineering research taking place to create a suitable 
alternative for fuels from cheap and renewable feedstock's such as carbon monoxide, yeast 
extract and corn steep liquor (Abubackar et al. 2015, Abubackar et al. 2012 and Maddipati 
et al. 2011). However in all three examples titres remained low. This could be as a 
consequence of the emphasis being placed on optimising the fermentation rather than 
fundamental cell engineering. To substantiate this claim, evidence could be found by Hanai 
et al where they created an E.coli K12 strain containing genes for three enzymes cloned 
from two Clostridium species and a Thermoanaerobacters. After screening several 
homologues, the optimum combination was found and yields were reported at 43.5% 
mol/mol of glucose in shake flask culture and 81.6mM total. This is almost a 3 fold increase 
on the best known natural producer C.beijerinckii. (Hanai, Atsumi and Liao, 2007).  
Another example is the microbial production of 1,3-propanediol. This is naturally produced 
by several bacteria (e.g Clostridium sp.) when grown solely on glycerol and in anaerobic 
conditions to ensure an excess of reduced NADPH is present. 1,-propanediol has been used 
in a hybrid process with chemically produced terepthalic acid to produce a polymer similar 
to Nylon. The key enzyme is glycerol dehydratase which relies on a second enzyme, glycerol 
dehydratase reactivase for vitamin B12 reactivation. In this reaction the coenzyme B12 is 
sometimes rendered inactive which ceases catalysis. In this way the GHR as a chaperone to 
remove inactive B12, rendering the glycerol dehydratase capable of biding active vitamin 
B12. After screening and isolating a library of glycerol dehydratase enzymes, several 
variants were isolated and cloned which displayed a higher tolerance to substrate, product 
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and a lower B12 dependence (Nakamura and Whited, 2003). To highlight the industrial 
relevance of 1,3-propanediol, DuPont and Genecor International Inc engineered and 
patented an E.coli K12 strain with a minimal diversion from the designed pathway by 
several gene deletions and fermentation optimisation. A yield of 130g/L was achieved 
(Nakamura and Whited, 2003). 
Further examples of molecules produced by metabolic engineering include Polylactic acid 
(Jung and Lee, 2011), the compound GABA which has interests in the food industries and 
Nylon 4 production (Park et al., 2013), succinic acid (Ho Hong and Yup lee, 2004)  and even 
aldehydes which are not produced naturally in any known living organism since they are 
converted to their corresponding alcohols rapidly (Kunjapur and Prather, 2015).  
 
1.6  The bottlenecks of metabolic engineering 
The idea of engineering a host to produce a product it naturally does not produce is rife 
with problems to overcome. By looking at the literature, several bottlenecks in achieving 
high, commercially viable yields can be identified. In several of the reports the host's 
metabolism proved to be a significant blockade by inherently expressing numerous 
competing enzymes and hence the carbon source metabolism was diverged from the 
desired pathway. The innate metabolic flux of the host has been fine-tuned by evolution 
and hence can be a significant obstacle (Na, Kim and Lee, 2010). The effect of such has 
been shown to be mitigated by either deleting the most probable enzymes and/or coupling 
with the expression of the synthetic genes from medium/high copy number plasmids. By 
expressing the proteins in such plasmids it is assumed that the protein concentration out 
competes natively expressed alternatives as well as the kinetics of the endogenously 
expressed proteins being such an extent that the conversion rates are smaller than the 
exogenous proteins. This funnels the majority of the carbon source through the engineered 
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pathway. Secondly, optimisation of fermentation is an additional requirement. A review by 
Rosalam and England on Xanthan gum bioproduction detailed the effects of improving 
culture conditions and identifying optimum feeding strategies not only reduced the 
fermentation time but also doubled the yield e.g. a feeding strategy of glucose in 5 equal 
time increments gave a maximum product yield of 18g/L however by enriching the media 
at 34 hours into the fermentation, yields achieved were 40g/L and this reduced the total 
time to complete by 20 hours. It is notable that in this particular case the option for strain 
engineering wasn't possible since any attempt produced lower yields or rendered a lack of 
growth (Rosalam and England, 2006).  
As mentioned above the pathway will be competing with innate enzymes however 
individual expression levels of each enzyme may be important in yield optimisation. This 
starts at the ribosome binding site. Variations on the RBS code and distance between it and 
the start codon  greatly affects both the ability of tRNAfmet to bind to the start codon as well 
as the molecular interaction of the 16s rRNA of the ribosome which therefore impacts on 
protein expression levels (Na, Kim and Lee, 2010). The fickle nature of the RBS was 
illustrated by Park et al who showed significant protein level increases upon 1 or 2 base 
changes to the sequence however any modification to the last GAG sequence showed 
considerably lower expression (Park et al., 2007).  
Finally, cofactor availability within a cell may be problematic and limit enzyme activity. The 
cells enzymes which require NAD+, NADPH, NADH, FAD etc have developed a finely tuned 
supply chain which minimise wasted energy expenditure. When over-expressing several 
enzymes in a synthetic pathway, it can be imagined that the supply of the cofactors may 
not necessarily balance with the demand from the exogenous enzymes.  
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1.7 Nylon precursor research from the literature 
Whilst there have previously been notable efforts in chemistry research to produce greener 
routes to Nylon precursors involving process development and catalytic engineering (Usui 
& Sato 2003, Thomas & Raja 2005) whole cell biocatalysis and metabolic engineering is 
rapidly coming of age. Reported titres between the literature are varied and methodologies 
are broad. Schmidt et al developed a pathway in E.coli which consisted of an alcohol 
dehydrogenase followed by a Baeyer-Villegar monoxygenase and then Lipase A to produce 
poly-ε-caprolactone at 20g/L based on a 200mM feed of cyclohexanol (Schmidt et al., 
2015). Their approach was unique in the fact that they expressed ADH from one plasmid in 
one cell, CHMO from another in another cell, added each type at a ratio of 1:10 
respectively and then added the Lipase A into the media. It is notable to mention they used 
an engineered CHMO for improved stability and reduced product/substrate inhibition 
capabilities. In addition they reported that isolation of poly-ε-caprolactone involved a  
simple solvent extraction (Schmidt et al., 2015). In any bioprocess the most costly part of 
the chain is downstream processing and so by being able to simply extract the product 
using resins able to bind amine groups is imperative to Nylon precursor biosynthesis scale 
up.  
There have been several attempts to capitalise on the natural tricarboxylic acid cycle by 
developing pathways to adipic acid bioproduction from glucose. Yu et al, developed an 
E.coli strain that co-expressed two plasmids, one containing the gene’s paaj (β-ketoadipyl-
CoA thiolase) and Ter (Trans-enoyl-CoA reductase) and another containing the gene’s Hbd 
(3-hydroxybuttyrl-CoA dehydrogenase), Ech (Enoyl-CoA hydratase), ptb (Phosphate 
butyryltransferase) and Buk1 (Butyryl kinase). By growing this strain on minimal media 
supplemented with 10g/L glucose at 30oC for 120h and engineering the cell for excess 
Succinic acid production, titres of 639µg/L were achieved (Yu et al., 2014). An interesting 
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approach by Frost et al, combined both biochemical and chemical methods of 
manufacture. Firstly they engineered an E.coli strain to express two copies of DHS 
dehydratase from K.pneumoniae on the E.coli chromosome and a PCA decarboxylase and 
catechol 1,2-dioxygenase from A.calcoaceticus on a plasmid. After 48h of culture a titre of 
36.8g/L of cis, cis-muconic acid was produced representing a 22% mol/mol yield on D-
glucose. Following this the cis, cis-muconic acid was treated with activated charcoal and 
filtered followed by hydrogenation with a 10% platinum on carbon catalyst at 3400 kPa for 
2.5 hours achieving a 97% conversion yield  to adipic acid (Niu, Draths and Frost, 2002). 
1, 5-diaminopentane is naturally produced by C.glutamicum and is a precursor to Nylon 5,4 
or 5,10. Buschke et al, performed a flux analysis on this organism but based on a xylose 
substrate . They predicted that a maximum yield would result from a strain with high 
oxidative pentose phosphate pathway activity but zero TCA cycle. After engineering the cell 
to this design remit,  a yield of 100g/L was achieved after 75 hours of culture (Buschke et 
al., 2013).  
Four and five carbon length diamino-alkanes offer an interesting route to molecules which 
are currently difficult to produce by traditional chemical routes. Kind et al developed a 
strain of the soil bacterium Corynebacterium glutamicum which produced Cadaverine (a 5 
carbon diamino-alkane) and polymerised it with sebacic acid from castor oil to produce 
polyamide 5.10. Their approach was three pronged; firstly they cloned a Lysine 
decarboxylase into a previously engineered high Lysine producing strain, secondly they 
deleted an N-acetyltransferase which eliminated any side-product formation, and lastly 
they expressed exporters for lysine and the diaminopentane (Kind et al., 2014). This rather 
elegant approach meant they achieved yields of 88 g/L with a specific productivity of         
2.2 g/L/h. This is perhaps not surprising since their substrate is a natural metabolite of 
which a large tolerance is inbuilt into the clone.  A similar approach was taken when 
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generating diaminobutane (Aka. putrecine) when Schneider and Wendisch engineered 
Corynebacterium glutamicum with an ornithine decarboxylase and the deletion of a 
carbamoyltransferase and achieved titres of 6 g/L with a yield of 0.12g/g of glucose 
(Schneider and Wendisch, 2010).  
Clomburg et al engineered an E.coli strain MG1655 to produce a mixture of hydroxyacids 
and dicarboxylic acids from glucose or glycerol sources in a multi-enzyme cascade and 
reported producing adipic acid, 6-hydroxyhexanoic acid, suberic acid, sebacic acid and 
various dicarboxylic acid chain lengths from C6-C10 and reported titres of 0.5 g/L of 
dicarboxylic acids and 0.8 g/L of hydroxyacids (M.Clomburga et al., 2015).  
Hexamethylenediamine (HDMA) has however had significantly less research published to 
date for bio-based routes. A study by Dros et al has suggested that alternative routes 
towards it's manufacture can exist and outline a route from starch. Their method starts 
with an enzymatic conversion of starch to high fructose syrup followed by dehydrogenation 
to 5-(hydroxymethyl)furfural. One of the routes outlines then hydrogenating this to 2,5-
Bis(hydroxymethyl)tetrahydrofuran, then hydrogenolysis to 1,6-Hexanediol and finally an 
amination step to HDMA. Although this was largely an economical and feasibility study, 
they have stated that this process would cost 20-25% less than the petro-dervied HDMA 
route as well as a 50% reduction in green house emissions (Dros et al., 2015).  
So far the above research discussed in this section have been mostly described using 
intracellular enzymes in reproducing cells for the reason of co-factor recycling, without any 
requirement for enzyme purification. However Sattler et al has constructed a co-factor self-
sufficient pathway in vitro producing 6-aminohexanoic acid. This compound can then be 
treated with superheated steam creating ε-caprolactam. The method they describe uses 
cyclohexanol as a substrate which is metabolised by an alcohol dehydrogenase, followed by 
a Baeyer Villiger monoxygenase (BVMO), an esterase, a primary Aldehyde dehydrogenase 
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(ADH), a ω-Transaminase and finally another esterase. This last step is completed in 
conjunction with an Alanine dehydrogenase, ammonia and L-alanine. Furthermore they 
additionally showed that by supplementing with methanol, a cap was placed on side 
product formation therefore an increase in yield was observed (Sattler et al., 2014). Yields 
were reportedly 12mM of of 6-aminohexanoic acid however their conversion rates were 
low which may be resultant of non-optimum buffer conditions or protein instability. Whilst 
their work clearly is successful in their own right, they encountered protein stability 
problems from an ADH from Acinetobacter calcoaceticus and subsequently used an 
alternative enzyme. Moreover in terms of scalability, purification and pooling of each 
enzyme this will not be an ideal process and more than likely will not to be cost effective 
but useful at lab scale as a proof of principle.   
Perhaps the research which would more closely resembles the approach taken in the work 
presented in this thesis was published in 2015 by Turk et al. The group reports cloning six 
genes on two plasmids which convert 6-alphaketoglutarate from the TCA cycle to 6-ACA. 
They report titres of 160mg/L of 6-ACA but also state that 2 g/L of total Nylon producing 
chemicals (i.e. 6-aminovaleric acid, adipic acid, aminopimelate) were achieved in fed-batch 
lab scale fermentations. They postulated a bottleneck in their pathway which resulted in 
significant accumulation of a range of bi-products such as 5-aminoadipate and 5 
aminovaleric acid and suggested both could be products from α-ketoadipate the result of 
endogenous aminotransferase for the former biproduct, and a decarboxylase followed by 
an aminotransferase for the latter (Turk et al., 2015).  
So far I have described several research groups and publications in a university setting 
however this area of metabolic engineering already stretches beyond and into industry. An 
American company called Verdezyne has developed and patented a yeast cell strain 
capable of growing on and metabolising all fatty acid compositions to produce adipic acid. 
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Also being a yeast, it is invulnerable to bacteriophage infections which present a risk to 
microbial fermentations. They have designed their strain to lack the gene POX4 and 
amplified genes involved in the β-oxidation pathway and are achieving adipic acid yields of 
50g/L in 120h at 300L pilot scale fermentations (Beardslee and Picataggio, 2012).  More 
recently, in November 2014 Verdezyne announced that they had secured a deal with Bio-
XCell, a Malaysian biotechnology park focusing on sustainables, to build a facility to 
manufacture 30 million pounds of dodecandioic acids and adipic acids annually; an 
unprecedented move in this field (see www.verdezyne.com). However Verdezyne are not 
alone, there are currently 3 other companies heavily invested in producing sustainable 
Nylon precursors. Genomatica were recently successful in gaining a patent for producing 
caprolactone in E.coli and hold 7 additional patents. BioAmber is another company 
producing in yeast however they have licenced their technology and are currently focusing 
on downstream purifications. Renovia is also another example which has developed E.coli 
strains and is aiming to commercially produce adipic acid by 2018.  
1.8 Acinetobacter calcoaceticus 9871 and the proposed pathway 
 This study will focus on a synthetic pathway constructed of 4 genes from Acinetobacter 
calcoaceticus coupled together with a Transaminase enzyme that will confer the host with 
the capacity to metabolise cyclohexanol into 6-aminohexanoic acid (aka 6-aminocaproic 
acid). A schematic of the pathway is shown in Figure 1.5.
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Figure 1.5 Schematic of the synthetic pathway from cycloexanol to 6-aminocaproate. Cyclohexanol dehydrogenase produces cyclohexanone from cyclohexanol, a cyclohexanone 
monooxygenase then produces caprolactone (aka BVMO - baeyer villiger monooxygenase), a lactonase (gene - ChnC) produces 6-hydroxyhexanoate, a alcohol dehydrogenase (6-
hydroxyhexanoate dehydrogenase encoded by ChnD) then produces the aldehyde 6-oxohexanoate which is then aminated by a transaminase at the omega position.  
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A.calcoaceticus was first isolated in 1975 by Donoghue and Trudgill (Donoghue and Trudgill, 
1975) and was isolated from soil samples using cyclohexanol as its sole carbon source. 
Additionally a pathway is proposed which, along with a 5th enzyme (substituting the 
Transaminase) is capable of producing adipic acid. In the pathway above however that 
enzyme (ChnE) has been removed from the cluster (Figure 1.6) and a Transaminase added 
to produce 6-aminocaproate. Since this monomer consists of an amine group and a 
carboxylic group, theoretically the monomers will be able to undergo a dehydration 
polymerisation and create a Nylon polymer. Genes involved in the same pathway tend to 
be located close together in clusters and this can be seen in Figure 1.6. It illustrates that 
ChnA, ChnC and ChnD are in the reverse orientation to that of ChnB. Very little work has 
been published on this pathway and the only enzyme in the cascade which has been 
extensively studied is CHMO (a Baeyer-Villager monoxygenase). Research published by 
Cheng et al identified a similar pathway in an Acinetobacter sp SE19. Having isolated this 
strain from an industrial waste water stream and after creating a library of E.coli clones 
harbouring cosmid sections with a length of genomic DNA from Acinetobacter sp SE19, they 
were screened for cyclohexanol oxidation. They identified a gene cluster with high 
homology to the Acinetobacter NCIMB 9871 strain and by random mutagenesis 
experiments were able to identify gene functions in the 14kb fragment harbouring the 
pathway (Cheng et al., 2000). Table 1.1 shows a summary of the genes located in that 
pathway.  
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Gene name Description 
ChnA Short chain zinc-independent alcohol dehydrogenase. Converts 
cyclohexanol to cyclohexanone 
ChnB Authors mutated, caused accumulation of cyclohexanol. Encodes a 
cyclohexanone monooxygenase (CHMO/BVMO) 
ChnC Caprolactone hydrolase; converts caprolactone to 6-hydroxyhexanoic 
acid. 
ChnD Zinc independent long-chain alcohol dehydrogenase. 
converts 6-hydroxyhexanoic acid to 6-oxohexanoate.  
ChnE Aldehyde dehydrogenase; 6-hydroxyhexanoic acid accumulated when 
mutated.  
Table 1.1. Summary of the gene’s isolated from an Acinetobacter sp.  by Cheng et al. 
Using their gene knock-out variants and analysing the accumulated products they were 
able to determine a function for the proteins in the pathway. An interesting observation 
was that when ChnE was mutated, instead of 6-oxohexanoate accumulation, 6-
hydroxyhexanoic acid accumulated as well as 30% adipic acid (Cheng et al., 2000). 
Aldehydes are rarely produced intracellularly due to their level of toxicity and so organisms 
have evolved to be able to rapidly convert these. For example, in E.coli BL21 there are 19 
aldehyde dehydrogenases (search of the BL21 (DE3) genome at 
www.kegg.jp/kegg/genome.html). Additionally Cheng et al found that the recombinant 
E.coli were unable to grow on cyclohexanol as a sole carbon source (unlike Acinetobacter 
calcoaceticus NCIMB 9871) suggesting other adaptations, perhaps involving the TCA, PPP or 
β-oxidation pathways which generate ATP and metabolise adipic acid in Acinetobacter 
calcoaceticus  NCIMB 9871. They also suggested that aldehydes may react with cellular 
amines such as amino acids which would explain why none were observed (Cheng et al., 
2000).  
 
42 
 
 
Figure 1.6 Schematic to show the gene cluster as it appears in the Acinetobacter calcoaceticus 9871 
genome. Note that the genes (ChnA-D) are not in the same direction but are located in close 
proximity. 
As mentioned above, chnB encodes for a cyclohexanone monooxygenase (CHMO) which is 
a Baeyer-Villiger monooxygenase (BVMO) a much studied enzyme of great interest in 
chemistry. Baeyer-Villiger reactions were first discovered over 100 years ago and describe 
an oxidation of cyclic or acyclic ketones to their corresponding ester or lactone using a 
peroxide catalyst (Alphand et al., 2003). The oxidant used is often unstable and lacks 
enantioselectivity therefore has moderate success (Alphand et al., 2003). CHMO is a type 1 
flavoenzyme BVMO requiring bound FAD, NADPH and O2 for activity. BVMO’s have 
attracted large interest because of their broad substrate specificity which is capable of 
producing a range of lactones of great industrial interest. For example, the need for 
enantioselectivity is never more prevalent than in the synthesis of pharmaceuticals. 
Monocyclic lactones are small biologically active molecules and bi/polycyclic lactones have 
shown potential as anti-tumour compounds and cardiac ATPase activators as well as being 
intermediates in the synthesis of glaucoma and hypertension drugs and even in the 
manufacture of flavours and fragrances (Alphand et al., 2003). Although there are several 
well documented papers detailing attempted scale up of these enzymatic reactions, the 
major hurdle to circumvent is that BVMO’s exhibit significant substrate and product 
inhibition, i.e. is inhibited to a degree by both cyclohexanone and the lactone, albeit a 
much greater tolerance to lactone (Alphand et al., 2003). 
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Unfortunately there has been a significant lack of research into the individual gene cluster 
proteins in the cluster and the only research article published to date looking at the 
enzyme kinetics is the original article published by Donoghue and Trudgill (Donoghue and 
Trudgill, 1975). They describe using crude cell extracts and looking for an absorbance 
change at 340nm in an NADH absorbance assay for ChnA oxidation of cyclohexanol to 
cyclohexanone at pH 10 and then subsequent confirmation by thin layer chromatography. 
They then subsequently showed that cyclohexanone is rapidly metabolised at pH9 and the 
only detectable product was 6-hydroxyhexanoic acid. Additionally they suggested that the 
3rd enzyme (ChnC) had an activity 27 times greater than that of ChnB and hence the 
product of this was rapidly metabolised therefore overcoming product inhibition. Having 
the knowledge we do now about CHMO’s product inhibition, in evolutionary terms it would 
make sense for ChnC to have a high substrate affinity. Finally they identified ChnD as a 
dehydrogenase based on stoichiometric oxygen consumption in the presence of NAD+ and 
6-hydroxyhexanoate as a substrate to crude cell lysates. They also found the protein was 
very labile requiring fresh preparations and even then only exhibiting low activity 
(Donoghue and Trudgill, 1975).  
As can be seen in the schematic of the synthetic pathway (Figure 1.5), the fifth and final 
enzyme is a ω-Transaminase. Transaminases are a diverse family of enzymes which 
function to transfer an amine group from a donor to an acceptor (an aldehyde or keto 
group). This effectively exchanges the Ketone group for the amine group between the two 
molecules. In nature these enzymes are amongst the most prevalent; every living cell 
expresses several of these to fulfill roles in interconverting amino acids and their 
derivatives, to synthesise vitamins and amino sugars for bacterial cell walls etc. They are 
therefore crucial for nitrogen metabolism (Ward and Wohlgemuth, 2010). Interest in these 
enzymes is high due to the fact that 70% of marketed pharmaceuticals  are made from 
chiral amino acids. Chemical synthesis is a non-selective method and the absolute 
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requirement for stereoisomer purity from regulators is helping to drive interest in these 
enzymes. There are 5 classes of Transaminases in total, all of which use pyridoxal 5’-
phosphase (PLP) as a cofactor in the transfer of the amine group to the donor which is then 
recycled after conversion to Pyridoxamine 5'-phosphate (PMP). Within these classifications, 
enzymes transfer the amine group to different position’s on the acceptor i.e. α 
Transaminases transfer to position 1, β to position 2, γ to position 3 and ω to the last 
position. The ω-Transaminases are a class III enzyme and have been subject to significant 
amount of research in recent times owing largely to their broad substrate specificty. The 
reactions catalysed by Transaminases are a reversible reaction therefore equilibria are 
established and can become unfavourable (Ward and Wohlgemuth, 2010). While the 
characteristics are described in broad terms, some Transaminase varients may exhibit less 
enzyme activity, less substrate range, lower stability etc and therefore techniques such as 
random mutagenesis and site-directed mutagenesis have been employed to make 
improvements (Mathew et al., 2013). Transaminases therefore provide a versatile method 
for producing a wide variety of compounds and as such may be a popular choice when 
constructing synthetic pathways.  
 
1.9 DNA cloning and operon construction 
The emergence of recombinant technology can be considered one of the greatest scientific 
discoveries of all time and is common place in bioengineering. Through a series of 
discoveries starting with the observation of DNA transferring between bacteria in the 
1920’s, followed by the discovery of restriction enzymes and DNA ligases and subsequent 
plasmid transformation (Pray, 2008) the field of whole cell engineering emerged. Today, 
various techniques have been developed to allow construction of multi-cistronic plasmids 
i.e. plasmids expressing several independent proteins. This allows the construction of 
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complex synthetic pathways on one or more plasmids. A brief description of methods to 
assemble DNA constructs is below. 
 
1.9.1 Restriction digestion and ligation 
This is the oldest and most established method of DNA cloning and is restriction cloning. 
Restrictions enzymes are added to both the DNA and the plasmid vector which recognise 
and cut specific sites either creating a blunt end or a sticky end with 3’ or 5’ over hangs. 
Ideally the digestions should be performed with two different enzymes in the same 
reaction (aka a double digestion) since this adds directionality (i.e. the gene is inserted in 
the correct orientation for expression). If the vector is singularly digested it can be 
dephosphorylated to prevent re-circularisation upon ligation. The DNA segments are then 
ligated and transformed. This method can be applied to assembling multiple genes in 
succession however each gene requires its own unique restriction site and it is very 
laborious requiring many PCR reactions to create the sites at the gene ends, purifications, 
ligations and transformations.  
 
1.9.2 TOPO/Multisite GATEWAY® cloning 
Invitrogen’s TA/TOPO technology relies on the enzyme DNA Topoisomerase I which has a 
dual function of restriction enzyme and a ligase. They supply linearised vectors with TOPO 
covalently bound to the 3’ end with an overlapping Thymine residue. The gene to be cloned 
is then PCR amplified with a Taq polymerase which adds a single Adenine to the 3’ ends 
and then both parts are combined. They also have vectors available for directional 
insertion. Following from this they then developed GATEWAY® which allows rapid transfer 
of DNA segments by generating overlapping bacteriophage att sequences on gene 
fragments, using proprietary donor vectors which recombine with the gene fragment 
46 
 
creating an entry clone. This entry clone is then recombined with a destination vector and 
transformed. Initially they designed only 2 att sequences however recognising the growing 
need of researchers to build multi-cistronic pathways they then developed MultiSite 
GATEWAY® in which they utilise 5 att sequences and used the same process to allow 
construction of up to 4 genes in the same vector (more information is available at 
www.lifetechnologies.com). There are several drawbacks to this method. Firstly vectors are 
proprietary from Invitrogen meaning a limitation on expression hosts. Secondly a maximum 
of only 4 fragments can be assembled together and finally it is very expensive (c.a. 
£1500/20 reactions).  
 
1.9.3 Gibson assembly/In-Fusion HD/HiFI cloning 
These three methods are variations of each other and are used to assembly gene 
constructs together or assemble stretches of DNA. Gene fragments are PCR amplified to 
contain 15-30 nucleotide flanking regions that are homologous to the DNA stretches which 
are planned to flank it (see Figure 1.7). The fragments and linearised vector (with overlaps 
homologous to the 5’ gene and the 3’ gene) (up to 6 fragments in total) are combined with 
their master mixes containing a 5’ exonuclease which ‘chews the DNA back’ and creates 
single strand overlaps. The homology between these overlaps to each other allows them to 
anneal specifically in the same way PCR primers work. A ligase in the mix then seals the 
nicks and the assembled plasmid is then transformed. All of this is completed in 15-60 
minutes at 50oC. All three kits (Gibson from NEB, In-Fusion HD from clontech and HiFi from 
NEB’s own brand) claim to have a high efficiency. Theoretically the fragments should only 
anneal to the fragments with the homologous overlaps however data published by NEB 
claim that in a 6 fragment assembly (5 x 1kb fragments + 3.3kb vector), Gibson assembly 
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achieved a correct arrangement of only 10% of the transformed cells while their HiFi 
cloning achieved 92% (see www.NEB.com).  
 
 
 
 
 
 
 
 
Figure 1.7 Schematic of the Gibson assembly reaction 
(image copied from www.NEB.com). 
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1.9.4 Ligation independent cloning 
Ligation independent cloning is another method which uses homologous DNA stretches to 
anneal sequences in order however the homologous sequences are added to both vector 
and insert. Firstly using a high fidelity polymerase the overlaps are added. Then a T4 
polymerase is used as it exhibits exonuclease activity and after a short time, addition of 
only one nucleotide is added which halts the exonuclease activity and stalls the polymerase 
activity at the first occurance of the base which has been added. The fragments are then 
annealed at 37oC and subsequently transformed. An adaptation to this method was 
developed and named SLIC (sequence and ligation independent cloning). In this method 
the overlaps can include any nucleotide however RecA (recombinase) must be present. This 
method was first used by Li and Elledge in 2007 (Li and Elledge, 2007) where they showed 
that the success of the reaction was dependent upon the length of the homologous region 
and the number of inserts. They showed that a 5 fragment assembly with 40bp overlaps 
produced 20/20 correct digestion patterns however two of these had single base mutations 
obtained from the PCR. In a 10 fragment assembly only 20% were the digested as expected 
(Li and Elledge, 2007). Although the fidelity of even the worst polymerases is quite good, it 
is imperative to use a high fidelity polymerase when performing PCR where the amplified 
fragments will be used in cloning.    
 
 
1.8 Schematic of the LIC exonuclease method. After the homologous ovrelaps are added, the 
exonuclease function of T4 polymerase cuts back until the first base of the only nucleatide present. 
The polymerase domain takes over and then stalls creating single stranded overhangs.  
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1.9.5 Circular polymerase extension cloning 
This method is the newest and most possibly the most promising method of multi-enzyme 
cloning available. Published in 2009, Quan and Tian reported the first use of a polymerase 
based assembly method that requires only overlapping sequences, a thermocycler, a high-
fidelity polymerase and dNTP’s and showed an impressive success rate (Quan and Tian, 
2009). The premise is much the same as Gibson/HiFi/ Phusion by which fragments 
(including vector) are modified to contain flanking overlapping regions to the segments 
designed to be either side. The fragments and vector are then combined in ratios of 1-30:1 
insert to vector in the presence of a polymerase, dNTP’s and buffer and are then cycled (5-
30 cycles) through 98oC denature, 55oC annealing of the primer homologous sequences and 
finally 78oC. They advise that the overlapping segments have as close an annealing 
temperature as possible (between 60-70oC and +/- 2oC) with the length of the overlaps of 
secondary importance (Quan and Tian, 2011). A small volume is then transformed into 
E.coli. Reports suggest the degree of success is dependent upon the individual annealing 
temperature of the combined overlaps as well as the number of cycles of annealing. CPEC is 
not an amplification, it simply joins two complimentary fragments and since it is ligase  
independent, 1 nick per fragment pair is created. This is not a problem however since host 
DNA repair enzymes seal the nicks in vivo(Bryksin and Matsumura, 2010). It is clear that the 
number of fragments which can be cloned in the same reaction is likely to be limited to 5-
10 and is also likely to decrease in efficiency as the number of fragments increases. 
Following this Bryksin and Matsumura used the same principle but adapted it and showed 
that a gene can be cloned into a plasmid, anywhere on that plasmid at any specific place, 
without the need for restriction digestion, purification and ligation. Figure 1.10 shows a 
schematic of the process. A fragment is again designed with overlaps flanking the left and 
right of the intended insertion site. The plasmid is then heat denatured, the fragment then 
anneals anneals and is followed by extension. The next step is to remove any original 
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template plasmid so the reaction is digested with DpnI. The resultant circular plasmid is 
then transformed (Figure 1.10).  
 
 
 
 
 
 
 
 
Figure 1.10 Method developed by Bryksin and Matsumura for modular insertion of a gene 
anywhere on a plasmid (image from Bryksin & Matsumura 2010).  DpnI is added to digest the residual 
template backbone DNA.  
Potential uses of this include extending existing operons or allowing easy deletion and 
replacement of plasmid genes in a modular fashion, ligation free. They also state that a 
high concentration of inserts and a low annealing temperature (5-10oC below the Tm of the 
primers) is best for optimal results. Although they achieved colonies with a molar ratio of 
5:1 and 50:1 insert to vector, they found that a 250:1 molar ratio between plasmid and 
insert is optimal (Bryksin and Matsumura, 2010). CPEC therefore offers considerable 
advantages over other pathway construction methods by being a rapid, versatile and cost 
effective cloning method.  
Figure 1.9 Schematic of CPEC. 4 genes represented by 
different colours and a purple vector are amplified to 
contain homologous overlaps to the part it is required to 
flank. 
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1.10 Codon usage bias 
In DNA translation, there are 64 different triplicate sequences coding for only 20 amino 
acids. This ‘degeneracy’ has led, through evolution, to different species possessing varying 
amounts of the individual tRNA’s e.g. organism A may prefer to use one codon to code for a 
particular amino acid yet organism B may prefer to use a different codon with which to 
recruit the same amino acid (Behura and Severson, 2013). The same can be said for the 
ability of a ribosome to recognise a ribosome binding site (Park et al., 2007). Part et al 
showed that even slight differences in the Shine-Delgarno sequences and the distance it is 
from the start site can greatly impact the level of protein expression (Park et al., 2007). 
Therefore, this must be considered a potential weak link when constructing novel 
pathways. However, Chen et al suggested that the codon usage in Acinetobacter 
calcoaceticus NCIMB 9871 is similar to that of E.coli (Chen, Peoples and Walsh, 1988) and 
may therefore not affect the expression levels of each protein in E.coli BL21 (DE3). The 
basis for their suggestion is that when they were cloning the Acinetobacter calcoaceticus 
NCIMB 9871 BVMO into E.coli the expression levels were reasonable.  
 
1.11 Project aims 
The aim of this project will be to generate create an E.coli clone which functionally 
expresses the Acinetobacter calcoaceticus NCIMB 9871 genes coupled with an omega 
Transaminase obtained from the Ward group's library. This will lead to the in vivo 
conversion of cyclohexanol into 6-aminocaproic acid (6-ACA). The aim will be met by the 
achievements of several objectives.  
 The first objective will be to assemble the four genes (ChnA, ChnB, ChnC and ChnD) 
from the Acinetobacter calcoaceticus NCIMB 9871 genome into an operon under the 
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control of a single promoter harbouring an individual ribosome binding sites. This will 
confer the ability to metabolise cyclohexanol to 6-oxohexanoate.  
 
 The second objective will be to clone each of these individually into E.coli BL21 (DE3) 
cells with a His-tag and assay them for activity indications. The reason for doing this 
second to assembling the operon is because the operon generation is anticipated to 
take the most time and will likely be where a large portion of problems will happen.   
 
 Thirdly, a bank of Transaminases, previously cloned by members of our group, will then 
be screened for optimal activity for conversion of 6-oxohexanoate to the final product 
6-aminocaproate (6-aminohexanoate) whilst possessing minimal activity for 
cyclohexanone. The enzyme showing optimal activity will then be cloned into the 
pathway.  
 
 The fourth objective will be to develop an analytical method with which to quantify the 
metabolic intermediates. Given the inherent difficulty analysing amino acids, a robust 
method will be developed and confirmed by mass spectrometry. Lastly, given enough 
time, iterations of the plasmid will be attempted in order to minimise the effect of any 
bottlenecks and feeding strategies will be explored in a simple manner.   
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2 Materials and methods 
2.1 General DNA techniques and the 4 Acinetobacter sp. gene 
operon assembly 
2.1.1 Genome viewer and editor 
Genomic sequences were obtained from the NCIB genbank and viewed and edited in either 
ApE (downloaded from: http://biologylabs.utah.edu/jorgensen/wayned/ape/) or SnapGene 
viewer (downloaded from: http://www.snapgene.com/products/snapgene_viewer/). 
Schematics of assembled plasmids were also designed and obtained from these programs.  
2.1.2 PCR 
A nested approach was chosen in which to amplify chnA, ChnB, ChnC and ChnD from the 
genome of Acinetobacter calcoaceticus NCIMB 9871. Performing PCR on genomic 
templates can be problematic due to off-target effects which can therefore result in lower 
yields and many bands on an agarose gel. In this case the 5’ and 3’ ends of the target genes 
are low in GC content and the required primers to extract also contain several hairpin loops 
and 3D structures, hence more appropriate flanking sequences approximately 100bp either 
side of each gene were chosen. These nested fragments were then used to extract each 
gene specifically. 20ng of template DNA was used in all PCR reactions. All reagents were 
sourced from New England Biolabs (USA) and the primers were purchased from Eurofins 
MWG (Germany). The primers were supplied as a pellet and re-suspended to a 
concentration of 100mM in DI water. Q5 polymerase was chosen and used in 50 µL 
reactions. Reactions were set up according to manufactures instructions. Genomic 
sequences were obtained from Genbank. 2 µL of each PCR reaction was added to 8 µL of 
water and 2 µL of 6 x Loading dye (NEB, USA) and visualised on agarose gel. The Tm of each 
gene binding portion of the primer was calculated using Oligo Calc (available at: 
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http://biotools.nubic.northwestern.edu/OligoCalc.html) and a gradient of +/-5 oC was 
typically chosen. An extension time of 30 s/kb was used on all PCR's at this stage. See 
appendix for primer sequences used.  
2.1.3 Agarose gel electrophoresis and gel extraction 
DNA samples were separated by agarose gel electrophoreses at 0.8% concentration 
containing 0.005% (vol/vol) ethidium bromide and running at 120V for 40-50 minutes in 1X 
TBE buffer (Sigma Aldrich, USA).  To confirm whether the reaction had amplified, 2 µL of 
the PCR reaction was added to 8 µL of water followed by 2 µL of 6X loading dye(NEB, USA). 
Bands were visualised under UV at 302 nm (Alphaimager mini, Protein simple, USA). If a 
DNA band was to be purified, the whole PCR reaction mix was loaded with a volume of dye 
at 1X and ran on a gel. It was excised using a scalpel under UV light and digested using the 
QiaQuick gel purification kit (Qiagen, Netherlands) following the manufacturer’s 
instructions. To ascertain DNA concentrations, samples were measured for absorbance at 
280 nm on a Nanodrop 2000 (Thermoscientific, USA). 10 µL of either 1 Kb or 2- log ladder 
(NEB, USA) was used as a size reference.  
2.1.4 Gibson assembly 
Each gene fragment concentration was converted into pmol/µL using the equation: 
pmol/µL = concentration (ng/µL) x 1000/ (base pairs x 650 daltons) 
The protocol described for a 2 (paired inserts A+B, C+D),  4 (4 gene inserts) or 5 fragment 
assembly (4 inserts + vector) was followed according to manufacturer instructions (NEB) 
using a total amount of the fragments equivalent to 1 pmol. After addition of the master 
mix and Di water, the mixture was heated to 50oC for 1 hour and then either transformed 
in 10β cells or visualised on an 0.8% agarose gel.  
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2.1.5 Restriction digestion and ligation 
For cloning the Acinetobacter calcoaceticus NCIMB 9871 genes individually, 1µg of pET29a 
plasmid (Novagen, Germany) was digested in a 50µL reaction containing 1µL 
(20units/reaction) of both NdeI and NotI-HF restriction enzymes (NEB, USA), 5µL of 
CutSmart buffer (10X; 500mM potassium acetate, 200mM Tris-acetate, 100mM magnesium  
acetate, 1mg/ml BSA, pH 7.9) for 16 hours. All other digestions were performed with their 
respective enzymes and digested for 1 hour. Preparative digestions (i.e. to obtain gene 
fragments for ligation) were carried out in the same 50µL reactions and DNA mass of <1µg. 
Confirmatory digestions (i.e. post operon construction plasmid miniprep digestions) were 
carried out in a 10µL volume digesting 200 ng of DNA, 0.2 µL of each restriction enzyme, 1 
µL of CutSmart buffer and Di water was added. Digestions were then run on a 0.8% agarose 
gel with ethidium bromide and visualised under UV. Purifications of the required fragment 
were done using a QIAquick gel extraction kit (Qiagen, Netherlands). A 3-10 fold molar 
excess of insert to vector was used in ligation reactions using a Quick ligationTm Kit (NEB, 
USA) in a 10 µL reaction following the manufacturers protocol and left to ligate at room 
temperature for 1 hour and then subsequently either stored at -20oC or transformed into a 
cloning strain. 
2.1.6 Circular Polymerase Extension Cloning (CPEC) 
The methods described by Quan et al and Speltz et al (Speltz and Regan, 2013) were 
followed and either equimolar amounts of insert and linearised vector, a 2 fold insert to 
vector ratio or a 30 fold molar excess to vector approach were tried. A 50 µL reaction was 
set up containing Q5 polymerase, CutSmart buffer, dNTP's and fragments in the same 
concentration as for a PCR reaction. The thermocycler procedure of an annealing 
temperature of 52oC for 26 cycles was used in multi-fragment assemblies whilst an 
annealing temperature of 55oC was used at 15 cycles maximum for two fragment 
assemblies. Following the reaction, samples were either visualised on a 0.8% agarose gel 
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and the band removed and digested followed by transformation or, 5uL was then 
transformed directly. Several colonies were grown in 5ml LB broth (Merck Millipore, USA) 
cultures at 37oC for 16 hours. They were then miniprepped using a QIAprep miniprep kit 
following the manufacturer’s instructions (Qiagen, Hilden, Germany). Plasmids were 
digested with HindIII for 1 hour to confirm the presence of ChnB and ChnD; AccI for ChnC ; 
PstI and NotI for ChnA (NEB, Ipswich, Massachusetts, USA). Correct plasmids were then 
sequenced by Sanger sequencing (Source Bioscience, Nottingham, UK) for the first and last 
800bp (approximately). Successful assemblies were then transformed into BL21 (DE3) (NEB, 
Ipswich, Massachusetts, USA). The native and non-native RBS operon variants were 
subsequently named pQR1543 and pQR1548. 
 
2.2 General bacterial culture and transformation 
2.2.1 Plasmid preparation and E.coli transformation 
From an assembly reaction, 5uL was transformed the cloning strain of choice, E.coli 10β 
cells (NEB, USA) via the heat-shock method following the manufacturer’s protocol. A tube 
of cells was thawed on ice for 10 minutes and the DNA was added to the tube and gently 
mixed by flicking the tube. This was placed on ice for 30 minutes followed by heating at 
42oC for 30 seconds and placing back on ice for 5 minutes. 950 uL of SOC media (supplied 
with the cells) was added and mixed at 250rpm at 37oC for 1 hour. 200 uL was plated on 
50µg/ml Kanamycin LB agar (Merck Millipore, USA) plates and incubated over night at 37oC. 
If successful, the plate was stored at 4oC for up to 3 weeks. When a plasmid miniprep was 
required, a single colony was picked and cultured overnight in 5mls of LB media (with 
50µg/ml of kanamycin(Sigma-Aldrich, USA)) in a 50ml Falcon tube and incubated at 37oC. 
LB broth media was made according to manufacturer’s recommendations (Merck, 
Germany) and autoclaved and stored until needed. Following overnight culture, the 
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suspension was centrifuged at maximum g and at room temperature for 10 minutes to 
pellet the cells. A QIAprep kit was used (Qiagen, Netherlands) to extract the plasmids 
following the manufacturers' instructions. 100ng of each plasmid was then transformed via 
heat shock into the expressing strain E.coli BL21 (DE3) (Novagen, Germany) because it 
encodes an inducible copy of the T7 polymerase required for protein expression from 
pET29 vectors. pET29a was chosen for cloning because it’s a medium copy number plasmid 
which, when used with BL21 (DE3), has minimal leakiness of protein expression. 
Transformation of BL21 (DE3) was much the same as 10β cells however they were only 
heat shocked at 42oC for 10 seconds. 
2.2.2 Routine culture of pQR1553-7 
A transformed plate containing colonies stored at 4oC for up to 3 weeks. After this time a 
single colony was picked and re-spread onto a fresh Kanamycin plate, grown at 37oC 
overnight and placed at 4oC. For culture experiments to identify pathway metabolites, a 
single colony was picked and inoculated into 5-10ml of 50ug/ml Kanamycin LB and shaken 
at 250rpm at 37oC overnight. 20-100ml of the chosen media in non-baffled glass flasks was 
then inoculated to an O.D. of 0.1, grown to 0.6-0.7 and then induced with 1mM Isopropyl 
β-D-1-thiogalactopyranoside (IPTG) (Sigma-Aldrich, USA).   
2.2.3 Glycerol stock generation 
To make a glycerol stock, single colonies were cultured in 5mls of LB (30µg/ml Kan) 
overnight. 500µL of the overnight growth was then mixed with 500µL of a 50% glycerol 
solution (v/v) and stored at -80oC and 4.5mls of overnight culture were minipreped and the 
plasmid stored at -20oC.  
2.2.4 Cell culture growth and pH measurements 
Cell cultures were innoculated in 50ml of LB broth in unbaffeled flasks to an O.D of 0.1 and 
periodically the OD was measured using a spectrophotometer at a wavelength of 600nm. 
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Dilutions were made to keep the the measurements in the linear range. Cultures were 
induced at an O.D of 0.6-0.7 and cyclohexanol was added 2 hours later at 10 mM, 30 mM 
and 50 mM. Culture pH was measured at the same interval using a pH probe.  
 
2.3 Protein expression and purification 
2.3.1 SDS-PAGE  
Single colonies of the cell strains expressing either the operon or the individual genes were 
suspended in 5 ml of LB (30µg/ml kanamycin) overnight and used to inoculate 50mls of LB 
(30µg/ml Kanamycin) in a 250ml shake flask to an OD600 of 0.1 and incubated at 37
oC and 
250 RPM. Once an OD600 of 0.6-0.7 has been reached the cells were induced with 50 µL of 
1M IPTG at a working concentration of 1mM. 1 ml samples were taken periodically and 
spun at max g in a bench top centrifuge in microfuge tubes and the supernatant was 
removed and discarded. The cell pellet was then stored at -20oC overnight. Pellets were 
then thawed and re-suspended in 100 µL of BugBuster (Merck, USA) and incubated at room 
temperature for 10 mins with gentle shaking to allow adequate time for cell lysis. Samples 
were then centrifuged at 4oC, 12 000g for 20 minutes. 450 µL of 4x Laemmli Sample Buffer 
(277.8 mM Tris-HCL, pH 6.8, 4.4% LDS, 44.4% (w/v) glycerol, 0.02% bromophenol blue, 
BIoRad USA) was added to 50 µL of β-mercaptoethanol (Sigma, USA) and mixed at a ratio of 
3:1 sample to sample buffer and, together with a broad range 10-250kDa ladder (NEB, 
USA), boiled at 95oC for 5 minutes followed by centrifugation at maximum g for 5 minutes. 
10-20 µL’s we’re loaded onto 12% or 4-20% Mini-PROTEAN®TGXTM (BioRad, USA) gels and 
run at 180V for 45 minutes. The gel was then washed with RO water (3 x5 minute washes) 
and gently rocked in 20 mls of InstantBlue protein stain (expedeon, UK) for 1 hour. The gel 
was washed briefly and then imaged. 
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2.3.2 Protein purification 
The cell strain expressing the isolated genes were first plated from a glycerol stocks onto LB 
agar (30 µg/ml Kan) and grown over night. Single colonies were isolated and grown in 10 ml 
LB (30µg/ml Kan) over night and this was used to inoculate 100 ml of LB (30 µg/ml Kan) in a 
250ml flask to an OD600 of 0.1. This was incubated at 37
oC, 250RPM until an OD600 of 0.6-07 
and this was then induced with 1mM IPTG and grown for 6 hours. The culture was then 
removed from the flask and centrifuged at maximum g. The supernatant was discarded and 
the pellet stored at -20oC overnight. The pellet was then re-suspended in BugBuster 
(Merck, USA) to a volume of 10% the original culture volume and centrifuged at maximum 
RPM at 4oC for 20 minutes. An empty PD-10 column (GE healthcare, UK) was packed with 2 
ml of Ni-sepharose 6 Fast flow chromatography medium (GE healthcare, UK) and 
equilibrated with 10 column volumes of Binding buffer (20mM imidazole, 100mM NaCl, 
50mM HEPES, pH 7.5) on ice. The supernatant was firstly passed through a 0.2 µm filter 
and then loaded onto the column and 2 ml of flow through collected and stored at 4oC until 
needed for SDS-PAGE analysis. The column was then washed with 10 column volumes of 
binding buffer and 1 ml samples collected. A crude assay to ascertain the presence of 
protein was performed by diluting Bradfords reagent (Sigma aldrich, USA) 1:4 with water 
and adding 10 µL of the wash flow through; a blue colour change indicated the presence of 
protein. Once zero protein was detected, the His-tagged protein was eluted with 10 column 
volumes of elution buffer (100mM imidazole, 100mM NaCl, 50mM HEPES, pH 7.5). 1 ml 
fractions were collected in eppendorf tubes (Eppendorf, Germany) and 10 µL samples 
we’re mixed in the crude bradford’s assay to test for the presence of eluted protein. Once 
none could be detected visually, the column was washed with 10 column volumes of RO 
water and 10 column volumes of 20% Ethanol (vol/vol). It was then stored in this at 4oC. 
The eluted fractions were then kept on ice. The fractions containing the highest 
concentration of eluted protein we’re then pooled to a total volume of 2.5 ml. A PD-10 
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desalting column (GE healthcare, UK) was used to buffer exchange the protein into 100mM 
phosphate buffer (pH 7.5) and then the sample was concentrated in a vivaspin 20  (10 kDA 
cut off, GE healthcare, UK) for 15 minutes in a fixed angle centrifuge or until reduced to 
approximately 1ml. 10 µL aliquots of all fractions were analysed on an SDS-PAGE to confirm 
the presence of the target protein. The eluted protein concentration was determined at 
280nm using an extinction coefficient calculated from the ExPASy ProtParam algorithm.  
The elution was then separated into 100 µL aliquots and flash frozen in liquid nitrogen and 
finally stored at -80oC.   
2.4 Acinetobacter calcoaceticus NCIMB 9871 individual enzyme 
activity assay 
To identify enzyme activity, purified protein samples or whole cell lysates were diluted 1:10  
and assayed in 100mM Phosphate buffer (pH 7.5) and 0.5 mM of either NADH or NADPH 
co-factor in a 200 µL reaction. Each substrate was added to a final working concentration of 
0.5mM, 5mM, 50mM and 500mM in a 96 well plate. Note that not all enzyme reactions 
were done at all four of these concentrations. NADH or NADPH absorbance was measured 
at 340nm in a Tecan plate reader. Cyclohexanol, cyclohexanone and ε-caprolactone were 
purchased from Sigma-Aldrich (USA) whereas 6-hydroxyhexanoate was purchased from 
Alfa Aesar (USA). 
2.5 ω-Transaminase screening and cloning 
2.5.1 Enzyme generation; deep-well plate culture 
28 Ω-Transaminases were screened from a library of recombinant E.coli  BL21 (DE3) cells 
expressing TAm's. This library was generated by previous members of the Ward group and 
stored at -80oC for long term storage in glycerol stocks. Fresh glycerol stocks were made in 
a 96 deep-well plate format. This was done by inoculating 0.8 ml of LB broth (50 µg/ml 
Kanamycin) in each well of a new PlateOne® deep well plate (Sigma-aldrich, USA) directly 
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from the glycerol stock using a plastic loop and swabbing the ice. This plate was sealed with 
a microporous gas permeable Breathe-Easy® sealing membrane (Sigma-aldrich, USA) and 
grown at 37oC at 250rpm overnight. 0.4 ml of this was then added to 0.4 ml of 50% glycerol 
in the same pattern as from the original plate. This was then stored at -80oC. To generate 
reaction plates, a mimic of the glycerol stock plate layout was made by inoculating a new 
PlateOne® deep well plate (Sigma-aldrich, USA) containing 800µL of 2xTY medium (50µg/ml 
Kanamycin) per well. The cultures were grown at 37oC, 400 rpm, 85% humidity for 8 h and 
induced with 1mM IPTG for 16 h at 30oC before harvesting the cells by centrifugation 
(3000g, 15 min, 4oC). Supernatants were then discarded and the pellets stored at -20oC for 
up to 1 month or used immediately. 
2.5.2 6-oxohexanoate synthesis 
Two different methods of synthesising 6-oxohexanoate were used. In method 1, cell pellets 
from 1 ml of induced pChnC and pChnD  cultures were lysed using 1x BugBuster (From 10x 
concentrate; Merck, USA ) in 100mM phosphate buffer with 1 µL/ml Benzonase (Merck, 
USA). 100 µL of purified caprolactone hydrolase and 6-hydroxyhexanoate dehydrogenase 
was then added to an assay mix (denoted as assay mix A; 0.625 mM NAD, 1.11 mM 
pyridoxal 5'-phosphate, 111mM L-Alanine and 45mM ε-caprolactone) in a total volume of 
5.5 ml. The reaction was then followed to completion by analysing a 200 µL aliquot at 340 
nm on a plate reader (Tecan, UK). Assay mix A was then aliquoted into 180 µL per well into 
28 wells on a 96 well plate ready to be used in the ω-TAm reaction. Method 2 involved the 
acid hydrolysis of methyl-6-oxohexanoate and this was completed by Dr Damien Baud. 
80mg of methyl-6-oxohexanoate (Santa Cruz Biotechnology, Inc, Dallas, Tx, USA) was 
solubilised in 4 mL of H2O/MeOH followed by the addition of 400 mL of an aqueous 
solution of 10 M NaOH and stirred at room temperature under Argon for 24 hours. The 
reaction mixture was then acidified using 1M HCL to pH3 and then extracted with three 
volumes of 15ml dichloromethane. The organic layer was then dried over MgSO4 and 
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concentrated in a vacuum. The formation of 66mg of yellowish oil was confirmed as           
6-oxohexnaoate by NMR. Following this the sample was diluted in methanol to a 50mM 
stock solution and stored at -20oC until required. 
 
2.5.3 Screening reaction assay set-up 
 When using method 1 to synthesise 6-oxohexanoate, as mentioned above, 180 µL of assay 
mix A was pipetted into each of the 28 wells. When using the chemically synthesised 
version, 4 µL of the 50 mM stock was added to 176 µL of assay mix B (1.14 mM pyridoxal 
5’-phosphate, 114 mM L-Alanine; both purchased from Sigma-Aldrich, USA) in a 96 well 
plate. Note Assay Mix A and B differ only slightly by concentration since Assay mix A is used 
at 180 µL and assay mix B is used at 176 µL - both result in the same final concentration of 
1 mM and 100 mM of PLP and L-Alanine respectively. Assay mix B also required the 
addition of NAD since this wasn't required in the TAm reaction with chemically derived         
6-oxohexanoic acid. The frozen ω-TAm cell pellet plates were lysed using 50 µL per well of a 
1 x BugBuster (Merck, USA) solution in 100 mM phosphate buffer with benzonase  and 
lysed as in section 1.5.2. 20 µL of the TAm lysates was then added to each new reaction 
mix, sealed and shaken at 750 rpm at 37oC for 16 hours. In order to detect potential 
candidate TAm, when assay mix A was used, 195 µL of the 16 hour reaction was transferred 
to a new 96 well plate. When assay mix B was used, 185 µL was transferred and added to 
10 µL of 10 mM NADH in 100 mM phosphate buffer. In both cases 5 units of Lactate 
dehydrogenase (Sigma-Aldrich, St. Louis, Missouri, USA) was added to the new plate. The 
oxidation of NADH (produced from the pChnD reaction in the case of assay mix A) upon 
catalysis of pyruvate was followed at 340 nm on a plate reader (Tecan, UK). 
The ω-TAm screen for activity on cyclohexanone was done using a similar method. 160 µL 
of assay mix C (1.25 mM PLP, 125 mM L-Alanine in 100 mM phosphate buffer) was added 
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to 20 µL of 50 mM cyclohexanone (final 5 mM) and 20 µL of ω-TAm cell lysate and 
incubated at 37oC, 750 rpm for 16 hours. PLP and L-Alanine were again used at 1 mM and 
100 mM final concentrations respectively. 175 µL was transferred to a standard 96 well 
plate. 5 units of LDH and 20 µL of 5 mM NADH was added and read on a plate reader 
(Tecan, UK) immediately as above. 
The methyl-6-oxohexanoate (Santa Cruz Biotechnology, USA) screens were performed by 
firstly making small aliquotes of 50 mM methyl-6-oxohexanoate in 100 mM phosphate 
buffer.  4 µL of the 50 mM stock was added to 176 µL of assay mix B (1.14 mM pyridoxal 5’-
phosphate, 114 mM L-Alanine; both purchased from Sigma-Aldrich, USA) in a 96 well plate 
and 20 µL of each ω-TAm cell lysate was used in the 16 hour reaction. 185 µL was 
transferred to a new standard 96 well plate 10 µL of 10 mM NADH in 100 mM phosphate 
buffer and 5 units of LDH were added. The reaction was again immediately followed at        
340 nm. 
 
2.5.4 Cloning in the top three performing ω-Transaminases 
pQR810 (containing Pseudomonas putida PP_5182) and pQR983 (containing Deinococcus 
geothermalis Dgeo_2743) plasmids were miniprepped from 5 ml overnight cultures as 
described in 1.2.1. A plasmid list is located in the appendix. Both of these Transaminases 
were PCR amplified adding overlaps homologous to ChnD  and the pet29a vector were 
added at the 5’ and 3’ regions respectively. An RBS of AGGAG at position -7 was also added. 
BamHI was used as the 6 bp spacer after the RBS and NdeI restriction sites were added 
immediately after the TAm. See appendix for the list of primers used. The pQR1543 (4 
Acinetobacter calcoaceticus genes in an operon; natural RBS) and pQR1548 (4 
Acinetobacter calcoaceticus genes in an operon; artificial RBS)  plasmids were inverse PCR 
linearised (i.e. primers going backwards to linearise the plasmid) and RBS, restriction site 
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and ω-TAm overlaps were added at flanking ends. An extension time of 30 seconds per kb 
was used on the TAm genes whilst anything longer than 15 seconds per kb on the inverse 
PCR would fail. A CPEC reaction was used to assemble the completed pathways using an 
insert to vector ratio of 5:1 and 10 cycles in the thermocycler annealing at 55oC. The 
reaction mix was directly transformed and colonies were screened by digestion with 
BamHI-HF and NdeI (NEB, Ipswich, Massachusetts, USA) as previously described.  
Micrococcus Luteus' TAm gene MLUT_12025 was amplified from pQR1014 and 
incorporated the RBS as above. CPEC reactions were tried however all resulted in deletion 
of the existing genes in the operon. Standard restriction cloning was done on this gene and 
only into pQR1543. AvrII and BbcvI restriction sites were also added at its 5’ and 3’ regions 
respectfully due to the presence of the BamHI sequence in the gene. The same restriction 
sites were incorporated into pQR1543 when inverse PCR amplified. The RBS was instead 
added on to the inverse PCR of pQR1543 at the end of ChnD and the AvrII site after this. 
The PCR fragments were purified, ligated and transformed as described earlier. 
 
2.6 Assemblying pQR1559; cloning a second T7 promoter, ChnD 
gene and terminator into pQR1553 
Standard restriction cloning was used to add a second copy of ChnD under the control of its 
own T7 promoter, operator and terminator. The operator, T7 promoter and AvrII 
restriction site were added (plus 6 random bases to aid with digestion) to the 5'end of the 
natural RBS using the nested fragment generated earlier. The reverse primer at this stage 
included only the 3' end of the gene. The second stage added the terminator to the 3' end 
of the gene in a single reaction following this. This fragment was then purified and a SalI 
restriction site added to the 3' end of the terminator (again, with 6 random bases added to 
the 5' end). The pQR1553 plasmid was linearised by inverse PCR at a site between the LacI 
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and Rop genes and the AvrII site was added at the Rop side and SalI added at the LacI side. 
This was done using a 15 s/kb extension time as previously described. The two fragments 
were ligated and cloned as described above. Several miniprepped colonies were digested 
with AvrII and SalI-HF® (both from NEB, USA) for 1 hour and bands were observed on 
agarose gel to confirm the correct assembly. After transforming into E.coli BL21 (DE3), the 
protein profile was examined on SDS-PAGE to identify the presence of all protein bands as 
well as any possible differences seen with pQR1553. The clone was renamed pQR1559.  
  
2.7 Cell culture sample and standard preparation  
2.7.1 Sample preparations from cultures 
Single colonies of the completed pathway clones were inoculated into 5ml of LB 
supplemented with 50 µg/ml Kanamycin and grown for 16 hours. 50-100ml of fresh LB (or 
other media) containing 50 µg/ml Kanamycin was then inoculated to an O.D. of 0.1 in non-
baffled flasks, grown at 37oC shaking at 250 rpm and induced with 1mM IPTG at an O.D of 
0.6-0.7. After 2 hours cyclohexanol was fed as a bolus into the flasks which were then left 
for18  hours. A 1 ml sample was then taken, and sonicated on ice for 2 cycles at 10 µm 
amplitude for 25 seconds each cycle. The sample was split into two 500 µL aliquots. One 
was mixed in a 1:1 ratio with Ethyl Acetate, vortexed and mixed thoroughly and then 
centrifuged at max g for 10 minutes. The top organic layer was then taken and pipetted 
into a 300 µL chromacol glass vials with inserts and crimped shut (Thermo Fisher Scientific, 
Waltham, MA, USA). They were then ran on GC-MS immediately (see next section). In order 
to identify molecules after ε-caprolatone, the second 500 µL sonicated sample was then 
dried in one of two ways. Initially the samples were left to dry at 75oC, ependorf cap open 
overnight until a dried paste was left. However, results indicated this was suboptimal and 
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so subsequently smaller samples of 100 µL and concentrated to dryness under vacuum at 
room temperature using a Jouan RC 10-22, (Thermo Scientific, USA). 
The dried pastes were then derivatised with a molar excess (80 µL) BSTFA + 1% TMCS 
(Sigma-Aldrich, USA) and 120 µL Ethyl Acetate (Sigma-Aldrich, USA) and heated to 70oC 
shaking at 1000 rpm in a thermocycler for 1 hour. The paste was broken into fine particles 
using a sterile blunt ended instrument to maximise availability for derivatisation. The 
volume was topped up to 200 µL to replace that which had evaporated and then samples 
were then centrifuged at max g for 10 minutes. Supernatents were then transferred to 
chromacol glass vials with inserts and crimped shut (Thermo Fisher Scientific, USA) and 
analysed on GC-MS. The resultant concentrations were then multiplied by the dilution 
factor of 2. 
 
2.7.2 Standard preparations 
Initially standards of 2TMS derivatised 6-ACA were prepared by firstly derivatising 1ml at a 
concentration of 1g/L or 10g/L using 300 µL BSTFA  + 1% TMCS in with 700 µL. Derivitisation 
was complete when the white solid of 6-ACA dissolved. This was then subsequently diluted 
in ethyl acetate to make a range of appropriate final concentrations.  As indicated in the 
results section 5.2.2, there were two other peaks present which were the main molecules 
present in the standards. In order to circumvent this all standards were prepared as 
follows. A number of induced pQR1553 cells were inoculated into 100 mls LB broth in non-
baffled flasks and induced as previously described. They were not fed any cyclohexanol. 
They were grown for 24 hours to ensure completed fermentation growth. 6-ACA standard 
was weighed and added to each culture vessel i.e. one flask corresponding to one 
concentration of 6-ACA, a second to smaller concentration and so on. It was dissolved and 
shaken for 5 minutes and 1 ml samples were taken, sonicated and dried in the same 
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manner as if the culture produced it themselves. This method produced a linear and 
repeatable curve and the trace lacking the presence of either of the previously two 
identified molecules.  This method was also used for cyclohexylamine. The first method of 
bulk derivatising the standard was used for 6-hydroxyhexanoic acid and adipic acid due to 
the presence of only a single peak on the GC trace. All other standards were weighed and 
prepared to 1 g/L in 1 ml of ethyl acetate. Several standard concentrations were then 
prepared from the 1 g/L standard in ethyl acetate and transferred to chromacol glass vials 
with inserts and crimped shut (Thermo Fisher Scientific, USA) They were then analysed on 
GC-MS and a curve was made using the Chromeleon™ software. Cyclohexanol, 
cyclohexanone, cyclohexylamine and adipic acid were all sourced from Sigma-Aldrich, USA. 
6-hydroxyhexanoic acid and 6-ACA were sourced from Alfa Aesar, USA. 
 
2.8 Gas chromatography mass spectrometry  
A Thermo Fisher Scientific Trace 1300 GC coupled with an ISQ QD single quadrupole mass 
spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) was used to identify pathway 
intermediates. The column inlet was heated to 270oC, MS transfer line to 300oC and the ion 
source to 300oC also. These temperatures were chosen so as to completely vaporise the 
sample as well as maintain the phase so as to not condence in the machine. The column 
was pre-washed with 2 cycles of Ethyl acetate followed by 1 µL of sample was injected into 
the column using a split ratio of 1:5. This ratio was predetermined after trial and error to 
achieve the best peaks and detectability available. Total run time was 11.2 minutes 
consisting of 1 minute at 85oC followed by a 5oC/min ramp to 100oC then a 25oC/min ramp 
to 280oC resulting in a 11.2 minute run. This method was optimised using standards and 
cell culture samples. The MS detector was set to scan within a range of 10-300 amu. A 
Restek RXI-5 sil MS, 30 meter, 0.25 mm I.D and 0.5 mm O.D column was used and at times 
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both a 0.5 µm and a 0.25 µm film thickness was used (Restek, Sauderton, U.K.). An 
alternative column used was the Agilent HP-5ms Ultra inert, 0.25 mm I.D, 0.5 µm film 
thickness and a 30 m total length (Agilent technologies, USA). The column was conditioned 
when the baseline at the latter end of the run rose. This was done according to 
manufacturers' instructions. Retention times of the intermediates on a 0.5 µm thick film 
were as follows; Cyclohexanol (2.53 min), cylohexanone (2.63 min), ε-caprolactone               
(5.5 min), cyclohexylamine (6.5 min), 6-hydroxyhexanoic acid (7.73 min), 6-ACA (8.1 min) 
and Adipic acid (8.55 min). These times were slightly altered when a 0.25 µm column was 
used or when a different flow rate was chosen. In order to reduce burden and fouling of 
the ion source, detection times were often shortened to 9 minutes when all the pathway 
intermediates had been detected. This was to allow the higher molecular weight molecules 
to burn off and vent.               
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Chapter 3: Assembling the 
Acinetobacter calcoaceticus NCIMB 
9871 genes 
71 
 
3 Results 
3.1 Isolating the gene fragments and creating homologous flanking 
sequences 
Amplifying genes from genomic DNA is intrinsically more difficult than isolating from DNA 
libraries primarily because of the difference in size. Standard PCR primers are typically 18-
25nt in length and should theoretically only bind to the specific sequence. However if the 
primer has significant homology with other unknown stretches of DNA, some primers may 
anneal to these instead of the target sequence and therefore amplifying off-target 
products. Owing to the size difference, it is likely that this will occur more frequently in 
genomic templates. Therefore in cases where the gene of interest has flanking regions 
which have a more ideal GC content (and therefore are more likely to be more specific 
primers) than the gene itself, it may be more preferable to use a nested approach to 
increase the yield of target DNA. This is the case with Acinetobacter calcoaceticus NCIMB 
9871 genes of interest. There are short sections at both the 5’ and 3’ ends of the target 
genes in this pathway which have low GC contents, therefore a region outside of these 
genes was chosen leading to a target gene flanked by a a small portion of genomic, non 
coding DNA. In the first instance, two genomic DNA samples and one lambda phage clone 
(λ8.1; confirmed by Southern blotting previously by Prof. J. Ward to contain ChnB and so is 
likely to contain the pathway) were used in a PCR gradient amplification of ChnA. A DNA 
agarose gel confirmed the generation of a predicted 944bp fragment in both genomic 
samples but was absent in λ8.1 (Figure 3.1 1% agarose gel confirmation of an expected 
band at 944bp containing ChnA.).  
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As can be seen in Figure 3.1, although ChnA amplified in both genomic samples, it failed in 
λ8.1. The clone had been positively identified as encoding ChnB by Southern blotting 
previously and so to confirm this a PCR reaction was performed on λ8.1 and NCIMB9871(a). 
This was confirmed as a fragment of length 1752bp on a 1% agarose gel (Figure 3.2).  
 
 
 
 
Figure 3.1 1% agarose gel confirmation of an expected band at 
944bp containing ChnA. The gene can be identified in both genomic 
samples however it appears to be absent in the lambda clone. Above 
the wells is the annealing temperature for the gradiant PCR. 
Figure 3.2 1% agarose gel of PCR fragment containing ChnB 
from λ8.1 in lane 1 and NCIMB(a) in lane 2. The Marker lane 
is a 1kb NEB marker. Results show that the gene is present 
in both samples. Therefore the lambda clone is likely to be 
missing ChnA but does have ChnB which was the marker to 
confirm  previously clone of the cluster was successful. Each 
gene is several thousand basepairs away from each other in 
the cluster.  
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Given the incomplete pathway shown to be contained within λ8.1 all further PCR 
amplifications of the nested gene fragments were performed using NCIMB(a) genomic DNA 
(Figure 3.3).  
 
 
 
 
 
 
 
 
Since there was significant yields at all temperatures in the gradient, the PCR samples from 
the individual reactions were pooled together and 30 µL of each fragment was ran on a 
0.8% agarose gel and purified. The nested fragments were then used as templates to 
amplify the overlapping fragments with either their natural RBS (as identified by eye) or the 
RBS AGGAG at position -7 were amplified into the gene fragments to be used for assembly.  
The pET29a vector was also PCR amplified to contain overlaps for the 5’ end of ChnA and 3’ 
end of ChnD. Again, the fragment bands were excised from an agarose gel and purified 
ready for operon assembly. Significantly lower yields were obtained when purifying out the 
Figure 3.3 Nested fragment gradient PCR amplifications. Off target effects can  be seen 
at lower temperatures. a) ChnB (1752bp), b) ChnC (1040bp), c) ChnD (1137bp). 
Marker lane (M) is a 1kb ladder (NEB, USA). The temperature gradiant is displayed 
above each lane. All samples have amplified out successfully and with minimal off-
target products 
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pET29a vector owing to the difficulty in purifying larger fragments using column based 
separation. 
3.2 Operon assembly 
3.2.1 Gibson assembly as an operon construction tool 
Owing to varying reports of the success of Gibson assembly, the method was first tested to 
see how efficiently the reaction assembled the 4 genes in the proposed pathway. 
Equimolar amounts of each fragment were incubated following the manufacturer’s 
instructions at 50oC for 1 hour. The reaction mixture was visualised on a 1% Agarose gel 
(w/v).  
 
 
 
 
Figure 3.4 Gibson assembly post 1 hour 
incubation on 1% agarose gel (lane 1). 
The remaining 4 gene parts are 
highlighted and several smaller bands of 
larger size can be identified indicating a 
small degree of assembly. The marker 
used was a 2-log ladder (NEB, USA) 
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As can be seen in Figure 3.4, following the 1 hour incubation a significant amount of the 
genes have failed to incorporate into a single 4.4kb expected band and several faint bands 
of larger size can be seen. Note this is an assembly reaction and not an amplification so the 
DNA loaded is a very small amount. However, this indicates that the efficiency of Gibson 
assembly at assembling multiple fragments may be lacking. Given that two fragment 
assemblies have been reportedly more efficient, ChnA and ChnB were assembled in one 
reaction and ChnC and ChnD were assembled in a second, with the idea of then assembling 
the two larger fragments together in a two-step reaction. However, whilst ChnC and ChnD 
assembled with approximately 100% efficiency to create a ~ 2kb fragment, ChnA and ChnB 
completely failed to join (Figure 3.5).  This image is poor quality however the reason for this 
that the image is overexpossed so as to make visible the picomoles of DNA present. 
 
 
 
 
Figure 3.5 Paired fragment assembly. A total of 0.5pmol of 
fragments were assembled in each reaction as stated by the 
manufacturers for a two part assembly. Lane 1 shows the lack 
of assembly between ChnA and ChnB whilst lane 2 shows the 
completed assembly between ChnC and ChnD. Marker (lane M) 
is a 2 log ladder, NEB 
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In order to possibly increase the success of the 4 fragment assembly, an increase in the 
amount of time for the 50oC incubation step was compared to an increase in the amount 
incubation time plus increase in the amount of enzyme mix. In both cases the time was 
doubled to 2 hours and in the increased enzyme case, the volume of water used in previous 
reactions to bring the reaction volume to 20 µL was replaced with Gibson assembly master 
mix.  
 
 
 
 
 
Results of this experiment suggested that most likely an increase in the amount of enzyme, 
above what was recommended is needed as it greatly increased the efficiency of fragment 
assembly (See www.NEB.com for the gibson assembly protocol). As can be seen in Figure 
3.6, as well as two or more fragment bands being present at around 4.5kb can be observed. 
However, less of the faint bands were seen in the 2 hour incubation compared to the 1 
hour incubation suggesting significant experiment variation in efficiency.  
Figure 3.6 Excess time is compared to excess enzyme  in order to increase the proportion of each 
fragment that are assembled into an expexted 4.5kb stretch of DNA. It can be seen that with 
extended tiem and excess enzyme, there is less remaining DNA fragments compared to only 
excess time. There is also a band at 4.5kb which could be the expected assembly. Therefore, after 
following the protocol from the manufacturer, in order to optimise assembly, excess enzyme is 
required.  
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With the observed inefficiencies in assembling 4 small fragments, the prospect of adding a 
5th, much larger fragment (NdeI and NotI double digested pET29(a) plasmid) of 5.23kb, to 
the reaction looked likely to be unsuccessful. With this in mind, a double digestion of the 4 
fragment assembly was performed and ligated with the vector and subsequently 
transformed.  The number of colonies that arose was excessively large indicating perhaps 
incomplete digestion of plasmid and transformation of circularised pET29(a) vector. One 
colonies plasmid was isolated and then digested singularly and double digests according to 
manufacturer’s instructions to identify the 4.4kb operon from a total construct of 9.63kb. 
Figure 3.7 shows an undigested, NotI, NdeI and double digests and the agarose gel 
confirmed the absence of the two bands (4.4kb operon and 5.23kb vector).  What can also 
be seen is there is a prominent band at just below 4kb, a faint band at just above 5kb and 
one above 10kb. This suggests a partial DNA digestion was loaded and that three forms of 
DNA can be seen. The total length of pET29(a) plasmid is 5.371kb and therefore the band 
lower than 4kb is possibly supercoiled DNA, the faintest band above 5kb is linearised (fully 
digested DNA) whilst the largest faint band is possibly nicked/relaxed circular. Therefore 
not only is there no operon but also the digestions haven’t worked and are likely to require 
a longer digestion time e.g. 1+ hours. Since neither NdeI or NotI have star activity, an 
overnight digestion is possible.  
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Results indicate that Gibson assembly is an inefficient method of assembling this multi-
fragment gene segment however to comment further would require a 5 fragment Gibson 
reaction and transformation and subsequent complete digestion of the minipreps.  Future 
digestions with NdeI or NotI will also require a longer incubation period. 
 
3.2.2 CPEC as an operon construction tool 
Circular polymerase extension cloning (CPEC) is a novel method of DNA assembly requiring 
no exonucleases or ligases and therefore reactions can be performed with higher DNA 
concentrations in a thermocycler compared to proprietary kits. Since the fragments which 
were generated for Gibson assembly contained the desired overlaps, the same fragments 
were used in a CPEC reaction to assess if they would anneal as described by Quan and Tian 
(Quan and Tian, 2009). Initially only the 4 gene fragments were used in equimolar amounts 
Figure 3.7 A gel of undigestd (lane 1), NotI (lane 2), NdeI (lane 
3) and NotI and NdeI digested (lane 4) of a plasmid miniprep 
from a colony from the Gibson assembly transformed cells. 
Three forms of DNA can be seen and no operon insert. Results 
suggest this length of time of digestion is insufficient as 
directed by the manufacturer (NEB, USA). 
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and visualised on an agarose gel. A single prominent band was observed with a small smear 
which could possibly indicate linear fragments of different sizes. However a much larger 
conversion into the 4.4kb fragment can be observed compared to Gibson assembly of the 
same fragments (Figure 3.8). 
 
 
 
 
 
This showed the potential for CPEC to be a plausible method of operon construction. The 
pET29a vector was amplified with a high fidelity polymerase to contain a 5’ homologous 
sequence for ChnA and a 3’ homologous sequence to ChnD. The sizes and properties of the 
homologous regions between the fragments are summarised in Table 3.1.  
 
 
 
Figure 3.8 CPEC reaction of the 4 gene fragments used to create 
operon A showing a single prominent band at ~4.4kb from . Minor 
smearing can be observed however these are thought to be linear 
fragments. A much larger yield of joined fragment is seen compared 
to Gibson assembly. The marker lane (M) is a 1kb ladder (NEB,USA),  
5µL of the CPEC reaction was loaded onto a gel (lane 1) and a single 
band can be seen between 4 and 5 kb. Smearing either side could 
indicate varying length DNA.  
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Section Length of homology (bp) Tm (oC) 
Vector-ChnA 49 60 
ChnA-ChnB 43 65 
ChnB-ChnC 44 65.5 
ChnC-ChnD 55 69.8 
ChnD-Vector 49 73.8 
Table 3.1. Summary of the homologous overlaps between the fragments and the Tm of the stretch 
of DNA 
 
A second CPEC cycle was then performed using all five fragments (including amplified 
pET29a vector incorporating homologous sequences) and in both operon A and operon B a 
small sample was visualised on a 0.8% agarose gel as well as directly transformed. An 
agarose gel of the 5 fragment CPEC reaction showed an unusual circular DNA band which 
failed to move past the well (Figure 3.9). This could be possible concatenation and can be 
seen in the high cycle number CPEC reactions (30 cycles) shown in figure 2 of Bryksin and 
Matsumura (Bryksin and Matsumura, 2010). Despite this, the transformation yielded many 
colonies. Several colonies were then chosen for overnight growth and miniprepped for 
restriction digestion in order to ascertain which colonies contained the operon in the 
correct alignment. 
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Figure 3.9 0.8% agarose gel of the 5 fragment CPEC reaction for 
operon B shows a thick band which moved little from the well. 
Several reasons for this include an entanglement of DNA when 
assembling, contatenation of the DNA orprotein impurities binding 
the DNA. Interestingly this effect is only seen when the product 
formed is circular. It is not seen when the product is linear (lane 1). 
Marker (lane M) is a 1kb ladder (NEB, USA).  
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Figure 3.10 Operon A (native RBS) (Top - A)): an agarose gel of 7 
miniprepped colonies digested singularly with NdeI (first lane of 
each sample) and a second with NdeI and NotI (second lane of each 
sample). Bottom (B)): miniprepped plasmids 1- 4 from above 
comparing 1 hour NdeI and NotI (left lane of each sample) to 16 
hours (right lane of each sample).  Expected bands with the double 
digestion is 4.4kb operon and 5.2kb backbone. It can be seen a 16 
hour digestion greatly improved digestions. Colony 1 failed to 
digest  but contains two fragments ( right lane of A) sample 1). 4/7 
colonies therefore exhibited the correct digestion. Lane M denotes 
the marker lane using a 1 kb ladder (NEB,USA).  
Figure 3.11 8 colonies from the operon B assembly (lanes 1-8) were 
miniprepped and double digested with NdeI and NotI for 16 hours. Highlighted 
are the 4kb and 6kb DNA ladder bands in the marker (M) lane. The two 
digested bands fit between these as expected. Only colony 7 failed to digest as 
expected.  
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Out of the 7 colony DNA samples of operon A digested, 4 digested in the correct manner 
whereas operon B, 7 out of the 8 digested as expected with NotI and NdeI. The plasmid size 
is 9.632kb and when double digested produce two bands of 4.4kb and 5.2kb, i.e. the 
operon and backbone respectively. Given that each gene is of similar size, digestion of the 
colonies with only the enzymes at the beginning and at the end does not mean that there is 
only one copy of each or that they’re in the correct orientation. Theoretically the fragments 
should anneal to the specific partners however even with proprietary kits like Gibson 
assembly, misalIgnments and incorrect assemblies occur (figure 4 on: 
https://www.neb.com/products/e5520-nebuilder-hifi-dna-assembly-cloning-kit). Therefore 
each gene has to be digested with a specific enzyme which will identify any errors in 
assembly. PstI cuts once only through ChnA and so by digesting this with NotI, two bands 
can be identified of sizes 4151bp and 5481bp (Figure 3.12). If only one band appears then 
ChnA is absent. HindIII cuts nowhere on the pET29a plasmid and only through ChnB and 
ChnD, therefore if two bands are shown, one at 2451bp and another at 7181bp then both 
genes are present in the correct orientation (Figure 3.13). AccI cuts once through pET29a 
and once through ChnC therefore fragments of 5857bp and 3775bp would be expected 
(Figure 3.12).  
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N.b. Note that the only difference between the two clones is the RBS and so it is not possible 
to tell by looking at gel images which operon is which since there is only a few bases 
difference between the two. 
Figure 3.12  Left; a schematic of the restriction map digestions. Right top gel; three colonies from 
operon A digested with AccI in the first lane of each sample and PstI+ NotI  in the second lane of 
each sample. Right bottom gel; 8 colony minipreps from operon B assembly are digested with PstI 
+NotI in the first 8 and AccI in the second 8 samples. All three colonies in Operon A digested as 
expected whilst, although 7/8  contained ChnA,  3/8 showed irregularities in  ChnC  in the case of 
the operon B digests.  
 
Figure 3.13 Top; operon A, 4 colonies each with a linearised vector in the left lane (digest with NotI) 
and a HindIII digestion in the right of each. Only colony 1 of operon A looks to have some partitally 
digested plasmid with a single cut from HindIII.  Bottom; HindIII digest of all 8 plasmid DNA's from 
the 8 colonies picked. Clone 3, 5 and 7 digested in the same incorrect manner. 
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Taken together it is likely that 4/7 clones of operon A construction were assembled in the 
correct formation however only 3 of the DNA samples can be confirmed due to errors 
when preparing the experiments meant samples ran out.  However in the case of operon B 
only 4/8 digested as expected.  
 
3.2.3 Operon expression and sequencing 
Once the plasmids with the correct assembly were identified, they were transformed into 
the pET29a expression strain of E.coli (BL21(DE3)). Overnight cultures were miniprepped 
and a sample stored as a glycerol stock. A plasmid sample of pQR1548 (operon B) and 
pQR1543 (operon A) was sent for sequencing of the beginning and ending operon regions 
using T7 primers. Sequencing confirmed ChnA and ChnD had correctly assembled as 
predicted. An example of the sequence readout is  shown below (Figure 3.14). The 
incorporation of the NdeI site at the expected place as well as the RBS sequence was 
confirmed. The forward read out was 349bp and the reverse was 1028bp long and was also 
correct confirming zero mutations.  
 
ACTTTAAGAAGGAGATATACATATGAGGAGAAAATTATGTCAAATAAATTCAA 
Figure 3.14 Segment of the sequence of Operon B revealed correct assembly as predicted. Blue: pET29a, 
Green: NdeI site, yellow: ChnA RBS and coding region. This is an example of the sequencing read out  and 
note that the ends of the fragment on both operaon versions were confirmed as correct.  
 
Overnight cultures of each clone were then used to inoculate a shake flask and were 
induced with IPTG at OD600 of 0.6-0.7 (see materials and methods; 2.3.1). A non-induced 
flask inoculated with the same overnight growth was used as control. Samples were taken 
periodically and a cell pellet collected for SDS-PAGE verification of soluble protein 
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expression. The SDS-PAGE (Figure 3.15) confirmed the presence of 4 separate and over-
expressed protein bands at the expected molecular weights (ChnA = 25.7kDa, ChnB = 
60.9kDa, ChnC = 33.2 kDa, ChnD = 37.2kDa). Although a negative control was not included 
for operon B, expression of 4 clear and distinct protein bands with the same patterning as 
the operon A can be seen. Interestingly ChnB expression cannot be seen at 23 hours. 
According to ExPASy ProtParam, ChnB has the lowest instability index and should therefore 
be the most stable however this has previously been noted by Chen et al (Chen, Peoples 
and Walsh, 1988). In accordance with their work, the protein bands looked most intense at 
4 hours and were less so at 23 hours.  
 
 
 
 
 
 
 
Figure 3.15 SDS-PAGE of pQR1543 and pQR1548 (operon A (a) and B (b)) confirms the expression of the 
clone genes. ChnB is no longer present at 23 hours (circled) suggesting it is vulnerable to proteolytic 
cleavage and removal. Both operons are confirmed to have been constructed as expected by partial 
sequencing and express all 4 proteins intracellularly. By eye, it could be suggested that operon B expressed 
slightly more than operon A of chnA, C and D however possibly slightly less chnB. 
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Chapter 4: Individual enzyme 
cloning, expression and purification  
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4 Results 
4.1 Cloning 
In order to test if the enzymes the cells are expressing are in fact active, each enzyme has 
been cloned individually and modified by removal of the stop codon to incorporate a His-
tag for nickel affinity purification. The reason for this is that detecting activity using singly 
expressed enzyme is easier than if all were combined and metabolic analysis was done e.g. 
by GC-MS. In the first instance ChnA was cloned into pET29a using standard restriction 
cloning techniques. Figure 4.1 shows the PCR amplification of ChnA, ChnB, ChnC and ChnD 
encoding NotI and NdeI flanking restriction sites.   
The stop codon was removed to use the pET29a encoded His-tag. This was then digested 
along with the pET29a vector, ligated to each other and subsequently transformed into 10β 
cells. An overnight culture of a colony was then miniprepped and the plasmid subsequently 
double-digested with NotI and NdeI to confirm the incorporation of the Acinetobacter 
genes into the pET29a vector (Figure 4.2).  
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Figure 4.1 Agarose gel to show PCR amplifications of ChnA-D incorporating individual restriction sites for 
restriction cloning. Lane 1 is chnA (744bp), Lane 2 shows chnB(1632bp), lane 3 shows ChnC (903bp) and 
lane 4 shows ChnD (1059bp) were all successfully amplified. Only ChnB showed significant off target 
effects.  The marker lane is a 1kb ladder (NEB, USA) 
4 
 
3 
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Figure 4.2 Colony plasmid minipreps double digestion with NdeI and NotI confirms the insertion of 
ChnA-D into the pET29a vector. A) shows the correct digestion of chnA (Backbone in all is 5.2kb), 
chnA is 744bp) whilst B) shows the correct digestion of chnB-D(lane B, C and D; B is1632bp, C is 903 
bp and D is 1059bp)). The ladder (lane M) is a 1 kb ladder (NEB,USA). 
 
A) 
B) 
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4.2 Expression 
The miniprep DNA was then transformed into the BL21 (DE3) E.coli expression strain and 
glycerol stocks of this were also made and renamed pchnX where X is the gene letter. A 
shake flask culture of the plasmid carrying clones was then performed and induced/non-
induced (control) samples were taken. SDS-PAGE analysis confirmed an over-expressed 
band at the expected molecular weight of 25.7 kDa (pchnA) (Figure 4.3)  60.9 kDa (pchnB), 
33.17 kDa (pchnC) and 37.19 (pchnD) (Figure 4.4) . This clone uses the RBS encoded on the 
pET29a plasmid which is presumed to be a more optimal RBS as well as the fact the cell is 
only over-expressing one protein compared to four and why there is significantly less of 
each protein expressed in either operon.  
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Figure 4.4 An SDS-PAGE confirms the expression of the cloned pchnA-D plasmids in E.coli BL21 
(DE3). Lane marked ChnB shows cyclohexanone monoxygenase circled. Expression of this CHMO 
appears to be substantially less than the other enzymes. 
 
 
80 kDa 
40 kDa 
30 kDa 
Figure 4.3 SDS PAGE varification of pChnA expression of cyclohexanol dehydrogenase in BL21 
(DE3) cells. A prominent band can be seen at 25 kDa which intensifies with time 
60 kDa 
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4.3 Purification 
Nickel affinity chromatography was then used to purify the individually expressed His-
tagged proteins. Firstly not all of the protein was found to have been bound during column 
loading because as can be seen in Figure 4.5, Figure 4.6, Figure 4.7 and Figure 4.8 the flow 
through fractions contain a relatively large amount of protein. Secondly wash 1 removes a 
large proportion of host cell proteins but also some weakly bound his-tagged protein 
however by wash 6 most of it has been removed. After purification the different elution 
fractions were pooled and concentrated using a Vivaspin 20 concentrator followed by 
buffer exchange into 100mM phosphate buffer pH 7.5. To determine protein 
concentration, a 1 µL sample was analysed on a Nanopdrop at 280nm using an extinction 
coefficient which was calculated using the ExPASy ProtParam online programme. The 
concentrations are shown in Table 4.1 Although this is not a particularly high 
concentration, a relatively large amount of protein is lost in the buffer exchange and in the 
flow through. However, the concentration is sufficient for use in assays to identify activity. 
In addition it is unlikely that any residual co-eluted protein would have any influence in 
reactions and so it is considered to be sufficiently pure for activity assays. 
Cyclohexanol dehydrogenase 0.385 mg/ml 
Cyclohexanone monoxygenase 77 µg/ml 
Caprolactone hydrolase 0.147 mg/ml 
6-hydroxyhexanoate dehydrogenase 0.086 mg/ml 
Table 4.1 Table of the final concentrations of each purified enzyme stored in 100 mM phosphate 
buffer at pH 7.5. Extinction coefficients were calculated from the ExPASy ProtParam programme. 
Aliquots were then flash frozen in liquid nitrogen and stored at -80oC.  
 
 
94 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 SDS PAGE of the course of the protein purification. L (cell lysate), FT 
(flow through), W1/6(wash 1/6), E1-5(elution 1-5). Bottom arrow shows a 
prominent band at aproximately 25kDa corresponding to cylohexanol 
dehydrogenase and a second, fainter band at around 45kDa also co-eluted. 
Figure 4.6 an SDS-PAGE of the course of the purification of cyclohexanone dehydrogenase. Note 
the identical co-eluted band at 45 kDa similar to other protein purifications. Elution looks to be 
steady throughout the 5 elution steps. CL (cell lysate). FT (flow through), W1 (wash step 1), W10 
(wash step 10), E1-3 (Eluted fractions 1-3). 
 
25kDa 
50kDa 
40kDa 
80kDa 
50kDa 
40kDa 
60kDa 
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Figure 4.7 An SDS-PAGE of the course of purification of the lactonase. Significant protein 
loss can be seen in the flow through and the first column volume wash. Very little 
lactonase remains in th eluted fraction (indicated by the blue arrow). CL (cell lysate). FT 
(flow through), W1 (wash step 1), W10 (wash step 10), E1-3 (Eluted fractions 1-3). 
 
Figure 4.8 An SDS PAGE showing the purification of 6-hydroxyhexanoate dehydrogenase. Similar to the 
lactonase in Figure 4.7, very little protein remains in the eluted fractions. CL (cell lysate). FT (flow through), 
W1 (wash step 1), W10 (wash step 10), E1-3 (Eluted fractions 1-3). 
30kDa 
20kDa 
30kDa 
40kDa 
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4.4 Assaying for activity 
Activity of enzymes was indicated by following absorbance changes of the required co-
factors at 340nm. The co-factors being either the oxidation of NADH or the reduction of 
NAD(P). The aim of these absorbance assays is not to determine the absolute activity since 
the behaviour is likely to be markedly different in vivo and would provide little useful 
information, rather, if there is any activity at all it would likely indicate a functioning 
enzyme. Lack of functionality would have subsequently led to searching for alternative 
enzymes or directed evolutionary approaches with aims to increase to notIceable levels.  A 
serial dilution of substrate concentrations were used with a final molarity of 50mM, 5mM 
and 0.5mM in all Acinetobacter enzyme assays. Since these experiments were purely 
speculative, a wide range of substrate concentrations were used. A final concentration of 
0.5mM co-factor was used and the reactions were followed immediately for approximately 
20 minutes or until the curves plateaued. 20µL of cell lysate or purified protein was used 
and an empty pET29a transformed E.coli BL21 (DE3) cell lysate or zero enzyme wells were 
used as a control.  
 
4.4.1 Cyclohexanol dehydrogenase 
Cyclohexanol dehydrogenase, encoded on gene ChnA (EC1.1.1.245), is an ezyme with low 
substrate specificity and also possibly thought to catalyse the reverse direction from a 
cyclic-ketone to cyclic-alcohols. Although very little work has been reported on this 
enzyme, indications suggest it is also capable of oxidising alicyclic diols and conversely 
reducing alicyclic diketones. Reaction rates have been reported to be between 0.8 µmol 
cyclohexanol · min-1 · mg-1 protein at pH7 up to 2.5 µmol · min-1 · mg-1 protein at pH10 with 
increased reverse reaction rates with a more acidic pH environment (Dangel et al., 1989). 
Results using both purified protein and cell lysate suggest is possesses a high substrate 
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tolerace and a good activity. It appeared that it is able to maintain an excellent reaction 
rate at cyclohexanol concentrations as high as 50 mM. Higher concentrations were not 
tested however no substrate inhibition can be identified. Lower substrate concentrations 
reduced the reaction rate however this was not quantified (Figure 4.9; graph produced 
using cell lysates as an enzyme source) 
 
 
 
 
 
Figure 4.9 The absorbance reaction at several concentrations of cyclohexanol using protein from a 
cell lysate (see section 2.4). 20µL of cell lysate was used in a 200 µL reaction in 100 mM phosphate 
buffer (pH 7.5). 0.5 mM NAD+ was added, the reaction was followed at a wavelength of 340 nm. Note 
that this experiment was not aiming to quantify the activity but merely look to see if any is present 
and how it compares are different substrate concentrations. Therefore no kinetic parameters are 
reported. A schematic of the reaction is above the graph. 
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4.4.2 Cyclohexanone monoxygenase  
Cylohexanone monoxygenase (hereafter referred to as CHMO, EC 1.14.13.22) is a member 
of the Baeyer-Villieger monooxygenase family belonging to the larger super family of FAD 
bound flavoenzymes. This group of enzymes have been extensively studied with CHMO 
being amongst the most well studied. Much hype around this enzyme was generated due 
to it characteristically being able to produce lactones and esters from cyclic ketones and 
aromatic aldehydes producing water as the only by-product. A broad substrate specificity 
and excellent enantiomeric excess values are ideal for use in large scale chemical 
manufacture such as the production of new pharmaceuticals (Sheng, Ballou and Massey, 
2001). The mechanism of action of CHMO is as follows; the non-covalently bound FAD 
molecule is reduced by NADPH and then reacts with molecular oxygen to form a C4A-
paraoxyflavin intermediate. This intermediate then acts as a nucleophile and attacks the 
carbonyl carbon of the ketone forming a Criegee intermediate which then cleaves giving a 
lactone and a hydroxyflavin product. Water is then released and the hydroxyflavin is 
oxidised back to FAD. NADP+ then leaves the complex (Mirza et al., 2009). 
 
4.10 The mechansim for the CHMO to convert cyclohexanone into a lactone using enzyme bound 
FAD. The figure is copied directly from Mirza et al., 2009 
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After cloning into pET29a and fusing with an N-terminal His-Tag, expression levels were 
relatively low. Purification yielded 77 µg/ml in 1 ml of 100mM phosphate buffer pH 7.5. 
Protein concentration was determined by Nanodrop and the extinction coefficient was 
determined using the online tool expasy ProtParam using the molecular weight of 60.9 kDa.  
The concentration of the purified CHMO was low however it was only weakly expressed. 
Figure 4.11 Top is a schematic of the reaction. Bottom, the absorbance reaction of the CHMO using different 
concentrations of cyclohexanone. Substrate inhibition is shown in agreement with the literature. See 
material and methods for details on the absorbance reaction (2.4). In brief, 20 µL of cell lysate was added to a 
total reaction volume of 200 µL in 100 mM phosphate buffer (pH 7.5) with 0.5 mM NADPH and the 
absorbance was measured and followed at  340nm. As with all individual enzyme reactions, no reaction rate 
was calculated. Instead any indications of the enzyme behaviour including response to different substrate 
concentrations and any inhibitions was investigated. A schematic of the reaction is above the graph. 
100 
 
Although BVMO has been shown to have very broad substrate specificity, inhibitory 
concentration of the substrate as well as product inhibition has been well documented. 
Cyclohexanone has been reported to inhibit reaction rates at a concentration of between 
0.2-0.4 g/L whilst caprolactone inhibits at much higher concentrations in the range of           
4.5-5 g/L leading to activity reducing to zero (Alphand et al., 2003). Assay results, although 
crude, appear in agreement with these reported values. At substrate concentrations of 0.5 
and 5mM (0.49 g/L and 4.9 g/L respectively) the activity curve is largely the same. However 
at higher concentrations such as 50 mM and 500 mM (49 g/L and 490 g/L) the activity of 
the CHMO significantly reduces however does not disappear or diminish to a large degree 
despite such high substrate concentrations being used (Figure 4.11).  
 
4.4.3 ɛ-caprolactone hydrolase (6-hexanolactone hydrolase) and                                    
6-hydroxyhexanoate dehydrogenase activity 
 ɛ-caprolactone hydrolase (a.k.a 6-hexanolactone hydrolase, EC 3.1.1 - ) is the 3rd enzyme in 
the pathway and is responsible for the ring fission of the lactone into a hydroxyl acid by 
hydrolysis (Bennett et al., 1988). Previous investigations into this enzyme have indicated it 
has high turnover numbers and is able to function over a broad range of pH values (Bennett 
et al., 1988). Smaller chained hydroxy acids are known to spontaneously reconvert back 
into their respective lactone however it is more typical with shorter carbon chains and is 
not known to happen with 6-hydroxyhexanoate. Although other lactonases have shown 
rather broad substrate specificities, ɛ-caprolactone hydrolase was found to be very specific 
in that it has shown only minimal activity on several lactones other than ɛ-caprolactone and 
very high turnover on this alone. Since this reaction has no requirement for co-factors, 
absorbance assay’s would be difficult and further investigation would likely involve GC or 
GC-MS and detection of 6-hydrohexanoate. However at this stage that would require 
101 
 
significant method development and so a simpler solution was to couple ɛ-caprolactone 
hydrolase with 6-hydroxyhexanoate dehydrogenase where only caprolactone and NAD+ are 
provided and following the reaction based on the appearance of NADH thus confirming 
both enzymes are active. Very little work has been done on 6-hydroxyhexanoate 
dehydrogenase but it was noted by Donoghue et al that aside from it being labile in storage 
it exhibited slow enzyme kinetics (Donoghue and Trudgill, 1975). Both enzymes were again 
cloned into pET29a and His-tagged. Although both appeared to be highly expressed they 
purified out at low concentrations; ɛ-caprolactone hydrolase was at 207 µg/ml and 6-
hydroxyhexanoate dehydrogenase was at 952 µg/ml. Again both co-eluted with a host cell 
protein. Never the less 20 µL of each enzyme was used in the reaction with the same range 
of substrate concentration.  Results suggested a very high tolerance to substrate 
concentration with excellent activity seen even at 500mM caprolactone and a significant 
drop in activity at 50mM (Figure 4.12). No observable reaction was observed at 5mM and 
0.5mM caprolactone. The cell lysate of BL21 (DE3) carrying empty pET29a showed no 
activity on ɛ-caprolactone therefore the activities observed are from the expressed 
enzymes.  
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To possibly identify if the kinetics of 6-hydroxyhexanoate dehydrogenase produce a similar 
response, cell lysate from pQR1552 cells expressing this enzyme was assayed in an identical 
fashion. E.coli BL21 lysates were used as a cotrol in order to see if the host cell is able to 
utilise the hydroxy-acid.  Results in Figure 4.13 suggest that the BL21 host cell enzymes cells 
do indeed possess some background activity on 6-hydroxyhexanoate. This is to be expected 
due to the very reactive nature of the aldehyde produced. It is also indicated that                 
6-hydroxyhexanoate dehydrogenase may have low activity. Although Figure 4.13 shows 
Figure 4.12 Top is the schematic of the coupled reaction. Bottom is the absorbance 
assay of purified caprolactone hydrolase and 6-hydroxyhexanoate dehydrogenase on 
caprolactone in the presence of 0.5 mM NAD+ in 100 mM phosphate buffer at pH 7.5. 
The graph shows a large substrate tolerance and activity remains good at high substate 
concentrations. 50 mM caprolactone rapidly plateu's after a slight rise in acitivty. A 
schematic of the reaction is above the graph. Because the activity of the lactonase is 
difficult to detect by itself the reaction was coupled with 6-hydroxyhexanoate 
dehydrogenase. The lactone was supplied as the only substrate whilst any absorbance 
change is as a result of the product from the lactonase, 6-hydroxyhexanoate, being 
converted to 6-oxohexanoate and the conversion of NAD+ to NADH. There was no 
direct activity measured. Whether the enzyme was functional and how it behaved 
under different substrate concentrations was investigated. Therefore no figures for 
specific activity are given. 
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only 500 mM 6-hydroxyhexanoate, it did produce the largest absorbance change when 
compared to other lower substrate concentrations (e.g. 50 mM). Both the control and 
enzyme performed poorly at 50 mM. This suggests the activity is overall a poor functioning 
enzyme and could indicate a potential bottleneck in the pathway. How it behaves In vivo 
could be markedly different however since the optimum conditions haven't been explored. 
Instead, it can be said however that it does definitely possess some activity for the 
substrate compared to the control.   
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Figure 4.13 6-HDH vs a pET29a cell lystate on 500mM and 50 mM 6-hydroxyhexanoate. 
At both substrate concentrations it can be seen that the 6-HDH enzyme performs 
marginally better than the E.coli BL29 (DE3) control however there does appear to be 
some background activity. The reaction schematic is seen as teh second half of the 
reaction in Figure 4.12. Any absorbance change was due to the formation of NADH and 
was detected via spectrophotometry. Activity wasn't measured, only an indication of 
activity was investigated i.e. is teh enzyme active and what are the crude substrate 
tolerances.  
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Chapter 5: ω-TAm cloning and 
screening 
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5 Results 
5.1 Introduction 
Following on from the successful operon cloning and activity indications the next phase of 
the project was to identify an appropriate Transaminase. Transaminases (aka 
Aminotransferase – E.C. 2.6.1 -) are of significant interest to industry because of their 
ability to produce optically pure chiral amines which are often used in the production of 
pharmaceuticals. Traditionally they have been produced using metals as well as having 
several reaction steps. Enzymatic routes however circumvent these issues. TAms are 
involved with the metabolism and generation of the 20 proteogenic amino acids and work 
by catalysing the reversible transfer of an amine group from an amino acid to a ketone or 
aldehyde (Wu et al., 2017). The mechanism of action involves a redox reaction where by 
oxidative deamination of the donor is in conjunction with the reductive amination of the 
acceptor. PLP (pyridoxal 5’ phosphate) is used as a prosthetic group; the biologically active 
form of vitamin-B6 and is regenerated after each reaction. The enzyme catalysis works by a 
ping-pong bi-bi mechanism and can be divided into two halves (Wu et al., 2017). Firstly the 
lysine at the active site of the TAm forms a Schiff base with PLP forming an internal 
aldimine. After contact with the amine donor the bond between the cofactor and the 
enzyme breaks and the PLP forms a new Schiff base with the amine donor. Following a 
proton abstraction step, the amine group from the donor is transferred by hydrolysis to the 
PLP forming enzyme bound PMP (pyridoxamine 5’-phosphate) and a corresponding ketone. 
The second half of the reaction now proceeds in the opposite direction starting with the 
acceptor ketone/aldehyde being transferred the amine group from the PMP forming an 
amine product and regenerating PLP in the process (Sayer et al., 2014).   
 
106 
 
 
Figure 5.1 Schematic of the transaminase reaction. Image copied from Sayar et al., 2014.  
 
TAms are part of a family of PLP-dependent enzymes which are divided into groups 
depending on their fold configuration. TAms belong to family fold groups I-IV. Further 
investigations into sequence alignments led to the development of 6 sub-classes. Classes I, 
II, III and V are all the same fold type where I and II are aspartate and aromatic TAm’s, III 
are ω-TAms and V are phosphoserine TAms. Another, broader classification system exists 
based on the position of the amine group on the carbon chain; α-TAms being able to react 
with amino groups on the α-carbon whilst ω-TAms act on distal amino groups. All TAms 
acting on β-amino acids are considered to be ω-TAms (Rudat, Brucher and Syldatk, 2012).  
TAms enzymes typically have several limitations for their immediate applicability in an 
industrial setting. Firstly the reaction equilibrium tends to either favour the reverse 
direction (i.e. substrate direction) and so product yield can sometimes be low or 
equilibirum can be split in a ratio of 50:50 product to substrate.  It is theoretically possible 
to push the reaction through by excessively loading the amine donor in the reaction to 
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push product formation, however, this can be limited by initial reaction rates. The second 
problem with TAms is that they can possess both substrate and product inhibition. There 
are several solutions to these problems including co-product removal using bi-phasic 
systems where an organic solvent is used to remove the product (Heintz et al., 2017) or in 
the case of isopropanol as a donor with the co-product being acetone, an evaporation step 
could be included. Protein engineering can also be used to effectively decrease or remove 
the substrate or product inhibition by rational or random mutagenesis and high throughput 
screening (Park and Shin, 2013).  
There are two potential targets in this pathway for a TAm to react. Upstream there is the 
ketone cyclohexanone produced from cylohexanol as well as 6-oxohexanoate, an aldehyde 
produced from 6-hydroxyhexanoate. In order to minimise any side product formation i.e. 
the transamination of cyclohexanone to cyclohexylamine, a suitable ω-TAm would need to 
be found with high activity on 6-oxohexanoate and minimal activity on cyclohexanone. 
 
5.2 Screening 28 ω-TAm’s for preferential activity on 6-
oxohexanoate over cyclohexanone 
5.2.1 Obtaining 6-oxohexanoate 
6-oxohexanoate is a linear aliphatic aldehyde, its commercial availability is therefore 
limited because of its instability for long term storage. Therefore making it synthetically 
drives up the cost and consequently the price from retailers but also makes validation of 
experiments difficult since there will likely be a reducing amount of the aldehyde over time. 
Aldehydes typically are very reactive because of the large electronegativity of the oxygen 
atom and the presence of only one electron donating R group as opposed to two with a 
ketone. The large δ+ on the carbonyl carbon is subject to nucleophilic attack by even the 
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weakest nucleophile. Consequently even moisture in the air can act as a nucleophile 
leading to the rapid formation of either a carboxylic acid, its equivalent salt (adipic acid in 
the case of 6-oxohexanoate) or a gem-diol (Hydrate) in a nucleophilic addition reaction is 
possible. This posed a problem for performing screening studies to find the best 
Transaminase. However the methyl ester of 6-oxohexanoate is commercially available. 
Although the methyl ester group is at the opposite end of the molecule, it could be thought 
not likely to affect the screening in a large way and should provide a suitable alternative. 
However because this is a best available model there may be differences in the reactivity of 
the TAm’s on the methyl ester compared to the in vivo 6-oxohexanoate. The degree to 
which this is so can be explored by chemically removing the methyl group leaving                
6-oxohexanoate. This was done by acid hydrolysis (see Material and Methods section 2.5.2) 
and the structure confirmed by NMR (NMR work done by Damien Baud). The methyl ester 
is an expensive molecule to purchase and so an initial activity screen was done and 
compared to the chemically synthesised 6-oxohexanoate. A third method of making fresh 
6-oxohexanoate was explored. Since the caprolactone hydrolase and the                                    
6-hydroxyhexanoate dehydrogrenase were both cloned individually and expressing to a 
large degree these could be used to synthetically produce in vitro 6-oxohexanoate from 
caprolactone. Following Ni-affinity purification of each enzyme from induced cultures of 
both clones, they were used in equal volume of 100 µL each in a 5.3ml reaction and  
supplying a final concentration of 0.625 mM NAD, 1.11 mM PLP and 111 mM L-Alanine and 
45 mM caprolactone at room temperature (see Materials and Methods 2.5.2). A sample 
was taken to follow the reaction using spectrophotometry and when it had completed the 
reaction mix was stored on ice.  PLP and L-Alanine were included in the reaction at a higher 
concentration than was required in the TAm screen (section 2.5.3) because, although they 
served no purpose in the formation of 6-oxohexanoate, the reaction mixture would serve 
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as the large component in the Tam screen i.e. it contains buffer, PLP and the amino acid at 
the required concentrations once diluted by addition of TAm cell lysate. 
5.2.2 Screening rational  
Following the generation of 6-oxohexanoate, a screening assay was developed based on an 
established method of TAm screening previously explored in our group and applied to both 
cyclohexanone and 6-oxohexanoate screens. This method involved using S-Methyl 
benzylamine (S-MBA) as an amine donor and detecting the appearance of the 
acetophenone co-product via HPLC at a wavelength of 254 nm (Richter et al., 2015). 
However since the most likely amine donor in vivo is an amino acid, Alanine was chosen for 
a number of reasons. Firstly in most microorganisms, it is most commonly only synthesised 
in vivo for the biosynthesis of proteins and is part of central metabolism and therefore 
likely to be one of the most abundant amino acids. Secondly its synthesis is very simple and 
requires only a glutamate-pyruvate TAm using pyruvate as a substrate which is provided by 
glucose metabolism (Akita, Nakashima and Hoshino, 2016).  Consequently the assay design 
is simple and requires only the detection of pyruvate as the co-product after 
transamination. It is simple to detect the presence of pyruvate by the addition of a lactate 
dehydrogenase which is added to the reaction post transamination. No additional co-factor 
needed to be added in the 6-oxohexanoate screen since the NADH produced during the 
production of 6-oxohexanoate from 6-hydroxyhexanoate (Figure 5.2) however it is supplied 
in the cyclohexanone screen. The conversion of pyruvate to lactate is detected again by 
following it on a spectrophotometer. The decrease in absorbance as NADH is oxidised to 
NAD+ is indicative of LDH activity. The more pyruvate present, and therefore the better the 
Transaminase on 6-oxohexanoate or cyclohexanone, the greater the degree of absorbance 
change.  
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Figure 5.2 Schematic of the TAm screen design showing co-factor and enzyme pathway 
 
 
5.2.3 Difference between Methyl-6-oxohexanoate and 
enzymatically produced 6-oxohexanoate 
Since the model methyl ester substrate was available it was useful to see if there was an 
appreciable degree of difference between it and the biocatalytically produced                          
6-oxohexnaoate. This would either validate using the methyl ester as a viable substitute or 
not. It is to note that when using the methyl ester the absorbance decreased as expected 
because the LDH uses the NADH and oxidises it to NAD+. Conversely however in the 
biocatalytically produced 6-oxohexanoate reaction, the absorbance actually goes up over 
time. The reason for this is that it is thought the excess (45 mM) ɛ-caprolactone that was  
used to generate 6-oxohexanoate before the TAm screen could only have used a maximum 
of 0.625 mM NADH to produce a stoichiometric amount of 6-oxohexanoate. When the 
Pyruvate from the TAm reaction is converted to lactate in the LDH assay, the NAD+ released 
from this can then feed back into 6-hydroxyhexanoate dehydrogenase to further produce 
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6-oxohexanoate and NADH again (Figure 5.3). When compared to all other reactions, the 
TAm reaction is likely to be one of the slowest relative to the other reactions in the 
pathway. This is suggested based on previous research by Richter et al (Richter et al., 2015) 
which showed that over the first 2 hours of a TAm reaction, conversion was low, ranging 
from 0-31 % conversion with most at the lower end of this range for non-natural 
substrates. Although this will differ with different substrate and enzyme combinations. This 
means that overall the LDH reacts quickly with the pyruvate producing NAD+ which is 
subsequently used by 6-hydroxyhexanoate dehydrogenase (still present in excess) to 
produce 6-oxohexanoate which as shown previously (section 3.4.3) is, generally, a rapid 
reaction. However the TAm is unlikely to react with very much of the newly synthesised               
6-oxohexanoate over the 40 minute spectral reading therefore producing minimal amount 
of pyruvate again in that time. Thus the absorbance decreases initially but it very quickly 
increases because of the generation of NADH which then presumably accumulates leading 
to an increased overall absorbance reading. This claim is substantiated by looking at an 
example absorbance reading of a reaction with the TAm expressed by pQR987 on                       
6-oxohexanoate (Figure 5.4). The first 200 seconds of the reaction shows a moderate 
decline in absorbance followed by a subsequent increase in absorbance and minimal 
decrease. It is likely that the initial decline is larger than is shown because of the time it 
takes to manually pipette before measuring.  
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Figure 5.3 TAm reaction schematic showing the fast reactions (green) and slower reactions (red).  
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The TAm clones were ranked with the largest absorbance change in the LDH assay being 
classified the highest ranked. Table 5.1 shows the results comparing the methyl ester to the 
biocatalytically produced 6-oxohexanoate. It becomes clear that although there are a few 
enzymes which appear to react in similar ways by having appreciable levels of closeness 
between the two ranks (e.g. pQR426 and pQR965), a considerable number showed 
opposing degrees of activity (e.g. pQR987). This cast doubt over the validity of the model 
substrate and therefore it would not be used in future experiments.  
 
 
 
 
Figure 5.4 An example absorbance spectra at 340 nm following the LDH assay of pQR987 TAm (Bacillus 
licheniformis) releasing pyruvate from alanine. Over approximately the first 200 seconds an initial decrease 
in absorbance due to the reduction of NADH can be seen which is followed by the increased absorbance as a 
consequence of the oxidation of the NAD+ by  in the dehydrogenase reaction of 6-hydrohexanoic acid to 6-
oxohexanoic acid. 
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Table 5.1 Numerical ranking of the methyl ester vs biocatalytically produced 6-oxohexanoate 
showing the differing results between the two. This could indicate that the methylated substrate is 
not a suitable alternative even though the methyl group is the opposite side of the molecule. 
 
 
 
Construct 
(pQR #) 
Methyl-6-
oxohexanoate  
(ranking of best 
performing TAm) 
6-
oxohexanoate 
(ranking of best 
performing TAm) 
426 19 18 
427 15 19 
803 17 9 
804 24 22 
805 22 7 
808 4 6 
809 5 13 
810 1 21 
811 18 1 
812 13 15 
813 3 8 
815 21 10 
CV2025 10 20 
965 14 12 
966 20 11 
967 8 17 
972 9 4 
974 7 23 
979 11 14 
983 2 16 
985 6 3 
986 12 5 
987 16 2 
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5.2.4 Overall rankings 
In order to identify the best candidate TAms a ranking system was designed to list the most 
ideal at postition 1 and least in the last position. Each experiment was done in triplicate on 
6-oxohexanoate (either chemically or biocatalytically synthesised) and were ranked with 
the highest score being that with the largest average change in absorbance i.e. the largest 
absorbance change is ranked at position 1. In contrast to this, when screened on 
cyclohexanone, the Tams were ranked with the highest being minimal change from the 
start of the reaction and therefore showing no or minimal activity on cyclohexanone i.e. 
the smallest change from zero is ranked at position 1. The first experiment was the only 
one using biocatalytically produced 6-oxohexanoate and experiments 2 and 3 used the 
chemically synthesised version. This was due to the logistics of the arrival of the chemically 
synthesised methyl-6 oxohexanoate and the time to produce it and validate it. Table 5.2 
shows the ranking tables and although there are certain experiments where values 
disagree with the others, overall there is no clear distinction between either method of 
obtaining 6-oxohexanoate i.e. broadly speaking, the biocatalytic experimental values do 
not appear to be significantly different to that of the chemically synthesised.  
The rankings from each of the triplicate experiments were averaged. In order not to let 
obvious outlying values impact the final rankings, any large disagreements were not 
included. For example pQR426; experiment 2 ranking was significantly different (10) to 
either 1 (26) or 3(21). The final overall ranking was determined by adding the averaged 
ranks from both substrate screens (i.e. how a clone performed on cyclohexanone and 6-
oxohexanoate) and ranked in ascending order, 1st being the highest combined ranking 
score.  
Because this screen is likely to be inaccurate to a degree, the top three performing TAm's 
which exhibited some of the lowest activities on cyclohexanone whilst having some of the 
116 
 
highest activities on 6-oxohexanoate were selected. It is likely that one of the three would 
be a top performer in vivo.  Also to note is that there was no weighting placed on either 
requirement i.e. a high activity on 6-oxohexanoate wouldn't substitute for having activity 
on cyclohexanone. For example pQR804 (4) was shown to have a slightly better activity on 
6-oxohexanoate than pQR810 (1) however it was shown to be only 8th best for minimal 
activity on cyclohexanone. Despite being ranked 9th for activity on cyclohexanone, because 
pQR983 shows the highest activity on 6-oxohexanoate it ranked number 2.   
Figure 5.5 is a graphical representation of the average absorbance change  of each clone. 
The screens identified three potential candidates which would be suitable for cloning into 
both operon versions (native and non-native RBS) for metabolite characterisation. These 
were pQR810 (Pseudomonas putida KT2440, PP5182, 49.87 kDa), pQR983 (Deinococcus 
geothermalis, Dgeo_2743, 37.32 kDA) and pQR1014 (Micrococcus luteus, MLUT_00920, 
50.2 kDa).   
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  6-oxohexanoate 
 
cyclohexanone 
 
    
PQR # Exp1  exp2 exp3 
Averaged 
rank 
 
Exp1 exp2 exp3 
Average 
rank 
 
Combined 
score 
Final 
rank 
pQR426 26 10 21 23.50 
 
5 10 1 5.33 
 
28.83 14 
pQR427 27 27 22 25.33 
 
14 5 2 7.00 
 
32.33 19 
pQR803 14 28 23 25.50 
 
20 14 10 14.67 
 
40.17 26 
pQR804 4 4 12 6.67 
 
8 21 8 8.00 
 
14.67 4 
pQR805 11 23 7 9.00 
 
16 22 26 21.33 
 
30.33 16 
pQR808 15 2 3 2.50 
 
27 26 22 25.00 
 
27.50 9 
pQR809 3 3 6 4.00 
 
28 28 14 28.00 
 
32.00 18 
pQR810 6 5 19 5.50 
 
7 2 3 4.00 
 
9.50 1 
pQR811 1 26 18 22.00 
 
3 4 12 6.33 
 
28.33 11 
pQR812 25 14 15 14.50 
 
2 3 27 2.50 
 
17.00 5 
pQR813 21 22 25 22.67 
 
11 13 7 10.33 
 
33.00 20 
pQR815 23 21 28 24.00 
 
15 11 4 10.00 
 
34.00 22 
CV2025 16 16 24 18.67 
 
12 8 9 9.67 
 
28.33 12 
pQR965 19 25 16 20.00 
 
24 20 18 20.67 
 
40.67 27 
pQR966 8 19 8 8.00 
 
13 27 19 20.00 
 
28.00 10 
pQR967 12 15 17 14.67 
 
22 16 17 18.33 
 
33.00 20 
pQR972 22 16 11 16.33 
 
23 23 21 22.33 
 
38.67 24 
pQR974 28 20 10 19.33 
 
19 15 25 19.67 
 
39.00 25 
pQR979 24 9 5 7.00 
 
26 24 15 21.67 
 
28.67 13 
pQR983 2 1 26 1.50 
 
6 12 11 9.67 
 
11.17 2 
pQR985 7 13 13 11.00 
 
17 18 20 18.33 
 
29.33 15 
pQR986 17 12 9 12.67 
 
21 25 24 23.33 
 
36.00 23 
pQR987 5 24 20 22.00 
 
1 17 23 20.00 
 
42.00 28 
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 pQR1003 10 6 27 8.00 
 
25 6 13 19.00 
 
27.00 8 
pQR1010 18 11 4 7.50 
 
9 19 28 23.50 
 
31.00 17 
pQR1011 13 7 14 11.33 
 
10 7 6 7.67 
 
19.00 6 
pQR1014 9 18 2 5.50 
 
4 9 5 6.00 
 
11.50 3 
pQR1015 20 8 1 4.50 
 
18 1 16 17.00 
 
21.50 7 
Table 5.2 Numberical rankings of each TAm in triplicate, averaged and then the combined score was rankied with the lowest number being the best performing TAm. A rank of 1 
in the 6-oxohexanoate screen means the most active whilst the rank of 1 in the cyclohexnaone screen means the least active. Yellow boxes indicate score which were not 
included in the averages due to extreme values. The combined score was then ranked itself so that the lowest score was ranked 1 i.e. the top performer. A list of each TAm 
encoded on the pQR contruct I.D's is available in Appendix B. 
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Figure 5.5 Average absorbance change on each substrate. pQR810, pQR983 and pQR1014 are outlined as the top 3 performing candidates showing good indications of activity 
on 6-oxohexanoate and minimal activity on cyclohexanone. 
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5.2.5 Cloning in PP5182, DGEO_2743 to operon A and B 
The strategy for cloning the Pseudomonas putida and Deinococcus geothermalis TAm's into 
operon A and B was to first remove the NotI site at the end of ChnD so that the RBS 
''AGGAG'' was immediately following it. This RBS was used for both operon versions since it 
is not from the Acinetobacter cluster and so by keeping the same RBS in both TAm, the idea 
that the native RBS have evolved to optimise flux through the pathway could still be tested. 
Overlaps complimentary for the TAm's were added to the primers whilst also linearising 
either plasmid. The observed yield of target  PCR product was quite low and contributing 
factors as to why this could be are because of the length of primers and large template 
(Figure 5.6 and Figure 5.7). Also there was a prominent second and third band also 
produced. However after gel purification, enough was recovered to proceed with the CPEC 
reaction in a 1:2 molar ratio of insert (TAm) to vector (operon and plasmid genes). Both 
TAms' amplified with no co-product other than potential primer dimers and incorporated a 
BamHI restriction site flanking the TAm gene (creating the spacer betweek the RBS and the 
gene and also directly at the end of the TAm gene).  
 
 
 
 
 
 
Figure 5.6 Agarose gel of the inverse PCR amplification of the 9.2 Kb operon A (lane 1) and operon B (lane 3) 
and add homologous overlaps to for PP5182 and the PCR of a 1.36 Kb PP5182 Pseudomonas putida TAm 
(lane 2). The targeted fragment is underlined in red. M is a 1kb ladder (NEB,USA). In short the TAm in lane 2 
will be CPEC cloned into linearised plasmids of operon A (1) and B (2).   
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An interesting finding regarding CPEC assembly was that when inserting a single gene, the 
number of cycles required appeared to be important. Initially 26 cycles were used however 
zero colonies grew. However when the number of cycles was reduced to 15 at a cycle 
temperature of 55oC, many colonies were observed. The reasons for this are unclear as to 
why with more fragments a higher cycle number appears to be important. It could be that 
the more cycles increased the formation of secondary structures which may result in 
degradation in the cell or it could be that the more cycles the higher the likelihood of 
binding to the ori or Kan genes resulting in a knock-out whereas with large constructs the 
chances are small because of the abundance of other separate sequences. The cycle 
number was not investigated further since it was only important that the assembly worked. 
NdeI and BamHI double digests were used to identify correctly assembled plasmids (Figure 
5.8 and Figure 5.9). Figure 5.9 shows the digestion patterns of several miniprepped 
colonies of all 4 plasmid variants. From the assembly of PP5182 minipreps 1a and 4b 
showed correct digestion and were transformed into BL21 (DE3). From the assembly of 
Figure 5.7 Inverse PCR amplification of the 9.2 Kb operon A (pQR1543), operon B 
(pQR1548)plasmids. In addition a 1.02 Kb DGEO_2743 Deinococcus geothermalis TAm (pQR983) 
was amplified with overlaps for CPEC assembly. Note a significant side product of Operon A and B 
amplification. 
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Dgeo_2743, minipreps 1 and 4 were transformed into BL21 (DE3). The new clones were 
then renamed according to Table 5.3. 
 
 
 
 
 
 
 
 
 
 
Figure 5.8 A general plasmid map showing NdeI and BamHI sites, Both of which are used to 
confirm the correct assembly from CPEC. pQR1553, pQR1554, pQR1555 and pQR1556 were 
all designed to contain a BamHI site as a spacer between the RBS and the gene as well as at 
the end of the TAm. This was so it could easily be digested out in a single digest. 
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Figure 5.9 NdeI and BamHI digested plasmid minipreps isolated from several colonies. Plasmids 
were double digested to identify which clones contain the operon, the backbone and the TAm. Top 
image (A) lanes are marked with a number to identify the miniprep and either the letter ''a'' or ''b'' 
refering to which operon version the TAm is in e.g. 3a is colony 3 with operon A assembly with 
PP5182. Clones 1a, 2a, 3a, 4b and 4a look to have digested correctly. Expected bands of succesful 
clones are 4.4kb (operon A), 5.2kb (plasmid backbone) and a thrid band for the TAm. PP5182 is 
1.36 kb. In the below image, B., plasmids 1-3 are operon A and 4-7 are operon B for Dgeo_2743 
assemblies. (Dgeo_2743  band expected at 1.02kb). Clones 1, 4 and 7 look to have digested 
correctly.  
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An SDS PAGE of pQR1553 and pQR1554 (Figure 5.10) confirmed the expression of all ChnA-
D genes as well as an over-expressed protein at the expected size of 49.87 kDa 
corresponding to PP5182. It is interesting to see that cyclohexanol dehydrogenase (the 
lowest band) shows a reduced expression in pQR1553 and a higher expression of PP5182 
relative to the other proteins compared to pQR1554. 
 
Figure 5.10 SDS PAGE of pQR1553 and pQR1554. A 5th over-expressed protein band can be seen 
between showing the expected molecular weight of 49.87 kDa of PP5182 in both operon versions. 
A pET29a induced sample shows the presence of two highly expressing host proteins. 
An SDS PAGE of pQR1555 and pQR1556 (Figure 5.11) shows the successful expression of all 
5 cloned enzymes under the control of a T7 promoter. Initial loading showed little 
resolution between ChnD and Dgeo2743 because the difference in mass is only 0.1 kDa. 
Construct I.D. Coding genes 
pQR1553 ChnA - D (natural RBS) + PP5182  
pQR1554 ChnA - D (artificial RBS) + PP5182 
pQR1555 ChnA - D (natural RBS) + DGEO_2743 
pQR1556 ChnA - D (artificial RBS) + DGEO_2743 
Table 5.3 A table listing plasmid construct I.D numbers along with the coding genes within them 
125 
 
Upon loading of significantly less sample, two clear bands can be seen at expected 
molecular weights. Both clone variants showed excellent expression of all target proteins. 
The volumes loaded on a gel weren't normalised by loading a certain percentage of total 
protein and were loaded only on a fixed volume. Comparisons between clones are 
therefore difficult however relative expression conclusions can be drawn. In pQR1556, 
cyclohexanone monoxygenase and both 6-hydroxyhexanoate dehydrogenase and Dgeo 
2743 are arguably expressed to a lower extent than in pQR1555. 
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Figure 5.11 SDS PAGE of pQR1555 and pQR1556. Top; non-induced and induced samples showing 
good expression of all cloned genes but with little resolution between Dgeo 2743(37.3 kDa) and 
ChnD(37.2 kDa). Bottom; SDS PAGE showing smaller sample loading where two bands with 
marginal size difference can be seen at less than 40 kDa. A prominent host cell protein above 40  
kDa can also be seen. 
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5.2.6 Cloning in MLUT_00920 to operon A and B 
Initially the strategy to clone MLUT_00920 was to follow the same as with Dgeo_2743 and 
PP5182 however the PCR to linearise the vector and MLUT_00920 whilst adding on 
overlaps failed repeatedly. Following this primers were designed to only linearise both 
parts. This was successful with MLUT_00920 and a significant band of 1.4 kb was amplified 
and used as a template to add vector homologous overlaps to using the same primers as 
were previously used directly on the pQR1014 plasmid (Figure 5.12). This showed that 
there were problems when using long primers where only part of it bind initially to the 
circular template but could be circumvented by linearising the plasmid and then adding on 
overlaps. With regards to linearising the operons plasmid, only a very faint band was 
amplified of either operon A or B (Figure 5.13). After gel overloading with the sample and 
purifying the correct band, only very small quantities were recovered. The purified PCR 
product was then used for further amplifications as a template using the primers to add 
homologous overlaps for MLUT_00902 however this was unsuccessful.  
 
 
 
 
 
 
 
Figure 5.12 . Left; linear amplification of MLUT_00902 with 3 different annealing temperatures showing a 
band of approximately 1.4 kb. Right; amplification using linear template to add vector overlaps 
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The result so far meant that in terms of a CPEC reaction, only the MLUT_00902 gene 
contains homologous overlaps of 21bp at each end containing BamHI flanking sites for 
ChnD and the vector backbone. The operon plasmid was only linearised and amplifications 
to add overlaps were unsuccessful. A CPEC reaction was attempted with these two parts 
(Figure 5.14) with 10 and 15 cycles and 52oC and 55oC with a vector to insert ratio of 1:5.   
 
 
Transformation of the CPEC reaction into cloning strain E.coli 10β cells produced plentiful 
colonies for operon A at 10 cycles annealing at 55oC and a small number of colonies with 
operon B assembly. Following overnight growth the plasmids from these colonies were 
miniprepped and digested with NdeI and BamHI for restriction mapping. Expected bands 
Figure 5.13 Linearising amplification of operon A and B producing a faint band of 
9.2 kb. Other off-target products were also produced. Further amplification using 
purified linear plasmids to add on ChnD overlaps failed.  
Figure 5.14 CPEC reaction attempted using only MLUT_00902 containing homologous 
overlaps to ChnD. 
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were a 5.2 kb pET29a backbone, a 4.3 kb operon fragment and two fragments of 
MLUT_00902 because BamHI cuts the 1.4 kb gene into a 0.8 kb and a 0.6 kb fragment 
(Figure 5.15).  
 
Figure 5.15 A) plasmid digestions of six operon A plus MLUT_00902 assemblies miniprepped from 
individual colonies and digested with NdeI and BamH I (lanes 1-6). B) Six operon B plus 
MLUT_00902 assembly colony digestions with NdeI and BamHI (lanes 7-12). 
 
Although MLUT_00902 was in 2/6 operon A colonies and 4/6 operon B colonies, only 1  
operon A colony showed the presence of 4 bands, both of which appeared to be slightly 
lower than expected. No colonies of operon B showed correct digestion. Given that 
sometimes incorrect digestion or other factors e.g. protein binding, can affect the 
appearance of bands on a gel, colony 1 from operon A and colony 7 from operon B were 
transformed into E.coli BL21 (DE3) and expressed to identify if, given that MLUT_00902 
appears in both, it expresses along with the Acinetobacter genes. Figure 5.7 however shows 
that neither plasmid expressed any of the proteins and indeed looks to have removed 
ChnA-D genes from both plasmids. 
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Figure 5.16 E.coli BL21 (DE3) expression shows removal of ChnA-D genes and no expression of 
MLUT_00920. 
The reason for MLUT_00920's, failure at CPEC cloning could be attributed to its high GC 
content (72%) compared to Dgeo_2743 and PP5182 being 64% and 62% respectively. The 
high GC content could have made the gene ''sticky'' and bind in non-specific regions. A 
change in cloning strategy was needed and it was decided that standard restriction cloning 
was the most appropriate method. However, more linear operon plasmid was needed than 
was currently able to be produced because not only was PCR amplification low but spin 
column purification also seemed to recover low single digit nanogram per microlitre 
concentrations. To that end the PCR amplification was investigated to optimise linear 
plasmid yield. An extended extension time of 50 s/kb was investigated following NEB's 
advice for amplifying longer fragments however this also failed. Long PCR primers were 
also tried with the reasoning that a 2 step PCR could be used and that the likelihood of 
large primers to bind to the plasmid was high also failed to produce any linear fragment. 
Fresh Q5 polymerase was also bought however the result was also the same. Finally a 
reduced extension time of 15 s/kb was tried and Phusion™ and Q5 polymerases were 
compared using previous primers which had failed with longer extension times. 
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Interestingly there were significantly different results between both polymerases with Q5 
producing bands in two of the three annealing temperatures and Phusion™ producing zero 
bands at any of the same annealing temperatures (Figure 5.17). Also it is interesting that a 
shorter extension time of 15 s/kb (using the same primers and template as used at 50 s/kb) 
produced much better 9.6kb product which contradicts NEB's advice for long fragments.  
 
 
 
 
 
 
 
 
 
In order to clone in MLUT_00902 standard restriction cloning was the next cloning strategy. 
After identifying BbvcI and AvrII restriction sites as being candidates due to their absence 
from both vector and insert as well as reported 100% activity in the same buffer, primers 
were designed to linearise both operon A and MLUT_00902 whilst adding AvrII and BbvcI 
restriction sites to the ends of each fragment (Figure 5.18).  
Figure 5.17 PCR amplification comparing Q5 and Phusion™ polymerases 
at 15 s/kb with primers previously used at 30 s/kb extension time. 
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Figure 5.18 A) PCR amplification of Operon A (lane 1), B) PCR amplification of 
MLUT_00902 (lane 2) adding in AvrII and BbvcI sites to both fragments. The marker (M) is 
a 1kb ladder from NEB, USA. 
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After digesting and ligating each fragment, several cloning colonies were grown overnight 
and miniprepped. They were then triple digested with NdeI, BbvcI and AvrII to check for 
correct assembly (Figure 5.3). All 8 colonies showed correct assembly of the plasmid and 
one was  transformed into BL21 (DE3) for expression and renamed pQR1557. 
 
 
Figure 5.19 NdeI, BbvcI and AvrII triple digest showing a 5.2 Kb fragment (pET29a), 4.4 Kb fragment 
(ChnA-D) and a 1.4 Kb fragment (MLUT_00920). All 8 colonies (lanes 1-8) show the correct 
digestion patterns expected. Marker lane is a 1 kb ladder (NEB, USA) 
 
Figure 5.20 shows the SDS PAGE of pQR1557. Five over-expressed protein bands can be 
seen however MLUT_00920 looks to be under the 50.2 kDa predicted size. An SDS PAGE of 
pQR1014 shows an over-expressed protein band at the same sub-50 kDa size which is 
evidence that it has been successfully cloned into pQR1557. It could be that the protein 
hasn't properly denatured and may require more rigorous denaturing and so has travelled 
further in the gel than predicted. However since the original pQR1014 expression shows an 
identical band size then it appears to have been cloned successfully. MLUT_00920 was not 
cloned into operon B because of poor analytical performance of pQR1557 (see next 
chapter) and would likely not be significantly different.  
 
134 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.20 A) an SDS PAGE of pQR1557. Non-induced (-) shows potentially leaky 
expression of ChnD however all 5 genes can be seen expressing (induced lane +) 
(underlined by a red line). B) pQR1014 SDS_PAGE showing a prominant band between 40 
and 50 kDa. This band is identical in size between pQR1557 and pQR1014 showing 
successful expression of the TAm. 
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Chapter 6: Metabolic intermediate 
detection by GC-MS 
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6 Results 
6.1 Introduction 
Analytical detection of non-aromatic amines has been known to be challenging for several 
reasons. Firstly because no chemical groups are naturally present which are UV active, that  
absorb UV or emit fluorescent light, techniques such as HPLC with UV detection is generally 
not possible (Cramer, Verma and Kiselewsky, 2011). GC (gas chromatography) offers 
several advantages for analytical measurements. It works by increasing the temperature of 
the oven and as the analyte evaporates it is carried in a constant gas flow and interacts 
with the stationary phase of the GC column. Depending upon the degree of interaction the 
analytes will elute at different times and temperatures e.g. low volatile large compounds 
eluting later. It is inherently simple, has excellent resolution capabilities, is highly sensitive 
and has short run times. However free amines are basic molecules, and short chained 
primary amines being the most basic due to the larger influence of the amine group which 
subsequently form a large dipole molecule. These large dipole moments have a strong 
capacity to interact with acidic silanol groups and siloxane bridges found in GC columns. In 
addition free amines are likely to oxidise under high temperature conditions and could also 
cyclise. These effects are typically seen by peak tailing, low detector response and low 
reproducibility. In order to improve detection, amine compounds are often chemically 
derivatised to reduce polarity and increase volitility, sensitivity and separation. There are 
several methods with which to derivatise amines notably by acylation, permethylation and 
carbamate formation (Kataoka, 1996). One of the most popular is silylation. Silylation 
agents are typically BSA (N,O-Bis(trimethylsilyl)acetamide), MTBSTFA (N-methyl-N(tert-
butyldimethylsilyl)triflouoacetamide) and BSTFA (N,O-bis(trimethylsilyl)acetamide). To 
compensate for  low reactivity of silylating reagents to amines (order; 
Alcohol>phenol>carboxylic acid>amine>amide) TMS (Trimethylchlorosilane) is added as a 
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catalyst. BSTFA/TMCS reacts with active hydrogens and replaces them with a trimethyl silyl 
group (- Si(CH3)) group which on amino acids or similar compounds (e.g. 6-ACA) is added 
onto both the carboxyl and the amine group (Figure 6.1).  It is very reactive with moisture 
and water and so is only used in the absence of either.  
 
6.2 Solvent selection, derivatisation and GC-MS intermediate 
analysis 
Since the intermediate molecules of the pathway are polar, a suitable polar solvent was 
required  which was compatible with GC-MS analysis. Although water is an excellent polar 
solvent, it's low volatility would cause condensation on the GC column at low temperatures 
and interfere with chemical-film interactions and possibly leave impurities e.g salts, metals. 
Cyclohexanol, cyclohexanone and ε-caprolactone all dissolved in a range of organic solvents 
and all up to 6-hydroxyhexanoic acid would readily dissolve in pyridine as well as methanol. 
Cyclohexylamine and 6-aminocaproic acid were much more problematic since no solvent 
(including harsh solvents such as DMSO) were found to dissolve the free compounds. The 
only solvent which would readily dissolve free 6-ACA was water. Ethyl acetate was chosen 
as a solvent which showed excellent ability to extract the first three intermediates from 
water into an hydrophobic layer and this was confirmed by GC. Ethyl acetate, although 
polar, lacks the ability to hydrogen bond and is therefore insoluble in water. 6-ACA was 
found to only dissolve in ethyl acetate when derivatised with excess BSTFA/TMS for 1 hour 
Figure 6.1 Image copied from Sigma Aldrich's (BSTFA + TMS, 99:1) product specificiation. The sample with 
the reactive group to be derivatised is mixed with BSTFA with TMCS where the active hydrogen from the 
sample is replaced with the alkylsilyl group in a nucleophillic attack on the silicon atom forming a transition 
state. The leaving group then reacts with the active hydrogen from the sample by donating the trimethyl silyl 
group. 
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at 70oC. When a solution of 6-ACA at 1 g/L was derivatised and injected on the GC-MS, a 
peak was confirmed by MS to be 2TMS derivatised, once on the amine and once at the 
carboxyl terminal (Figure 6.2). No derivitisation occurred at room temperature or when left 
for extended periods of time e.g. 24-48 hours at room temperature. 
 
In conclusion the solvent of choice for the first three intermediates (cyclohexanol to ε-
caprolactone) is to solvent extract into Ethyl Acetate. The rest of the intermediates will be 
derivatised in excess BSTFA and 1% TMCS at 70oC for 1 hour since it was found that once 
derivatised, the compounds then become soluble in Ethyl acetate (Figure 6.3) 
Figure 6.2 Spectra showing 2TMS derivative of 6-ACA detected at 8.1 minutes 
Figure 6.3 Schematic of the solvent of choice and derivatisation reagent for identification of 
each intermediate. Cyclohexanol to caprolactone were solvent extracted into ethyl acetate  
whilst 6-hydroxyhexanoateto 6-aminocaproate including the side products of cyclohexylamine 
and adipic acid were derivatised with BSTF + 1% TMCS in ethyl acetate.  
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6.2.1 Cell culture processing and preliminary result for in vivo 6-ACA detection 
Figure 6.4 shows a schematic for the method of processing from a cell culture. Firstly after 
the cells have been inoculated, induced and spiked with cyclohexanol, samples were take 
the following day and initially processed immediately. Initially the aim was to find any 
evidence of 6-ACA production and so a culture of pQR1556 cells were grown, induced and 
200 mM of cyclohexanol was added and left overnight. This concentration was chosen 
because, although it is very high, previous enzyme work (chapter 3.4) showed their capacity 
to catalyse high substrate concentrations. The cultures were then sonicated to lyse the 
cells, centrifuged and then processed (Figure 6.4). For this initial experiment the samples 
were dried in a drying oven overnight and then reconstituted in Ethyl Acetate and BSTFA     
( and 1% TMCS) and then derivatised. 
 
Figure 6.4  Cell processing for amine detection. The figure shows the method of processing from 
cell culture samples to GC-MS ready samples. The first stage (either spin or sonicate) indicates 
which fraction of the broth is being analysed. 
 
At this point the GC method required for running cell culture samples needed to be 
investigated further since a standard won't show if a longer run with different carrier gas 
flow rates or what split ratio is required once the intermediate is present in a complex 
mixture so a best guess was used and various split ratios tested. Nevertheless a small peak 
at a split ratio of 5, confirmed by GC-MS as 2TMS 6-ACA, was identified at 6.4 minutes 
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(Figure 6.5). Notably there was still a significant cyclohexanol peak found which would 
suggest inadequate uptake by the cells and also incomplete evaporation at 37oC. It is 
reported that as temperature increases, cyclohexanol becomes more soluble in water and 
at 30oC it is soluble at 4.2g/100ml of water owing to the large non-polar portion of the 
molecule (PubChem Database; accessed 07/09/2017)  200 mM is equivalent to 2.003 g/100 
ml and so should readily dissolve at 37oC. Compared to a control it appeared that the 
cyclohexanol also had an effect on the cell growth.  However given that 6-ACA is identified, 
a GC-MS method could be improved to achieve better peaks as well as investigating other 
parameters to improve the final concentration.  
 
6.2.2 Standards preparation and the difficulty of 6-ACA 
In order to quantify the intermediate peaks a standard curve of various incremental 
concentrations of a pure (>99% where could be bought, >95% for 6-hydroxyhexanoate) 
intermediate was used to generate a linear curve of concentration vs peak area. This was 
generated on the Chromeleon™ software. For intermediates from cyclohexanol to                
ε-caprolactone a 10 g/L stock concentration was made in ethyl acetate and then dilutions 
made into ethyl acetate were made ranging from 20 mg/L to 120 mg/L and it generated 
Figure 6.5 initial preliminary results gained from 200 mM cyclohexanol with pQR1556 cells identified 
a small peak which was confirmed as 6-ACA by MS. 
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linear curves confirmed by GC-MS. Cyclohexylamine, 6-hydroxyhexanoate and adipic acid 
were all derivatised with BSTFA + 1% TMCS to 10 g/L and diluted in Ethyl Acetate and again 
were confirmed by GC-MS. However 6-ACA would not dilute in this way and would produce 
two peaks at <1 g/L and three peaks at 1 g/L. The peaks followed a pattern of dilution e.g. 
reduced size at smaller concentrations and corresponded to the following; 6.94 minutes 
was identified as Trimethylsilyl 6-(acetylamino)hexanoate, 7.49 minutes was unidentified 
and only at 1 g/L was a small 6-ACA peak seen at 8.1 minutes. At no other concentration 
was this seen (Figure 6.6).  
 
Figure 6.6 Three peaks identified from 99% pure 6-ACA derivatised and diluted into lower  
concentrations. 
Given that the only solvent that could be found that 6-ACA is soluble in is water, a dilution 
series was made and speed vacuumed  until dry. This was then reconstituted into the 
original volume in ethyl acetate and BSTFA + 1% TMCS and derivatised. However, the 
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typical chromatogram was seen in Figure 6.7. Samples were also left for longer (14h) to 
derivatise as well as at 50:50 with Ethyl Acetate and BSTFA but this was also unsuccessful. A 
wide array of peaks were seen which couldn't be accounted for with signals strong enough 
to indicate that they are not trace quantities (Figure 6.7).  
 
Since 6-ACA was detected at the end of a fermentation in complex media but not with the 
standard it's possible that the acyl transfer from the Ethyl Acetate gets mopped up by more 
attractive amino acids or there is a potential pH influence. A set of three cultures of 
pQR1553 were grown, but not induced, for 18 hours in conical flasks in LB broth. 6-ACA 
standard was added to each to make a final concentration of 100 mg/L, 80 mg/L and 60 
mg/L and left for 1 hour as a mimic for bioproduced 6-ACA. The cells were lysed, processed 
in the same way as in reaction cultures and this produced a linear concentration curve 
which was confirmed by GC-MS (see Figure 8.8 in the appendix for the graph).  
Figure 6.7 6-ACA prepared in water and diluted out produced this typical pattern after drying and 
derivatising. 
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6.2.3 Operon clones supplied with 10 mM cyclohexanol successfully produce     
6-ACA  
Now that a GC-MS method and a sample processing method have been developed the 
clones were more thoroughly investigated for 6-ACA bioproduction. Being water soluble, 
initial investigations were made to determine if 6-ACA was cell permeable and if so, what is 
the degree to which 6-ACA is partitioned between the media and intracellular 
environments. Previously cultures were grown supplemented with 200 mM cyclohexanol 
and subsequently showed a very small peak of 6-ACA which wasn't quantified however a 
large peak of cyclohexanol was noticed which indicates that there may be some substrate 
inhibition at that concentration. Therefore 10 mM was chosen as a significant reduction in 
substrate concentration and was spiked 2 hours post-induction. Only clones pQR1553 - 
1556 were investigated at this stage because MLUT_00902 was proving a lot more 
problematic to clone. The cell cultures were then sampled and either sonicated followed by 
centrifugation or only centrifuged with no cell disruption. After particulate removal, the 
supernatant of both samples was then split into two fractions; one which was dried and 
then derivatised whilst the other fraction was mixed vigorously with Ethyl Acetate, 
centrifuged and then the solvent phase was analysed by GC-MS. Figure 6.8shows that in all 
but pQR1554, the cell lysate (CL) produced more 6-ACA than was in the supernatent (SN) 
alone. This is especially pronounced in pQR1553 which released 38 mg/L from the 
intracellular compartment. pQR1554 was approximately equal however the reason for this 
is not clear.   
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Figure 6.8 Graph showing amounts of 6-ACA recovered from supernatent (SN) only compared to 
when the cells are lysed (CL) which is a meansure of the total of intracellular and extracellular 6-
ACA.  The operon clones used at this time did not include pQR1557 since this was in the process of 
being assembled. The clones were grown on 10 mM cyclohexanol for 16 hours.  
 
When looking at the whole intermediate profile of clones pQR1553 - 1557 (excluing 6-
oxohexanoate; Figure 6.9) pQR1553 was identified as the largest producer of 6-ACA 
averaging 138.7 mg/L (operon constructed of natural RBSs and PP5182). Importantly it can 
be concluded that the RBSs have had significant impact on the performance of the 
pathway. pQR1554, having the same genes as pQR1553 but the RBSs are altered to AGGAG 
at position -7, achieved only 53.18 mg/L; a significant difference of 85.52 mg/L. pQR1557 
only produced 86.29 mg/L and since in all other constructs the operons regulated by 
natural RBSs were shown to be the best produces, the artificial RBSs version containing 
MLUT_00902 was not assembled. This was because of the difficulty of creating pQR1557 
combined with a likelihood of no significant increase in performance was deemed to be of 
little benefit.  No cyclohexanone was detected with pQR1557 however 303.87 mg/L of        
6-hydroxyhexanoate was found. 6-hydroxyhexanoate was also present in all other clones in 
amounts greater than 127.57 mg/L. This validates the isolated enzyme activity of                  
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6-hydroxyhexanoate dehydrogenase which highlighted its potentially low activity in vivo. 
Cyclohexanone was also only found in small amounts in pQR1553 compared to the other 
clones (averaging 12 mg/L). Interestingly all clones had large amounts  (>54.86 mg/L) of 
adipic acid, the largest of which was in pQR1557 (157.16 mg/L); this was largely predictable 
based on the knowledge that TAm reactions are relatively slow compared to the other 
enzymes in the pathway as well as the abundance of aldehyde dehydrogenases in E.coli. 
Furthermore, the low or absent quantities of cyclohexylamine would seem to confirm the 
viability of the TAm screen results since the top three TAms' were chosen based on their 
low activity on 6-oxohexanoate. When looking at the molar amounts produced, only a total 
of 2.99 mM of the 10 mM fed could be accounted for in pQR1553; 1.06 mM of that was 6-
ACA and 1.14 mM of 6-hydroxyhexanoate. In fact the highest combined molar amounts of 
intermediates was only 4.03 mM from pQR1557. Since the solvent extraction step for the 
first three molecules is immediate it is unlikely that there is great losses here. Instead, in 
the above experiments the lysed cell supernatant was dried in a drying oven at 75oC 
overnight. This temperature and the extended time at which 6-ACA would spend dissolved 
in a slowly reducing volume could increase the likelihood of cyclisation of the amine and 
carboxylic terminals reacting together to form caprolactam. The method of drying samples 
was then investigated to identify the impact on 6-ACA production.     
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Figure 6.9 Graphs showing intermediate concentrations in mg/L and molar amounts produced 
after 18 hours incubation with 10 mM cyclohexanol. 
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6.2.4 The speed at which samples are dried post-sonication impacts upon 
detectability of 6-ACA 
To test if the method of drying lysed samples had an impact on process yield only pQR1553 
was used since it had been identified as the best producing clone. Previously a drying oven 
set to 75oC had been used to dry samples overnight however as previously explained this 
could potentially be a source of problems with 6-ACA detectability. Triplicate cultures from 
separate colonies were grown and spiked with 10 mM cyclohexanol and left for 18 hours at 
37oC shaking. After this samples were taken in the same way as previously, the cells were 
disrupted, solid particulates removed and were subsequently dried in a speed vac until 
completely dry. This processes typically took 2-3 hours and was done at room temperature. 
The solid pellet was then mashed and broken up into fine powder using a pestle and 
mortar fashion in ethyl acetate and BSTFA. Figure 6.10 shows the concentrations of 
intermediates detected by GC-MS. Overall the total molar amounts of intermediates 
increased to an average of 5.97 mM, nearly double that which was previously detected. 
The amount of 6-ACA now observed averaged at 189.54 mg/L. Cyclohexanone obviously 
remained the same however a significant finding was the large increase from 150.28 mg/L 
to 443.51 mg/L of 6-hydroxyhexanoate. This could also be due to the previous cyclisation of 
6-hydroxyhexanoate into caprolactone and was not measured at the time. Adipic acid also 
increased from an average of 98.85 mg/L to 154.8 mg/L although the reason for this is 
unclear. Possible reasons for this include that a newer column was used in this second 
round of 10 mM cyclohexanol growths which might account for some increase in sensitivity 
however these results suggest that the speed and possibly temperature at which the 
samples are dried has a drastic impact on measured intermediate concentrations.   
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Figure 6.10 Intermediate concentrations for pQR1553 cells grown with 10 mM cyclohexanol and 
dried via speed vac for 2-3 hours until complete; (mg/L above, mM concentration below) 
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6.2.5 Media screen on 10 mM cyclohexanol with pQR1553 cells increases yields 
significantly 
Cell culture media is known to affect protein expression, alter metabolism and nutrient 
profiles and ultimately affect cell density and fermentation performance (Sivashanmugam 
et al., 2009). It may also alter cell membrane protein and the permeability of a cell. These 
factors need to be optimised for efficient production of any bioproduct however generating 
a defined media is a very arduous process. Instead a selection of four different complex 
media were used to grown pQR1553 cells and spiked with 10 mM cyclohexanol for 
comparison with LB media previously used. Intermediate compound concentrations were 
found to vary significantly between media. 2xTY media produced 264.48 mg/L of 6-ACA 
compared to none from NB.  Media choice also impacted on the amount of cyclohexanone 
present at the end of the growths and in 2xTY none was found however the next greatest 
producing media of 6-ACA, NZCYM, was found to have 145.42 mg/L of cyclohexanone 
(Figure 6.11). Possible reasons for this include the reduced expression of ChnB on NZCYM 
or an altered metabolism affecting the availability of NADPH. It is clear that in the two best 
performing media (2xTY and NZCYM), significant bottlenecks in the pathway are still the 
abundance of 6-hydroxyhexanoate and adipic acid. These different media have different 
amino acid concentrations to LB and even though some may achieve a higher OD, this 
doesn't necessarily correspond to a high yielding process. Interestingly, the total molar 
concentration of the intermediates in 2xTY and NZCYM was 9.12 mM and 9.48 mM 
respectively. Compared to an average of 5.97 mM on LB, this represents a significant 
increase in molar conversion from 10 mM cyclohexanol.   
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Figure 6.11 The intermediate profile in mg/L above and molar concentrations from pQR1553 
grown on different media and spiked with 10 mM cyclohexanol  2 hours after induction. See section 
2.7 in the Materials and Methods for details on the culture conditions. 
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6.2.6  Cyclohexanol concentration screen on pQR1553 in LB media 
In order to get an idea of the range at which cyclohexanol can be spiked at, three increasing 
concentrations were tested on pQR1553 cells grown in LB media. Cultures were grown in 
the same way as before and fed 20 mM, 30 mM and 50 mM bolus of cyclohexanol. Figure 
6.12 shows that 30 mM of cyclohexanol produces 222.3 mg/L (1.69 mM)of 6-ACA 
compared to 10 mM producing 189.54 mg/L (1.45 mM). For reasons not yet known, 20 mM 
only produced 112.5 mg/L (0.86 mM) but produced slightly more adipic acid (162.27 mg/L 
(1.11 mM) on 20 mM cyclohexanol and 154.8 mg/L (1.06 mM) on 10 mM cyclohexanol). At 
all concentrations however the amount of cyclohexanol increased by a minimum of 81 .73 
fold by doubling the amount of cyclohexanol from 10 mM to 20 mM. No cyclohexylamine 
was found in any sample. 6-hydroxyhexanoate was found at 624.54 mg/L (4.73 mM) at 20 
mM cyclohexanol and 773.07 mg/L (5.85 mM) on 30 mM cyclohexanol, a sharp increase 
from the 443.51 mg/L (3.36 mM) when grown on 10 mM cyclohexanol. Interestingly, when 
spiked with 50 mM only very large amounts of cyclohexanol (1.162 g/L, 11.6 mM) and 
cyclohexanone (1.015 g/L, 10.3 mM) were found. When total molar amounts of 
intermediates are calculated it was found that proportionate to the starting concentration 
of cyclohexanol, fewer moles were accounted for at the end of fermentation as the 
concentration of cyclohexanol increased, i.e. 15.36 mM of the 20 mM cyclohexanol was 
accounted for whereas only 21.96 mM of the 50 mM cyclohexanol substrate was 
accounted for. Although it was found that 30 mM cyclohexanol increased 6-ACA production 
on LB, there was proportionally more cyclohexanone and 6-hydroxyhexanoate generated 
by this increase in cyclohexanol; 8.67 mM increase in cyclohexanone and 2.49 mM increase 
in 6-hydroxyhexanoate compared to only a 0.26 mM increase in 6-ACA production.  
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Figure 6.12 Graph of pathway intermediates measured when pQR1553 is grown on LB media 
spiked with different concentrations of cyclohexanol. Below is a graph showing total molar 
concentrations of the pathway intermediates when grown with different cyclohexanol 
concentrations. (see Materials and Methods section 2.7) 
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6.2.7 Growth and pH are affected by the concentration of cyclohexanol 
During previous experiments it was observed that higher cyclohexanol concentrations 
produced smaller cell pellets during processing. Although 30 mM cyclohexanol has 
previously been shown to be the most productive, Figure 6.13 shows that when spiked with 
30 mM and 50 mM concentrations of cyclohexanol growth is impaired, albeit to the same 
degree, whereas OD was higher when grown on 10 mM but conversely 6-ACA yield was 
lower. The effect 6-ACA has on the pH of a culture is unclear although an impact of the 
pathway can be seen. The cells were induced at 0.6-0.7 OD, and spiked with cyclohexanol 
at 2 hours post induction. It can be seen that from this point on, the previously matching 
pH curves deviate from each other; 10 mM produced a final pH of 8.39, 30 mM at 7.07 and 
50 mM at 7.83. If no or very little 6-ACA is produced by 50 mM, the pH of the media will be 
buffered by other salts or amino acids in the media. At 30 mM, producing more 6-ACA 
lowered the pH to almost neutral whilst slightly less is produced at 10 mM a more basic pH 
is observed. 6-ACA is a lysine analogue which is a basic amino acid, that is it binds H+ ions 
onto the ε-NH2 group, becomes protonated and therefore pushes the solution towards an 
alkaline pH. It could be expected that the more 6-ACA is produced, the higher the pH of the 
culture would be and so it would be reasonable to assume that cultures grown on 30 mM 
cyclohexanol would be more basic. The reason why it is in fact more acidic than even 
cultures which don't produce any 6-ACA can be explained by the effect of the copious 
amounts of 6-hydroxyhexanoic acid which are produced at 30 mM compared to 10 mM 
cyclohexanol i.e. there's only a 0.26 mM increase in 6-ACA compared to a 2.49 mM 
increase in 6-hydroxyhexanoate. This large increase in 6-hydroxyhexanoate could result in 
the lowering of the pH and offset any increase in the pH by the relatively small increase in 
6-ACA production. Therefore higher cyclohexanol feeding concentrations reduce the 
culture OD but there is a balancing act between pathway intermediates as to its effect on 
pH. 
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Figure 6.13 pH and growth curves of pQR1554 on increasing amounts of cyclohexanol. Cultures 
were inocculated to an OD of 0.1 and induced at 0.6-0.7 OD. pH measurements were taken using a 
pH probe at the same time as an OD measurement was taken. See Materials and Methods sections 
2.5.4 
 
6.3 Cloning a second ChnD under the control of a second T7 
promoter and terminator into pQR1553 
Results shown in chapter 3.4.3, 5.2.3 and onwards have generated evidence to support the 
claim that 6-hydroxyhexanoate dehydrogenase is an enzyme of low activity. This has led to 
a significant bottleneck in the pathway representing a maximum of 56.3% of total detected 
molar  intermediates, when spiked with 10 mM cyclohexanol in LB media and a minimum 
of 30.7% when  spike with 20 mM cyclohexanol in LB media. In order to try and reduce this, 
a significant increase in expression of the rate limiting enzyme, ChnD was required. To do 
this, one approach would be to clone a second copy into the plasmid of pQR1553, however 
if it was included in the operon directly after PP5182 (i.e. the 6th gene in the operon) the 
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impact is likely to be much lower than if it was under control from its own promoter and 
terminator. Therefore a plasmid clone carrying the operon from pQR1553 as well as a 
second copy of the T7 promoter and terminator at the opposite side of the plasmid was 
required.  
6.3.1 pQR1559 assembly 
After looking at the pQR1553 sequence a suitable location to add another promoter, 
operator and terminator was identified. A region 343 bp upstream of the ROP gene was 
chosen and primers were designed to linearise pQR1553 by inverse PCR from this point and 
the for primer from 34 bp down from this which removes an area of large GC content. AvrII 
and SalI restriction sites were added to the ends of the linearised pQR1553 for restriction 
cloning once the ChnD fragment was created (Figure 6.14). Next, using the nested ChnD 
fragment generated from 1.1, primers were designed to add on an operator, a T7 promoter 
and and AvrII site from the natural RBS of ChnD. Since these features are small (50bp in 
total plus 6 random bp before the AvrII site which will get cleaved before ligation), they 
were successfully amplified (Figure 6.15). No terminator was added to the fragment at this 
point only a simple reverse primer from ChnD was used. Both of these fragments were gel 
purified and stored at -20oC.  
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Figure 6.14 Inverse PCR of pQR1553 adding AvrII and SalI restriction sites. The Annealing 
temperature is shown above each sample gel lane. Slightly more off target effects are seen at the 
lowest temperature compared to the highest. Marker lane (M) is a 1 kb ladder (NEB, USA).   
 
 
Figure 6.15 PCR on the nested ChnD including the natural RBS adding on a T7 promoter and 
operator and AvrII site upstream of the gene. Annealing temperatures are shown above the lanes. 
Marker (M) lane is a 1 kb ladder (NEB,USA). 
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This ChnD fragment was then used as a template to add a terminator at the 3' end of the 
gene. The T7 terminator is 48 bp and so a primer was designed to incorporate this in the 
next round of PCR. Figure 6.16 shows that this was successful.  
 
Figure 6.16 ChnD incorporating AvrII, T7 promoter and operator followed by the T7 terminator. 
Annealing temperatures are shown above each lane. Marker (M) is a 1kb ladder (NEB, USA). 
 
Next the PCR was gel extracted and moved into the final PCR stage in order to add a SalI 
restriction site to the end of the terminator sequence. Again this PCR was successful (Figure 
6.17) and was gel extracted. 
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Figure 6.17 The final PCR generating the complete AvrII, T7 promoter, operator, 
ChnD, terminator and SalI fragment. Annealing temperatures are shown above 
each lane. Marker (M) is a 1kb ladder (NEB, USA) 
 
446.5 ng of PCR linearised pQR1553 and 780 ng of the new ChnD insert were digested by 
AvrII and SalI for 4 hours followed by gel purification. The two fragments were ligated 
together at an insert molar excess 20 times that of the vector backbone and transformed 
into E.coli 10β cells (NEB, Massachusetts, USA). Five colonies were grown in 5 ml overnight 
cultures and miniprepped. Digestion of each colony with AvrI and SalI for 4 hours 
confirmed the presence of two predicted bands; T7-operator-RBS-ChnD-terminator at 
1.172 kb and an 10.938 kb band corresponding to the pQR1553 backbone (Figure 6.18). 
This clone was renamed pQR1559. Colony 4 was transformed into BL21 (DE3) and samples 
were grown for SDS-PAGE. A comparison between pQR1553 and pQR1559 shows there 
maybe some slight increase in expression of all proteins which may in fact indicate that 
simply more total protein was loaded since it was only loaded by volume and not equal 
amounts of total protein. Nevertheless 5 bands at expected molecular weights were 
confirmed (Figure 6.19). 
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Figure 6.18 (a) Is the AvrII and SalI digestion of 5 plasmid minipreps (lanes 1-5) from the ligation 
reaction of a second ChnD with a seperate promoter, operator and terminator. (b) Plasmid map of 
pQR1559. Marker (M) is a 1 kb ladder (NEB, USA). 
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6.3.2 pQR1559 performance on 10 mM cyclohexanol compared to pQR1553 
When pQR1553 was grown on LB and spiked with a bolus of cyclohexanol to a working 
concentration of 10 mM, samples were taken 18 hours later.  When analysed by GC-MS, 
the intermediate profile was different to that of pQR1553 when grown under identical 
conditions . This indicates the functional expression of ChnD and possibly an alteration in 
the levels of expression of the other enzymes. Expected results were that 6-
hydroxyhexanoate would decrease and 6-ACA concentration would increase. Whilst 6-ACA 
levels increased by only 0.2 mM, conversely all other intermediates also increased, 
particularly 6-hydroxyhexanoate by 1.21 mM (159 mg/L) (Figure 6.20). A possible reason 
for this is that the demand from another promoter and a 6th gene placed a strain on the 
Figure 6.19 pQR1553 and pQR1559 on an SDS PAGE. Samples taken from the same volume of culture and the 
same volume loaded onto the  gel. Five clear bands can be seen at the expected molecular weights. 
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host cells and either the amino acids or available cofactor profile was altered. This would 
cause the enzymes to have lower activity and consequently alter the pathway 
intermediates. However another possibility could be that the flux through the pathway 
actually increased but the TAm, being relatively slow, couldn't process the 6-oxohexanoate 
at a rate which was fast enough to either avoid aldehyde dehydrogenation into adipic acid 
or a reverse reaction back into 6-hydroxyhexanoate. Adipic acid concentrations increased 
by 0.79 mM (115 mg/L) which could substantiate the second possibility since the protein 
expression profile didn't look to be drastically different. Also interestingly, only a small 
increase in cyclohexanone and no cyclohexanol or ε-caprolactone was found which 
suggests that the flux through the upstream enzyme steps weren't changed drastically. This 
then implies that the downstream gene expression profile wasn't changed either since 
they're in the same operon. Therefore the bottleneck could actually be the TAm.  
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Figure 6.20 The concentration in mg/L of intermediates (top graph) and the molar concentration 
(bottom graph) of the intermediates with a comparison to pQR1553. All metabolites increased in 
pQR1559 indicating a potential bottleneck with the TAm. 
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6.3.3 pQR1559 performance on higher cyclohexanol concentrations and a small 
media screen 
In contrast to pQR1553, when cyclohexanol is increased to both 20 mM and 30 mM, 
although the latter produces more of every intermediate than the former, both are less 
productive than when grown on 10 mM cyclohexanol. When grown on 30 mM, only 151.24 
mg/L of 6-ACA was achieved compared to 215 mg/L 6-ACA when grown on 10 mM 
cyclohexanol. No solvent extraction phase was ran with these experiments because the 
samples were accidentally disposed of by a colleague (Figure 6.21). Because of the 
disappointing result with this clone it was not repeated.  
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Figure 6.21 The graphs show the  downstream intermediate concentration achieved when grown 
on 20 mM and 30 mM cyclohexanol in mg/L (above) and molar concentrations (below).  
  
Furthermore pQR1559 performed less well when spiked with 10 mM cyclohexanol on the 
four different media compared to pQR1553. The trend was the same in terms of the order 
which produced the most 6-ACA with 2xTY performing best and BHI the least however 
pQR1559 only produced 199.5 mg/L on 2xTY whereas pQR1553 produced 264.48 mg/L 
(2.016mM) (Figure 6.22).  
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Figure 6.22 pQR1559 was grown in 4 different media and fed with 10 mM cyclohexanol. The 
cultures were sampled 18 hours later. The intermediate concentrations achieved in mg/L (a) and 
below is the intermediate molar concentrations (b). 
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7 Discussion 
 
7.1 The Acinetobacter genes: the first stages of operon assembly 
and individual characteristics 
Genomic DNA preparations of Acinetobacter calcoaceticus NCIMB 9871 were used to 
amplify nested fragments of ChnA, ChnB, ChnC, and ChnD. These were then used as 
templates for further rounds of amplifications. The ultimate goal was to have all genes 
required on a single plasmid so as to only rely on a single antibiotic resistance marker as 
well as to avoid difficulties in co-transformations and potentially causing excess stress on 
the cells from two plasmids. Assembling multiple genes in a single plasmid by standard 
restriction cloning would be very challenging, possibly requiring many iterations, where 
each gene would be double digested and all would be assembled with unique restrictions 
sites. However in the late 2000's, the advent of several cloning methods which utilise 
homologous overlaps used a combination of multiple enzymes or single enzymes working 
in harmony such as exonucleases, polymerases and ligases which allowed multiple genetic 
elements to be assembled quickly, easily and include directionality (Gibson et al., 2009). 
Initially each gene was amplified to encode homologous overlaps, 15-25 bp long, as 
recommended for Gibson assembly®. Initial data showed a difficulty in assembling the 4 
genes together and produced bands of varying sizes with no clear target band assembled. 
Further investigation showed that the fragments of ChnC and ChnD assembled into a band 
of expected size however ChnA and ChnB failed to do so. Excess assembly mix and time 
showed better results however overall it seemed unlikely to be able to assemble 5 
fragments. Although rarely used in the literature, CPEC afforded the capability to use the 
same fragments designed for Gibson assembly® only in a cyclical, temperature profile 
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assembly method which is an extension of PCR but yields no amplification. This method 
proved to be very successful and very time efficient producing an operon in as little as a 
week from PCR to Cloning and SDS-PAGE verification. When the four Acinetobacter genes 
were assembled, a prominent expected band of 4.4 kb was seen. When made circular by 
adding the plasmid backbone the assembled DNA wouldn't migrate from the gel well. The 
reason for this is unknown however it's possible that at this stage the majority of DNA is 
entangled which prevent movement into the gel. When the well was excised and 
transformed, colonies were produced, the majority of which digested as expected, 
producing bands at 4.15 kb and 5.48 kb. Incorrect assembly is likely, to a certain degree, 
with CPEC and can be thought of in a similar way as mis-priming and off-target effects can 
be seen in a PCR. One clone was sequenced at the joining ends confirming the assembly of 
ChnA and ChnD and the SDS-PAGE showed that all four proteins were expressing at 
predicted molecular weights. Interestingly however after 23 hours of growth, CHMO ceases 
to express. Given that this is the second gene in the operon and the others aren't affected 
it is likely that the protein is expressing however is unstable and therefore degraded easily. 
Two operon versions were created, one harbouring natural RBS sites identified before each 
gene and one with an artificial RBS, both cloned easily and quickly using CPEC. The 
rationale behind this is that perhaps Acinetobacter has evolved and has finely tuned each 
gene expression to optimise flux through the pathway and so by using this, we can 
hypothetically achieve a maximum amount of 6-oxohexanoate funnelled through to the 
TAm. This is however assuming that E.coli BL21 (DE3) uses very similar RBS strength 
recognition.  
Moving on from these preliminary operon versions, each gene was cloned individually into 
a pET29a vector and His-tagged to allow Ni-affinity purification. The main aim was to be 
able to add to the library of cloned enzymes in the group but also to allow each enzyme to 
be assayed individually for activity indications. The alternative to this was to feed in 
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cyclohexanol and identify the intermediates however the extraction protocols, sample 
preparation and analytical methods need considerable thought and at this early stage, the 
quickest way was to clone them individually. Since most use a readily available co-factor, a 
simple spectrophotometry screen would suffice. The only enzyme with no detectable co-
factor requirements is the lactonase however activity was assayed by coupling with            
6-hydroxyhexanoate dehydrogenase, supplying caprolactone as a substrate as well as NAD+ 
showing that if the lactonase is active and producing 6-hydroxyhexanoate, the                     
6-hydroxyhexanoate dehydrogenase will be able to use that as a substrate and produce an 
absorbance change. A range of substrates were tested and results suggested that both 
CHMO and 6-hydroxyhexanoate dehydrogenase could potentially be bottlenecks in the 
pathway. CHMO exhibited substrate inhibition which is well documented and when tested 
as a standalone enzyme, 6-hydroxyhexanoate dehydrogenase showed little activity at all 
substrate ranges tested. However, the lactonase experiment showed it was clearly active 
however. These results were only indicative and were not meant to be absolute since their 
characteristics in vivo as well as the amount of protein expressed will be different. Since 
assembling the operon was initially thought to be likely to be the most problematic and 
time consuming part, that was completed first. That way if the enzymes showed no activity, 
alternatives could be found and substituted into the operon. Overall however, cyclohexanol 
dehydrogenase and the lactonase exhibited excellent activity profiles and were able to 
tolerate high concentrations of substrate. Even though the CHMO and 6-hydroxyhexanoate 
dehydrogenase were likely the weak links, no enzyme substitutions were made since they 
both showed activity and when working in the pathway, may behave differently when the 
dynamics of their respective products become substrates for the next enzyme.  
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7.2 The ω-TAm screen: an overview of the results and indications 
for candidate enzymes    
As outlined in section 4.2.1, the ability to purchase aldehydes is severely limited due to the 
very reactive chemistries of the compounds. The first challenge was therefore to source               
6-oxohexanoate or to find alternatives. The methyl-ester of 6-oxohexanoate is available to 
purchase and since the enzymes of the pathway are cloned individually there is the added 
benefit of using these to biocatalytically produce 6-oxohexanoate. In addition the methyl-
ester could also be hydrolysed to yield 6-oxohexanoate and stored at -20oC until required. 
All three were tested and although in the ester, the methyl group is at the opposite end to 
the molecule to the hydroxyl group and therefore steric hindrance should be minimal, the 
comparison between the ester and the biocatalytically produced 6-oxohexanoate was more 
severe than expected. In 12 of the 23 TAm's initially tested, the ranking scores obtained 
differed by more than 8 places and in some cases the difference was even more significant. 
This pointed towards the model methyl ester substrate being an unsuitable substitute for 
6-oxohexanoate due to too large a discrepancy between the two. More information on the 
TAm structure and docking studies would need to be completed to fully explain why this is 
so.  
A total of 28 TAm's were screened either on chemically or biocatalytically produced                     
6-oxohexanoate in a design which again used spectrophotometry and followed co-factor 
changes. After the production of pyruvate by the transamination of Alanine, LDH was used 
to convert this into lactate with the corresponding absorbsion change as NADH is 
converted to NAD+. The first TAm screen was completed using biocatalytically produced           
6-oxohexanoate and thus, as explained in 4.2.2, the overall absorbance increased since 
there was still likely copious amounts of caprolactone (the maximum produced in the initial 
reaction was 0.625 mM based on a 1:1 ratio of caprolactone to NAD+ leaving approximately 
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43.375 mM of unreacted caprolactone) and likely 6-hydroxyhexanoate present. Thus the 
NAD+ released from the LDH reaction drove the dehydrogenation reaction to produce more 
6-oxohexanoate. Because of the rate of reaction difference between the TAm reaction and 
the dehdyrogenation, this led to a net increase in absorbance. As expected in the next two 
screens where the chemically derived 6-oxohexanoate was used, the absorbance 
decreased since there were no enzymes and other substrates present to convert the NAD+ 
back into NADH. At the end of the three screening experiments the TAms were ranked by 
taking into account the largest absorbance change on 6-oxohexanoate and the smallest on 
cyclohexanone. Looking at the three screening experiments there were at times several 
experiments where the results were drastically different to the other two. When this was 
the case the outlier was not taken into account e.g. with pQR810, experiment 1 and 2 were 
in close agreement however 3 was vastly different and so wasn't included. Possible reasons 
for this difference could be attributed to experimental error, for example if the initial 
reaction rate was large and then quickly slowed, but the plate was slower to be read than 
in another experiment (e.g. slight delays in putting the plate in the reader or pipetting was 
slower than previously) then the result could look as if the clone didn't produce a large 
change relative to time 0 when previously it had done. It is interesting that only 7 from the 
cyclohexanone screen have one number not taken into account yet the 6-oxohexanoate 
reactions have 14. This could show the sensitive nature of working with an aldehyde. 
Moreover a total of 7 from the biocatalytically produced method were not included 
compared to 4 and 3 in experiments 2 and 3 when using chemically synthesised                   
6-oxohexanoate. A possible reason for this is that cell lysates were used and even though 
they were very dilute, aldehyde dehydrogenases from E.coli BL21 (DE3) will be present and 
possibly some variability was introduced here. Also, since the maximum amount of                     
6-oxohexanoate produced enzymatically is 0.625 mM (assuming all 6-hydroxyhexanoic acid 
had been converted to 6-oxohexanoate) certain enzymes may have different kinetic 
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properties and behave differently with the lower concentration of 6-oxohexanoate from 
the enzymatic route as compared to a higher concentration from the chemically pure 
method (working concentration of 1 mM). Due to these errors the screen was designed to 
only give an indication of likely candidates and therefore the top three ranked were chosen 
to be cloned. These were pQR810 (Psuedomonas putida PP5182), pQR983 (Deinococcus 
geothermalis DGEO_2743) and pQR1014 (Micrococcus luteus MLUT_00920).  
Both PP5182 and DGEO_2743 were cloned using CPEC into both operon versions, which 
interestingly only worked using lower cycle numbers but also a higher temperature than a 
reaction with more DNA parts. The reason for this is unclear since it is an assembly reaction 
and not an amplification. A BamHI site was cloned between the RBS and the TAm genes to 
act as a spacer as well as a restriction site to confirm successful assembly. MLUT_00920 
was significantly more difficult to clone and when assembled by CPEC, effectively knocked 
out all other genes in the operon. This was likely due to the high GC content (72%) of the 
gene which would make it more likely to bind to non-complimentary sites. Instead 
MLUT_00920 was cloned using restriction cloning by introducing AvrII and BbvCI sites 
which proved much more successful. It was only cloned into operon A however because 
GC-MS results indicated its poor performance (see later sections).  
7.3 The problem with 6-ACA detection  
Intermediate detection and quantification of the metabolites is arguably the most 
challenging part of the project. As outlined in section 5.1, amines require derivitisation for 
detection and in the case of GC-MS, to improve sensitivity and peak resolution by making 
the compound more volatile. An important observation that isn't necessarily immediately 
clear is the method by which is used to create a standard curve of 6-ACA on GC-MS. This is 
very important and crucial to achieving accurate results. After finding a small peak of 6-ACA 
present in pQR1556 samples grown on 200 mM cyclohexanol, 99% pure 6-ACA was used to 
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attempt to create a standard curve which presented  several challenges. The only solvent 
found to dissolve 6-ACA directly was water which cannot be put down a GC silica column. 
Instead a concentrated solution of 10g/L was made and diluted into a set of standards. 
After drying and derivitising with BSTFA and TMCS, a large variety of peaks were observed 
at all concentrations from 160 mg/L to 20 mg/L with no single peak corresponding to 6-ACA 
as observed in samples taken from cultures. The question of how this is possible given that 
6-ACA produced from the clones is effectively dissolved in a water base from the culture 
media is difficult to answer at first. The answer likely lies by looking at the equation of the 
condensation reaction of 6-ACA to produce an oligomer (Figure 7.1). 
 
 
Figure 7.1 The equation of reacting two 6-ACA monomers to create a oligomer releasing water 
 
The reason why 10 g/L or even 1 g/L 6-ACA was made up and different concentrations were 
diluted from this was because weighing the masses required to produce 1 ml of, for 
example 100 mg/L, were too small to handle so practically this makes sense. However, by 
looking at the equation to form an oligomer it can be reasoned that if the concentration of 
water becomes too low (i.e. a high concentration of 6-ACA is present) then the reversible 
reaction will be pushed to the right in order to increase the concentration of water by 
releasing it from a condensation reaction. Thus a solution of 10 g/L to 1 g/L would form 
oligomers which would be carried over to the standard dilutions. Presumably this would 
create a variety of oligomers and possibly even large ring molecules which explains why 
there are a variety of peaks detected in what is a 99% pure standard of 6-ACA (Figure 6.7). 
In fact, a paper from 1978 found that significant oligomers of 6-ACA can form at low 
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temperatures in water and that a high concentration of water (i.e. dilute 6-ACA solution) 
favours the monomers (Mares and Sheehan, 1978). This paper was also significant in 
understanding why, in this case, it is likely the oligomers and not caprolactam which is 
formed. They found that temperatures as high as 300oC are needed to cyclise 6-ACA to 
form caprolactam and that even then oligomers were still found in water. They also found 
that approximately 19% of 6-ACA would cyclise into caprolactam at temperatures as low as 
100oC over a 6 hour period. This could explain why there is a difference of 50.84 mg/L of              
6-ACA between drying at 75oC for 16 hours or speed vac drying at room temperature. The 
higher the temperature, the more likely some degree will cyclise into caprolactam. The 
effect can also be seen more dramatically with 6-hydroxyhexanoic acid where there is a 
large increase of 319.1 mg/L of 6-hydroxyhexanoate which could possibly be down to the 
reaction of the alcohol and carboxylic acid groups cyclising to form caprolactone. It is likely 
therefore that if, for example several 100ml solutions of concentrations of 6-ACA are made 
at <160mg/L, the water concentration would be large enough to favour monomers  yet the 
amounts could practically be weighed out. If then dried and derivatised less oligomers 
would be seen. However it is more complicated than that. Another problem was found 
when using only 99% pure 6-ACA and derivatising in ethyl acetate with BSTFA and TMCS. 
No water was present and 6-ACA doesn't dissolve directly into Ethyl acetate so stays in a 
solid phase and needed heating to 70oC for 1 hour to derivatise. Therefore no oligomers 
are able to form. It was found that there is likely a significant degree of Acyl transfer from 
the Ethyl acetate upon heating. However when a set of 50 ml cultures of non induced 
pQR1553 cells at the end of fermentation were spiked with 6-ACA and processed in the 
same way as if the clones produced it. A very clear linear standard curve was produced. 
This Acyl transfer is not seen when samples or standards are taken from culture medium 
and this is likely attributed to more reactive amino acids in the media which are Acylated in 
lieu of 6-ACA. However, dilute 6-ACA standards were not dried from pure water and so it 
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can't be concluded whether this acyl transfer will only occur at high 6-ACA. In summary, 6-
ACA must be in a dilute concentration in media and then dried and derivatised in order to 
create a linear standard curve.  
 
7.4 A high producing clone is identified 
The clones created based on indications from the TAm screen were initially grown on 10 
mM cyclohexanol and their metabolic pathway profile was quantified. There are two 
important findings from this screen. Firstly, in all clones, the ones where the Acinetobacter 
calcoaceticus NCIMB 9871 genes were under the regulation of their natural RBS produced 
the most 6-ACA overall. In some cases the difference was significant such as between 
pQR1553 and pQR1554, the former was the overall best producer with a total of                
138.70 mg/L under those drying conditions whilst the latter was only 53.18 mg/L; a 
considerable increase of 85.52 mg/L given the only difference between the two clones is 
the RBS. This could indicate that the subtle differences in the RBS may have large effects in 
vivo. This was the case with ChnB, in pQR1553 it's RBS is only GGAGA at position -6 
whereas in pQR1554 it was AGGAG at position -7 yet pQR1554 had 76.62 mg/L more 
cyclohexanone than pQR1553. In that instance no caprolactone was detected so a low 
functioning ChnC cannot account for this difference i.e. a build up of caprolactone could 
substrate inhibit cyclohexanone monoxygenase therefore creating a build up of 
cyclohexanone. Secondly, the prediction that the rank order of TAm's should be 
Psudomonas putida (PP5182), Deinococcus geothermalis (DGEO_2743) followed by 
Micrococcus luteus (MLUT_00920) was slightly inaccurate. In fact pQR1557 produced 72.51 
mg/L more 6-ACA than pQR1555 whilst the screen suggested that it would be closer 
between the two enzymes. However cyclohexanone concentration was important and 
pQR1553 had the lowest amount present at the end of fermentation.    
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After the drying method was shown to be very important to the amount of 6-ACA detected, 
pQR1553 was still the highest producing clone. Four different media were screened and 
showed that the medium drastically influenced the amount of 6-ACA produced from                
10 mM cyclohexanol. The four media screened were BHI, 2xTY, NB and NZCYM. The make-
up of these media is complex and have Nitrogen and Carbon supplies from different 
sources. NB performed the worst producing zero 6-ACA whilst 2xTY produced the largest 
amount achieving 264.48 mg/L from 10 mM cyclohexanol. This could suggest that the 
Nitrogen source is a critical factor. Both contain Yeast extract to provide a carbon source 
and vitamins plus some peptides however the largest source of Nitrogen is provided by 
either peptone or tryptone. Since NB and BHI contain peptone whilst NZCYM and 2xTY 
contain hydrolysed or tryptic digests of casein with the former two producing the lowest 
and the latter two producing the largest concentration of 6-ACA, the Nitrogen source 
appears to be important. Casein is a protein sourced from milk whilst peptone can be 
sourced by a variety of means ranging from soymilk to meat and so the Nitrogen content is 
variable. This could impact the amount of 6-ACA produced. 
The substrate concentration of cyclohexanol also play a pivotal role in the production of          
6-ACA. Although in vitro enzyme studies suggested that the majority of enzymes would 
remain active at high substrate concentrations (as high as 500 mM in some cases), the 
added complication of mass transfer as well as co-factor availability will impact the 
enzymes ability to replicate these results. Also the enzymes in vivo are at a significantly 
lower concentration than was tested in vitro which would also have an impact on the 
cyclohexanol concentration that could be utilised. The results suggested that after 
screening on three different concentrations of cyclohexanol, that at 30 mM, the largest 
concentration of 6-ACA was produced (222.3 mg/L) and at both 20 mM and 30 mM 
significantly higher levels of other intermediates were also present. However at 50 mM, the 
pathway really stalled at cyclohexanone. There was approximately 50:50 of cyclohexanol 
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and cyclohexanone but no other intermediates were detected. This is significant since it 
would appear that the overall total molar amounts of intermediates was also reduced with 
only 43.9% recovered compared to 76.8% accountable from 20 mM cyclohexanol. This 
could mean that over the course of the incubation period, because cyclohexanol could be 
slow to enter the cells because of the reduced solubility at this concentration, it partially 
evaporated. Also because there was no caprolactone present, the BVMO was therefore 
inactive and given that there was also substantial amounts of cyclohexanol present, it 
seems logical that the cyclohexanol dehydrogenase was substrate inhibited. It is also 
possible that at 500 mM and 37oC, cyclohexanol is only partially soluble in water since at 
30oC it's soluble to 2.15 g in 50ml of water (source: ncbi database, 500 mM 2.5 g in 50ml 
water) so it is possible at the higher temperature it may not be available to the cells.   
 
7.5 Addition of a second copy of ChnD and a T7 promoter and 
terminator offers no improvement 
A second copy of ChnD under the control of its own T7 promoter and terminator was 
cloned in order to try and reduce the amount of 6-hydroxyhexanoate building up so as to 
hopefully convert more into 6-oxohexanoate for transamination. Whilst a marginal 
improvement in 6-ACA was achieved on 10 mM cyclohexanol in LB media compared to 
pQR1553, pQR1559 also had higher concentrations of adipic acid and 6-hydroxyhexanoate 
acid. This suggests that the transamination was a bottleneck since a build up of                           
6-oxohexanoate could be converted to adipic acid and also lead to a build up of                          
6-hydrohexanoate. Conversely, pQR1559 overall performed less well at higher substrate 
concentrations and on the different media. Whilst pQR1553 produced 222.3 mg/L of 6-ACA 
on 30 mM cyclohexanol in LB media, pQR1559 only produced 151.2 mg/L. Less                         
6-hydroxyhexanoate was also detected as well as adipic acid than the pQR1553 
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experiments. This data suggests a conflict with the 10 mM cyclohexanol data for pQR1559 
because if there was a bottleneck in the transamination at these higher substrate 
concentrations then both adipic acid and 6-hydroxyhexanoate should have increased. 
Because solvent extraction wasn't done on the pQR1559 at higher cyclohexanol 
concentrations, the amounts of cyclohexanol, cyclohexanone and caprolactone can't be 
determined. It is entirely possible that at these higher concentrations there was a more 
significant build up of cyclohexanone and cyclohexanol in pQR1559. This could be feasible 
since there are indications of  back end substrate inhibitions in pQR1559 on 10 mM which 
could also lead to a front end build up of metabolites which become more apparent at 
higher cyclohexanol substrate concentrations. Kinetic modelling of each enzyme step 
would need to be done in order to determine if the TAm step is indeed the rate limiting 
step and rate equatons would need to be calculated. In conclusion, none of the conditions 
explored on pQR1559 increased the concentration of 6-ACA achieved with pQR1553 on 10 
mM cyclohexanol in 2xTY media.  
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Chapter 8: Conclusion and future 
work
180 
 
8 Conclusion 
8.1 Restatement of aims and achievements 
The aims of the project were initially split into three distinct phases. The first of these 
phases was to assemble an operon consisting of only the Acinetobacter calcoaceticus 
NCIMB 9871 genes. It was decided that it would be interesting to see what effect the RBS 
had on the intermediate profile and whether natural RBSS would be more productive since 
these may have evolved to finely tune the pathway flux by way of moderating enzyme 
expression levels. Two versions were assembled, one where all had their natural RBS and 
the other were they all had the same. Genomic samples of the Acinetobacter calcoaceticus 
NCIMB 9871 was used to amplify the four required genes. These genes exist as a cluster, 
directed in different orientations which made extracting the group together not an option. 
Instead this allowed the omittance of any gaps between the genes as well as it being easier 
to redesign the RBSS of each gene by way of simply altering the primer for the PCR. This 
phase of the project was anticipated to be the most challenging since assembling multiple 
genes in a single operon and plasmid has traditionally been difficult to do with restriction 
enzymes. Multiple unique restriction sites as well as several possible buffers would likely be 
needed. Coupled with potential problems which are inherent with PCR such as failing and 
the difficulty of assembling several DNA fragments (i.e. in terms of successful assembly 
with minimal false positives) a significant amount of time was thought to be needed. 
Instead however, because a nested approach was taken to each gene as well as successful 
PCR's, both operon versions were assembled very rapidly. Gibson assembly was initially 
attempted however this was unsuccessful and results suggested that only two of the four 
genes joined properly. Instead circular polymerase extension cloning (CPEC) was tried and 
worked very well. Throughout this work results varied in terms of how many successfully 
assembled plasmids were generated in each CPEC reaction although broadly speaking 
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around half of all colonies screened digested as expected. It's not quite clear why Gibson 
assembly was unsuccessful and would only join certain fragments up. The optimum 
conditions were not investigated however it did appear that cycle number had an affect; 
later on in the project when the TAm's were added into each operon they required a,  
fewer cycles to work as well as high gene GC content being problematic (see chapter 4.2.6).    
The second phase of the project was to screen a library of ω-TAm's for the best activity on 
6-oxohexanoate whilst having minimal on cyclohexanone. One screening method 
developed for testing for TAm activity which is popular in our research group involves using 
sMBA (S-Methylbenzylamine) as the amine donor and detecting the appearance of 
acetophenone at 254nm via HPLC. The larger the peak area for acetophenone, the greater 
the conversion of sMBA and therefore the better the enzyme activity.  Instead of this, 
Alanine was used since in vivo it is one of the most abundant amino acids. The pyruvate 
generated after transamination was detected via an LDH assay. Overall this method is likely 
to have a degree of inaccuracy for a number of reasons. Firstly there were significant 
differences seen when using 6-oxohexanoate produced biocatalytically or chemically 
however this could be attributed to reduced amounts of 6-oxohexanoate theoretically 
present from the biocatalytically produced route. However three candidates were found to 
exhibit good activity on 6-oxohexanoate whilst having minimal on cyclohexanone and these 
were PP5182 from Pseudomonas putida, DGEO_2743 from Deinococcus geothermalis and 
MLUT_00920 from Micrococcus luteus and were ranked in that order. Once pathway 
intermediates were detected and quantified by GC-MS, the actual order of best producing 
TAm was PP5182, MLUT_00920 and DGEO_2743 in the same operon construct with the 
natural RBS sites for the Acinetobacter calcoaceticus genes. Although the actual rank was 
slightly different to what was predicted, the important finding was that taking into account 
the activity on cyclohexanone was very important. PP5182 was not identified as having the 
largest activity on 6-oxohexanoate by a considerable margin, however it did have the 
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lowest activity on cyclohexanone. Importantly all three showed very little cyclohexylamine 
formation in either operon version which also helps to validate the TAm screening LDH 
assay. Looking at figure 34 in chapter 4.2.4 one can see that several TAms had either very 
good activity on either molecule or very poor activity. It is also likely that pQR804 might 
have been a potential target for incorporation ranking 4th overall and was the only other 
enzyme to exhibit good activity on 6-oxohexanoate and a low amount on cyclohexanone. 
Importantly 15 of the 28 TAm's showed very good activity on cyclohexanone also.  
The final phase of the project came after cloning in the ω-TAms into each operon (with the 
exception of MLUT_00920 into operon B; artificial RBS); the intermediate profile of cells 
grown with media supplemented with cyclohexanol was then identified. The first three 
molecules in the pathway have markedly different  chemistries to the latter half in terms of 
boiling points and solubility in solvents. This made detecting these by GC-MS simple and by 
mixing Ethyl acetate with the sonicated culture samples and centrifuging, the molecules 
pulled easily out of solution into the organic layer. 6-hydroxyhexanoate, 6-ACA, adipic acid 
and cyclohexylamine however have higher boiling points and were not very soluble in the 
Ethyl acetate. In this instance the samples were dried and derivatised in a molar excess of 
BSTFA and TMCS to increase volatility and solubility in the organic solvent. An important 
find was that the method of preparing the standards of 6-ACA was important. If it was 
prepared in a concentrated solution ( concentrations less than 1 g/L were not tested) in 
Ethyl acetate, derivatised and diluted at various concentrations, significant amounts of 
acyl-transfer appeared to have occurred. Alternatively if it was diluted from a concentrated 
solution in water (the only solvent to dissolve 6-ACA directly) and subsequently dried, then 
significant polymerisation appeared to be initiated. This is thought to be caused by the 
equilibrium moving to the right and releasing water to counteract the low concentration of 
water in a high concentration of 6-ACA solution (>1g/L only tested). To circumvent this, a 
standard curve was made by making different concentrations of 6-ACA in non-induced cell 
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cultures grown in LB and processed in the same way. That way alternative amino acids 
were thought to mop up the acyl transfer. Also because the volume of the culture was 
larger, the smaller concentrations of 6-ACA were easier to weigh. this method produced a 
linear standard curve. In future standards must be prepared like this or possibly in low 
concentrations and at high volumes of water e.g. 500 ml at 100 mg/L.     
Although it turned out that the method of drying the samples impacted on the amount of 
6-ACA that was detected (i.e. speed vac compared to leaving to evaporate), the highest 
producing clone on 10 mM cyclohexanol was pQR1553 i.e. natural RBSS for the 
Acinetobacter caloaceticus genes along with PP5182. This validated that the ω-TAm screen 
was correct as well as highlighting the large effect the RBS has on the intermediate profile. 
Although when expressed, by eye, there appeared to be no or very little change in enzyme 
concentration between the two operon versions, there must've been some at a level to 
cause significant differences. In all cases, operon A was the highest producer of 6-ACA and 
in the case of PP5182, a difference of 85.52 mg/L. From experiments done on the individual 
enzymes from Acinetobacter as well as information from the literature for the CHMO, it 
was highlighted that there would likely be large amounts of cyclohexanone and 6-
hydroxyhexanoate, the former because of substrate and product inhibition, the latter due 
to poor activity. After looking at the intermediate profile of pQR1553 in more depth these 
indications, at 10 mM were partially correct in that only very small amounts of 
cyclohexanone were present however 6-hydroxyhexanoate was present at the highest 
concentration. When grown on 10 mM cyclohexanol in LB media pQR1553 achieved an 
average of 189.54 mg/L 6-ACA. The choice of media actually had a large effect on the 6-ACA 
levels achieved as well as the intermediate profile in general. In fact 2xTY media was the 
best where cultures grown on 10 mM cyclohexanol produced 264.48 mg/L (2.02 mM). A 
cyclohexanol concentration screen was done using 20 mM, 30 mM and 50 mM 
cyclohexanol in LB media. 30 mM produced the most amount of 6-ACA at 223.3 mg/L 
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representing a 0.26 mM increase from 10 mM cyclohexanol. Interestingly however 
cyclohexanone and 6-hydroxyhexanoate concentrations  rose sharply (an 8.67 mM and 
2.49 mM increase respectively) and even at 20 mM cyclohexanone was found to be at over 
845.82 mg/L, a sharp increase from 10 mM cyclohexanol. Adipic acid concentrations also 
increased with higher concentrations of cyclohexanol with the exception of 50 mM where 
no compounds after cyclohexanone were identified. This increase could be attributed to a 
build up of 6-oxohexanoate for which the TAm's couldn't react with fast enough leading to 
high activity from aldehyde dehydrogenases.   
Whereas cyclohexanone levels seem to depend on the concentration of cyclohexanol fed in 
bolus, 6-hydroxyhexanoate was consistently shown to be present at high levels in all 
cyclohexanol concentrations and media screens. Efforts to reduce this by cloning in a 
second, independently expressed ChnD into the plasmid increased 6-ACA levels from 10 
mM cyclohexanol but reduced the amounts seen at higher substrate concentrations as well 
as achieving lower titres when grown on the various different media. Although no solvent 
extraction phase were ran for these experiments, there is a potential that the ω-TAm 
(PP5182) couldn't process the excess 6-oxohexanoate quick enough which led to an 
increase in 6-hydroxyhexanoate and adipic acid. More investigation into this would need to 
be completed to determine the metabolic profile better however the bottom line is that at 
no conditions tested (i.e. the same ones for pQR1553) did pQR1559 outperform pQR1553 
in terms of 6-ACA production. In conclusion the largest amount of 6-ACA observed at 
264.48 mg/L was when pQR1553 was grown on 2xTY media and then supplemented with 
10 mM cyclohexanol.   
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8.2 Yield comparison from published results 
In order to assess the success of the 6-ACA titre, it is important to, where possible, 
compare these results with published results from the literature. Whilst it is known that 
there are several industrial chemical companies which are manufacturing 6-ACA 
biologically; yield information from these is limited at best. Even still, published research 
for producing 6-ACA is also scarce. Zhou et al published results using design of experiments 
and in a 32 member fractional factorial library which simultaneously compared the 
expression levels and media composition and found optimum conditions. They have 
engineered an E.coli strain to produce 6-ACA from α-ketoglutarate using 6 heterologous 
enzymes each under the control of their own promoter (Zhou et al., 2015). They claim that 
in shake flask culture they increased titres from 9mg/L to 48mg/L and when grown in a 10L 
fermenter less side products were found and a titre of 160mg/L was achieved. Their work 
was interesting as it showed the power of a combined DoE method and the importance of 
the correct promoter and RBS as well as an optimum media.  A different approach was 
taken by Sattler et al who used a combination of enzymes to convert cyclohexanol into                
6-ACA in very similar to the work presented in this thesis with several notable differences 
(Sattler et al., 2014). Firstly their work was wholly in vitro and used purified enzymes in a 
one pot reaction. Secondly they considered 6-hydroxyhexanoic acid a dead end product 
and used methanol as a nucleophile to open caprolactone which would cap the carboxyl 
group. The reason for this is they had initially tested a library of primary alcohol 
dehydrogenases, including the 6-hydroxyhexanoate dehydrogenase from Acinetobacter 
calcoaceticus NCIMB 9871 that is presented in this thesis however this was one of only two 
that worked yet they had problems expressing ChnD and noted its inability to tolerate high 
substrate loading; this reaffirms the findings in this thesis. They found that, rather 
surprisingly, when the carboxylic acid moiety was converted into a methyl ester (i.e. ring 
openning of caprolactone with methanol), that the activity of all the alcohol 
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dehydrogenases greatly increased which suggested the actual carboxyl group was 
inhibitory to the oxidation. They then used an alcohol dehydrogenase to create                       
6-oxohexanoic acid and then subsequently an ω-TAm to create the 6-ACA. Their yields 
were 12mM 6-ACA (1.57g/L) from a 50mM cyclohexanol substrate concentration and after 
20h 17.5mM cyclohexanol was remaining. The supplementary data shows that each 
enzyme was purified and used in milligram quantities. Although the work was impressive 
from a yield point of view, industrial use would be limited due to the massive cost of the 
enzymes and co-factor which would be incurred which would ultimately prove inhibitory to 
large scale manufacture.   
The work presented by Turk et al shows they cloned 11 enzymes onto plasmids and utilised 
TCA intermediates for substrates to produce 6-ACA. They achieved yields of 160 mg/L                 
6-ACA from batch shake flask experiments. Of the three papers described above, it can be 
seen that the results from the work described in this thesis show a marked larger titres in 
comparison with other in vivo processes. With very little in depth optimisation, titres were 
still higher than even those achieved after DoE as well as from concentrating the cells down 
(Turk et al., 2015).  
 Although titres achieved were relatively high when compared with research producing               
6-ACA, in a wider context it still has some way to go to catch-up with amounts produced of 
other biopolymer monomers. Kind et al have produced a clone of C.glutamicum which 
firstly over-produced Lysine from glucose and then further engineered it to express a 
codon-optimised Lysine decarboxylase to produce the diamine cadaverine (aka 
diaminopentane) and achieved titres of 88g/L from fed batch fermentations (Kind et al., 
2014). The fact that the genes were incorporated into the genome as well as the fact that 
Lysine is a naturally occurring amino acid which is then decarboxylated are likely to have 
contributed to achieving this titre. Another Nylon precursor which is also produced in the 
187 
 
pathway described in this project is adipic acid. Of great interest in the bioproduction of 
adipic acid is the precursor cis cis muconic acid which chemically hydrogenated to produce 
adipic acid. Although usually produced from benzene, Niu et al, produced it from D-glucose 
in E.coli cells by transforming 6 enzymes and achieved an overall titre of 36.8 g/L from a fed 
batch fermentation (Niu, Draths and Frost, 2002). An interesting alternative to cis cis 
muconic acid production was by Jung et al who used Klebsiella pneumoniae which naturally 
expresses all enzymes to produce ccMA however lacks the necessary carbon flux to 
produce it. The group engineered the strain to increase the amount of catechol (a ccMA 
precursor) and subsequently over express the catA gene (catechol 1,2-dioxygenase) which 
converts it to ccMA. Further deletions of the degradative enzymes media improvements 
achieved a titre of 2.1g ccMA (Jung, Jung and Oh, 2015). Putrescine (1,4-diaminobutane), a 
4 carbon diamine is produced naturally in E.coli and is combined with adipic acid to form 
polyamide 6,4. This is currently produced at around 10,000 tonnes per annum and so is 
another molecule with potential interest. Qian et al, have engineered an E.coli strain to 
produce Putrescine by deleting degradation pathways and achieved a titre of 1.68g/L with 
a total conversion of 0.168 g/g of glucose (in comparison, the pathway described in this 
thesis produced 0.268g6-ACA/gcyclohexanol). After fermentation and high cell culture a maximum 
of 24.2 g/L was achieved (Qian, Xia and Lee, 2009).  
Finally, GABA (γ-aminobutanoic acid) is a 4 carbon homologue of 6-ACA and has been 
produced from the decarboxylation of glutamate by Le Vo et al and achieved a total titre of 
5.5 g/L (Vo, Kim and Hong, 2012).     
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8.3 Future work 
8.3.1 Design of Experiments and fermentation 
The original aims set out for this project have been completed however there are several 
avenues with which to progress this project. One option with regards to the current 
pQR1553 plasmid is to fully optimise the feeding strategy and growth conditions. The work 
presented in this thesis outline a potential starting point and since much time has been in 
developing the analytics and overcoming associated technical problems, very little time  
was left to explore the optimum conditions. Despite this, yields are comparatively high to 
what is currently published in the literature and by utilising DoE, factor interactions, ideal 
promoter and RBS designs as well as optimum conditions can be found. As explained 
above, there is a theory that the source of protein is important and so the make-up of the 
media and could also be investigated and an ideal minimal media could be designed. 
Potential factors to investigate include the rate of feeding of cyclohexanol (fed-batch or 
continuous), stirrer speed in a fermenter, pH and temperature. Whether a spike of 
cyclohexanol, or indeed the rate at which the 10 mM cyclohexanol was metabolised, or a 
continual dilute feed would be most ideal would need to be investigated. This work showed 
that high concentrations of cyclohexanol supplied in a bulk volume is detrimental to 6-ACA 
production however, can it be said that a 200 mM solution fed slowly over several hours is 
detrimental? I don't believe so. I feel it is likely that the cyclohexanol is metabolised quickly 
however the evolution of 6-ACA also needs to be identified.  
 
 
 
189 
 
8.3.2 Coupling with central metabolism and further plasmid engineering 
In the effort to produce 6-ACA in a wholly green method of manufacture, ultimately the 
synthesis of cyclohexanol will need to be coupled to the bacteria's central metabolism. 
Currently there is a PhD project in the Ward lab which is undertaking this. Schikimic acid is 
a molecule produced from glucose in the central metabolism of bacteria in the common 
aromatic biosynthetic pathway and is responsible for several amino acid synthesis 
(Herrmann, 1995). A gene cluster from Streptomyces rishiriensis (MycA4-1 )  is being 
integrated into the pathway and subsequent thioesterases, decarboxylases and P450's are 
being investigated to generate the cyclohexanol in a pathway shown in figure 1. Owing to 
the potential size of such a plasmid as well as taking into account the five genes in the 
operon from this work, genome integration is likely to be required to reduce the cellular 
burden.  
Figure 8.1 Proposed pathway for cyclohexanol production from central metabolism 
Aside from integrating with the genome, future work could be carried out on the pQR1553 
plasmid. The RBS has been shown to have a dramatic effect on the production titre of 6-
ACA and the intermediate profile and so further mutations and optimisations of this by 
introducing point changes and deletions could also be explored. 
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Appendix A 
This section contains the sequences and primers used to create the pQR plasmids 
containing with the full metabolic operon. The sequences include that which was used to 
generate the nested fragment templates which were then subsequently used in all other 
modification steps. Also included are the primers used to generate the individual his-tagged 
proteins for purification as well as the primers used to add in a second copy of ChnD T7 
promoter, operator and terminator.  
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A.1. Isolating the nested fragments and creating operon A and B 
 
Table 8.1 contains the primers used to generate the nested fragments which were 
subsequently used as templates for all further modifications such as changing RBS, adding 
homologous overlaps and restrictions sites. The gene cluster sequence of 16.141 kb was 
accessed from NCBI available at:           
https://www.ncbi.nlm.nih.gov/nuccore/AB006902.2?report=fasta&to=16160 
 
Nested ChnA for 5' CTTCTTCTCAGGCAGATTCGCAG  
Nested ChnA rev 5' AGACGAGTCATCTACCGGATCTG 
Nested ChnB for 5' AAG CCT TGT GAT TGC ATT CCT GC    
Nested ChnB rev 5' TTA GGC ATT GGC AGG TTG CTT G 
Nested ChnC for 5' CGTGTGGGCACTGATTTATGCT    
Nested ChnC rev 5' GTATCAAACCAGTGATGCAAAGCC 
Nested ChnD for 5' CACTCAGGTCTTTGCGCAATTTC 
Nested ChnD rev 5' GATTCATGCACTGTTACTGCGTG 
Table 8.1 A table of the primers used to generate the nested fragment from the metabolic cluster 
from Acinetobacter calcoaceticus NCIMB 9871 
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The above primers created the following gene fragments when using a genomic sample 
from Acinetobacter calcoaceticus NCIMB 9871. The gene is in bold and underlined and the 
flanking nested portion is not. ChnA, ChnC and ChnC were in the reverse direction and so 
the above ''for'' primer would then become the reverse primer of the gene.  
ChnA nested fragment 
AGA CGA GTC ATC TAC CGG ATC TGG TTT CTT GAA TCT TAA AAT ATG AAA CAA GCT TTG 
ATG CTT AAA ATT TGA AAT GGA AAA AAT T ATG TCA AAT AAA TTC AAC AAT AAA GTC GCT 
TTA ATT ACT GGC GCT GGT TCA GGT ATT GGT AAA AGC ACC GCA CTG CTT TTG GCT CAA 
CAG GGT GTA AGT GTA GTG GTT TCA GAT ATT AAC CTG GAA GCA GCA CAG AAA GTT GTG 
GAC GAA ATT GTC GCT TTA GGC GGG AAA GCG GCT GCG AAT AAG GCC AAT ACT GCT GAG 
CCT GAA GAC ATG AAA GCT GCA GTC GAG TTT GCG GTC AGC ACT TTT GGT GCA CTG CAT 
TTG GCC TTC AAT AAT GCG GGA ATT CTG GGT GAA GTT AAC TCC ACC GAA GAA TTG AGC 
ATT GAA GGA TGG CGT CGT GTG ATT GAT GTG AAC TTG AAT GCG GTT TTC TAC AGC ATG 
CAT TAT GAA GTT CCT GCA ATC TTG GCC GCA GGG GGC GGA GCG ATT GTC AAT ACC GCT 
TCT ATT GCA GGC TTG ATC GGG ATT CAA AAT ATT TCA GGC TAT GTC GCT GCA AAA CAT 
GGC GTA ACG GGT CTA ACG AAA GCG GCG GCA TTG GAA TAT GCA GAT AAA GGG ATT 
CGC ATT AAT TCA GTA CAT CCT GGC TAT ATC AAA ACG CCT TTG ATT GCA GAA TTT GAA 
GAA GCA GAA ATG GTA AAA CTA CAT CCG ATT GGT CGT TTG GGA CAG CCG GAA GAA GTT 
GCT CAG GTT GTT GCC TTC CTA CTT TCT GAT GAT GCT TCA TTT GTG ACC GGT AGT CAG 
TAT GTG GTC GAT GGT GCA TAT ACC TCG AAA TAA AAA ATG AGT AGA AGA TAC CCC CAT 
ATA AAG AGG AAA GAG GGG TGA TAC CCT CTT TTC TTT TAT CTA TTG TTG TAA GGG AAA 
ATT TTT CTT TGC TGC GAA TCT GCC TGA GAA GAA G 
 
ChnB nested fragment 
AAG CCT TGT GAT TGC ATT CCT GCG ATT CTT TAT TCA ATG AAT AAG CAA TGC TAT TAA TCA 
GCA ATG AAT AAC CAG CAC TGC AGA TTT TGA ATA AAT TCA CAT GTC GTA ATG GAG ATT 
ATC ATG TCA CAA AAA ATG GAT TTT GAT GCT ATC GTG ATT GGT GGT GGT TTT GGC GGA 
CTT TAT GCA GTC AAA AAA TTA AGA GAC GAG CTC GAA CTT AAG GTT CAG GCT TTT GAT 
AAA GCC ACG GAT GTC GCA GGT ACT TGG TAC TGG AAC CGT TAC CCA GGT GCA TTG ACG 
GAT ACA GAA ACC CAC CTC TAC TGC TAT TCT TGG GAT AAA GAA TTA CTA CAA TCG CTA 
GAA ATC AAG AAA AAA TAT GTG CAA GGC CCT GAT GTA CGC AAG TAT TTA CAG CAA GTG 
GCT GAA AAG CAT GAT TTA AAG AAG AGC TAT CAA TTC AAT ACC GCG GTT CAA TCG GCT 
CAT TAC AAC GAA GCA GAT GCC TTG TGG GAA GTC ACC ACT GAA TAT GGT GAT AAG TAC 
ACG GCG CGT TTC CTC ATC ACT GCT TTA GGC TTA TTG TCT GCG CCT AAC TTG CCA AAC 
ATC AAA GGC ATT AAT CAG TTT AAA GGT GAG CTG CAT CAT ACC AGC CGC TGG CCA GAT 
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GAC GTA AGT TTT GAA GGT AAA CGT GTC GGC GTG ATT GGT ACG GGT TCC ACC GGT GTT 
CAG GTT ATT ACG GCT GTG GCA CCT CTG GCT AAA CAC CTC ACT GTC TTC CAG CGT TCT 
GCA CAA TAC AGC GTT CCA ATT GGC AAT GAT CCA CTG TCT GAA GAA GAT GTT AAA AAG 
ATC AAA GAC AAT TAT GAC AAA ATT TGG GAT GGT GTA TGG AAT TCA GCC CTT GCC TTT 
GGC CTG AAT GAA AGC ACA GTG CCA GCA ATG AGC GTA TCA GCT GAA GAA CGC AAG 
GCA GTT TTT GAA AAG GCA TGG CAA ACA GGT GGC GGT TTC CGT TTC ATG TTT GAA ACT 
TTC GGT GAT ATT GCC ACC AAT ATG GAA GCC AAT ATC GAA GCG CAA AAT TTC ATT AAG 
GGT AAA ATT GCT GAA ATC GTC AAA GAT CCA GCC ATT GCA CAG AAG CTT ATG CCA CAG 
GAT TTG TAT GCA AAA CGT CCG TTG TGT GAC AGT GGT TAC TAC AAC ACC TTT AAC CGT 
GAC AAT GTC CGT TTA GAA GAT GTG AAA GCC AAT CCG ATT GTT GAA ATT ACC GAA AAC 
GGT GTG AAA CTC GAA AAT GGC GAT TTC GTT GAA TTA GAC ATG CTG ATA TGT GCC ACA 
GGT TTT GAT GCC GTC GAT GGC AAC TAT GTG CGC ATG GAC ATT CAA GGT AAA AAC GGC 
TTG GCC ATG AAA GAC TAC TGG AAA GAA GGT CCG TCG AGC TAT ATG GGT GTC ACC GTA 
AAT AAC TAT CCA AAC ATG TTC ATG GTG CTT GGA CCG AAT GGC CCG TTT ACC AAC CTG 
CCG CCA TCA ATT GAA TCA CAG GTG GAA TGG ATC AGT GAT ACC ATT CAA TAC ACG GTT 
GAA AAC AAT GTT GAA TCC ATT GAA GCG ACA AAA GAA GCG GAA GAA CAA TGG ACT 
CAA ACT TGC GCC AAT ATT GCG GAA ATG ACC TTA TTC CCT AAA GCG CAA TCC TGG ATT 
TTT GGT GCG AAT ATC CCG GGC AAG AAA AAC ACG GTT TAC TTC TAT CTC GGT GGT TTA 
AAA GAA TAT CGC AGT GCG CTA GCC AAC TGC AAA AAC CAT GCC TAT GAA GGT TTT GAT 
ATT CAA TTA CAA CGT TCA GAT ATC AAG CAA CCT GCC AAT GCC TAA 
 
ChnC nested fragment 
GTA TCA AAC CAG TGA TGC AAA GCC ACT CTT TAG ATT TGG ATC TTT GAT GGC ACT CAA 
GTT TTT ATA TCT TCA TGG AAT AAA ACT AGG ATT TAT TCC TTA AAT ATC AAA TCA AGG ATT 
TTA AA A TGA ATA GCA CAC AAA GCA ATA CTC AAT TTC TTT TCG ATT TAT ATG CGA ACT 
GGT CAA GAC GGA TGC AGG AAA ATC CGA ATA TGA CCA TTG AAG ACT TTC GCA GTA TGT 
TTG ATG AAT GGC ATC AAC CTA CAT TGG AAC CGG AAG AAG TGT CTT ATA AAT TCG ATG 
TTG TGG CAG GTG TAG AAG GTC TTT GGA TTT ATC CGA AAG ATG CTG ACT TAT CCA AAG 
TCA TCA TTT ATA CCC ATG GCG GTG GAT TTG CGG TCG GTT CTT CGG CCA GTC ACC GTA 
AGC TGG TGG GGC ATT TGG CCA AGT ATT TAG GGG TAT CCG CAT TTG TGG TTG ATT ACC 
GAC GTT CAC CAG AAC ATG TCT TCC CGG CAC AAA TTC AGG ACG TGA CAG CAG TAT ATA 
AAG AAC TAC TCC AGC GTG GCT TTA CTG CAA AAA ATA TGC TGA CCG CAG GGG ATT CTG 
CGG GGG GGA ATC TGG CGA TAT CAA CCG TAC TCA ATC TAC GAA ATG AAG GGA TTG AGT 
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TGC CAG GAG CAG TGA TTG CAT TCT CTC CTT GGC TGG ATA TGG AGC ACA AAG GTG AAA 
CCC TGA TCA GCA ACG ATG CCA CTG ATG CCT TGA TTA CAG TGG ATC TGC TTA AAG GCA 
TGT CAC AAA TGT TCT TGG GTG AAC ATG GTG ATC CGG CAA ATC CAT TGG CGA ATC CGT 
TAA AAG CCA ATT ATC AGG TTT TCC CAC GTT TGT ATA TCA ATG CCG GAT CAG TTG AAT 
CAC TTG TAG ACA ATG CAA CAC GTC TTG CTG ATA TTG CAA AAA AAG AGG GTG TTG ATG 
TGA CTT TAT CTG TGG TGG ACA ACA TGC AGC ACG TTT TTC CTT TCC TAG CTG GGC GTG 
CAA GTG AAG CTG ATC AAG AAT TAG CGA AAA TTG CGC AGT GGT TTA AAG CAT AAA TCA 
GTG CCC ACA CG 
 
ChnD nested fragment 
GAT TCA TGC ACT GTT ACT GCG TGA CGC ATC ATG GAC AAC CAC TCG AAG ACG TTG AGA 
AAG AAA TTC CGC AAC CGA AAG GTA CTG AAG TTT TAC TCC ATG TAA AAG CCG CAG GTC 
TAT GCC ATA CGG ATT TAC ACT TAT GGG AAG GTT ATT ATG ATC TAG GTG GGG GCA AGC 
GTT TAT CCC TTG CAG ATC GTG GGC TGA AGC CAC CCT TAA CCT TAA GTC ATG AAA TTA 
CAG GTC AGG TGG TTG CTG TCG GTC CAG ATG CGG AAT CAG TCA AGG TCG GCA TGG TCA 
GCT TGG TTC ATC CAT GGA TTG GTT GCG GTG AAT GCA ACT ACT GTA AAC GTG GCG AAG 
AAA ACC TGT GTG CCA AAC CGC AAC AGT TAG GCA TCG CCA AGC CGG GTG GTT TTG CCG 
AAT ATA TCA TCG TGC CGC ATC CAC GAT ATC TGG TGG ATA TTG CAG GTC TGG ATC TGG 
CTG AAG CTG CAC CTT TGG CAT GTG CAG GCG TGA CAA CAT ACA GTG CAC TGA AAA AAT 
TCG GTG ATT TGA TTC AAA GCG AGC CGG TGG TGA TCA TTG GTG CCG GTG GTT TAG GGC 
TGA TGG CAC TCG AGT TGC TCA AAG CTA TGC AAG CCA AAG GCG CAA TCG TAG TTG ATA 
TTG ATG ACA GCA AAC TGG AAG CAG CAC GTG CTG CCG GTG CAT TAT CGG TCA TCA ATA 
GCC GAA GTG AGG ATG CTG CTC AAC AGC TGA TTC AGG CAA CTG ACG GTG GTG CAC GTC 
TGA TCC TTG ATC TGG TTG GCA GTA ATC CAA CAT TGA GCC TTG CCT TGG CGA GTG CTG 
CAC GTG GTG GGC ATA TTG TGA TCT GCG GAT TGA TGG GGG GAG AAA TTA AGC TTT CCA 
TTC CGG TGA TTC CAA TGA GAC CAC TCA CAA TCC AGG GCA GTT ATG TAG GGA CGG TAG 
AGG AAT TAA GAG AGC TGG TGG AGC TGG TGA AAG AAA CCC ACA TGT CAG CCA TTC CCG 
TGA AAA AAC TGC CAA TTT CGC AGA TCA ATT CCG CAT TTG GAG ACT TGA AAG ATG GCA 
ACG TCA TCG GGC GTA TTG TGC TTA TGC ACG AAA ACT GA T CAC CCA ACG TTT TTC CAT 
ATT TAA TAC CCA AAT CAA AAT CAA GAA ATT GCG CAA AGA CCT GAG TG 
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The following Table (Table 8.2) contains the primers used to create the gene fragments for 
the CPEC and gibson assembly reactions to create operon A (native RBS). pET29a was 
inverse PCR amplified to linearise it and create overlaps to ChnA and ChnD. 
 
OPA ChnA for 
Vector overlap 
(with NdeI site) 
AAGAAGGAGATATACATATGGGAAAAAATTATGTCAAATAAATTCAACAATAAAGTC 
OPA ChnA rev B ov  CCATTTTTTGTGACATGATAATCTCCTTATTTCGAGGTATATGCACCAT 
OPA ChnB for A ov ATGGTGCATATACCTCGAAATAAGGAGATTATCATGTCACAAA 
OPA ChnB rev C ov GTGTGCTATTCATTTTAAAATCCTTTTAGGCATTGGCAGGTTGC 
OPA ChnC for B ov GCAACCTGCCAATGCCTAAAAGGATTTTAAAATGAATAGCACAC 
OPA ChnC rev  D 
ov 
CACGCAGTAACAGTGCATGAATCTCTCCTTTTATGCTTTAAACCACTGCGCAATT 
OPA ChnD for C ov AATTGCGCAGTGGTTTAAAGCATAAAAGGAGAGATTCATGCACTGTTACTGCGTG 
OPA ChnD rev 
Vector overlap 
(with NotI site)  
TGGTGCTCGAGTGCGGCCGCTCAGTTTTCGTGCATAAGCACAATACG    
OPA pET29a 
inverse PCR rev 
ChnA overlap 
GAATTTATTTGACATAATTTTTTCCCATATGTATATCTCCTTCTTAAAG 
OPA pET29a 
inverse PCR for 
ChnD overlap 
GTATTGTGCTTATGCACGAAAACTGAGCGGCCGCACTCGAGCACCACCA 
Table 8.2 Primers to create the fragments for operon A; native RBS on the Acinetobacter genes. In 
italics and underlined are the restriction sites (NdeI on ChnA and NotI on ChnD). In bold and 
underlined is the native RBS used in operon A and in bold only is the gene. The 5' of the forward 
primer contains a stretch of nucleotides homologous to the 5' flanking end of the gene e.g. in the 
case of ChnA it would be the pET29a vector. These are immediately before  or after the restriction 
site or RBS. The reverse primer has the homologous region following the end of the gene. 
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The following table (Table 8.3) are the primers used to create the artificial RBS and overlaps 
for the CPEC assembly into operon B. The template was each respective nested fragment. 
The Tm was calculated based only on the gene binding portion and not the overlaps. 
pET29a was inverse PCR amplified to linearise it and create overlaps to ChnA and ChnD. 
OPA pET29a inverse PCR for ChnD overlap was used in Operon B on pET29a since this 
portion of the plasmid is identical in both versions of the operon.  
OPB ChnA for 
Vector overlap 
(with NdeI site) 
TTAAGAAGGAGATATACATATGAGGAGAAAATTATGTCAAATAAATTCAACAATAAAGTC 
OPB ChnA rev B ov  CCATTTTTTGTGACATGATAAACTCCTTTATTTCGAGGTATATGCACCAT 
OPB ChnB for A ov ATGGTGCATATACCTCGAAATAAAGGAGTTTATCATGTCACAAAAAATGG 
OPB ChnB rev C ov GCTTTGTGTGCTATTCATTTTAAACTCCTTTAGGCATTGGCAGGTTGCTTG 
OPB ChnC for B ov 
CAAGCAACCTGCCAATGCCTAAAGGAGTTTAAAATGAATAGCACACAAAGC 
 
OPB ChnC rev  D ov CACGCAGTAACAGTGCATGAATCACTCCTTTATGCTTTAAACCACTGCGCAA 
OPB ChnD for C ov TTGCGCAGTGGTTTAAAGCATAAAGGAGTGATTCATGCACTGTTACTGCGTG 
OPB ChnD rev 
Vector overlap 
(with NotI site)  
GTGGTGGTGGTGCTCGAGTGCGGCCGCTCAGTTTTCGTGCATAAGCAC 
OPB pET29a 
inverse PCR rev 
ChnA overlap 
GAATTTATTTGACATAATTTTCTCCTCATATGTATATCTCCTTCTTAAAG 
 
OPA pET29a 
inverse PCR for 
ChnD overlap 
GTATTGTGCTTATGCACGAAAACTGAGCGGCCGCACTCGAGCACCACCA 
Table 8.3 Primers to create the fragments for operon B; artificial RBS on the Acinetobacter genes. In 
italics and underlined are the restriction sites (NdeI on ChnA and NotI on ChnD). In bold and 
underlined is the artificial RBS used in operon A and in bold only is the gene. The 5' of the forward 
primer contains a stretch of nucleotides homologous to the 5' flanking end of the gene e.g. in the 
case of ChnA it would be the pET29a vector. These are immediately before  or after the restriction 
site or RBS. The reverse primer has the homologous region following the end of the gene. 
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A.2. Cloning the ω-TAm into both operon versions 
 
As stated in the results section, the PP_5182 TAm from Pseudomonas putida KT2440 and 
Dgeo_2743 from Deinococcus geothermalis were both cloned using CPEC. The primers for 
doing so are found in Table 8.4. The DNA sequences for both genes are listed below and 
obtained from the KEGG database. The OpA/B primers were used to inverse PCR both 
operon versions and removing the NotI site. Both TAm's used the AGGAG RBS and a BamHI 
site was introduced as the 6 nucleotide spacer between the RBS and the TAm. the 
linearised vector was then used as a template with subsequent primers to add on 
homologous overlaps for the TAm. The TAm was then amplified with it's respective 
overlaps, RBS and BamHI site. 
pQR810: Pseudomonas putida KT2440 gene construct  PP_5182  
DNA sequence:  
atgagcgtcaacaacccgcaaacccgtgaatggcaaaccctgagcggggagcatcacctc 
gcacctttcagtgactacaagcagctgaaggagaaggggccgcgcatcatcaccaaggcc 
cagggtgtgcatttgtgggatagcgaggggcacaagatcctcgacggcatggccggtcta 
tggtgcgtggcggtcggctacggacgtgaagagctggtgcaggcggcggaaaaacagatg 
cgcgagctgccgtactacaacctgttcttccagaccgctcacccgcctgcgctcgagctg 
gccaaggcgatcaccgacgtggcgccgaaaggtatgacccatgtgttcttcaccggctcc 
ggctccgaaggcaacgacactgtgctgcgcatggtgcgtcactactgggcgctgaagggc 
aaaccgcacaagcagaccatcatcggccgcatcaacggttaccacggctccaccttcgcc 
ggtgcatgcctgggcggtatgagcggcatgcacgagcagggtggcctgccgatcccgggc 
atcgtgcacatccctcagccgtactggttcggcgagggaggcgacatgacccctgacgaa 
ttcggtgtctgggccgccgagcagttggagaagaagatcctcgaagtcggcgaagacaac 
gtcgcggccttcatcgccgagccgatccagggcgctggtggcgtgatcatcccgccggaa 
acctactggccgaaggtgaaggagatcctcgccaggtacgacatcctgttcgtcgccgac 
gaggtgatctgcggcttcggccgtaccggcgagtggttcggctcggactactacgacctc 
aagcccgacctgatgaccatcgcgaaaggcctgacctccggttacatccccatgggcggt 
gtgatcgtgcgtgacaccgtggccaaggtgatcagcgaaggcggcgacttcaaccacggt 
ttcacctactccggccacccggtggcggccgcggtgggcctggaaaacctgcgcattctg 
cgtgacgagaaaattgtcgagaaggcgcgcacggaagcggcaccgtatttgcaaaagcgt 
ttgcgcgagctgcaagaccatccactggtgggtgaagtgcgcggcctgggcatgctggga 
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gcgatcgagctggtcaaggacaaggcaacccgcagccgttacgagggcaagggcgttggc 
atgatctgtcgcaccttctgcttcgagaacggcctgatcatgcgtgcggtgggtgacacc 
atgatcatcgcgccgccgctggtaatcagccatgcggagatcgacgaactggtggaaaag 
gcgcgcaagtgcctggacctgacccttgaggcgattcaataa 
 
pQR983: Deinococcus geothermalis gene construct Dgeo_2743 
DNA sequence: 
atgagcaagaatatcgattggcagaacctgggcttcagctacatcaagaccgacctgcgc 
taccgctcgcactggaaggatggcgagtgggacgcaggggtgctcaccgaggacaactgc 
gttcacatcagcgagggctcgaccgctctgcactacgggcagcagtgctttgagggtctc 
aaggcataccgccagcgcgatgggtcggtggtcctctttcgccccgaccagaacgcggcg 
cggatgcaggcgagctgcgagcggctgctgatgccgaccatttcgaccgagcagttcatc 
gctgcttgcgtgcaggtcgtgaaggccaacctggactatctgcctccctacggcacgggc 
ggcgccctctacctgcggccctacatgatcggtgtgggcgacaacctgggcgtacgcacc 
gccccggagttcctcttctccgtgttttgcgtaccggttggcgcctactttaagggcggc 
ctgactcctgccaactttatcgtttcgccctacgaccgggccgcaccccacggcaccgga 
gcggccaaggtgggcgggaactatgctgcgagcctcctccccggccacctcgccaaggaa 
cgcggctttgccgacgcgatctacctcgatccacagacccataccaagatcgaggaggtg 
ggggcggccaacttcttcgccatcacgcaggatgaccgcttcgtcacgccgcagtcgccc 
tccatcctccccagcatcaccaagttctcgctgctgcagctggcaagggagcggctgggc 
ctggaggtggaggaaggagacatctacatcgatcagctcgaccggtacaaggaggcggga 
gcctgcggcacggcggcggtgatcacgcccatcggcggcatccagtacggtgaccacttc 
cacgtcttttacagtgaaacggaggtcggcccggtgacccggcggctgtatgatgagttg 
gttggcatccagttcggggacatcgcggccccagagggctggctcgtccgagtggagtag 
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OpA/B for TCAGTTTTCGTGCATAAGCACAATACGC 
OpA/B rev GCTGCTAACAAAGCCCGAAAGG 
CPEC 810 rev 
 
GTTGTTGACGCTCATGGATCCCTCCTTCAGTTTTCGTGCATAAGCACAATACGC 
 
CPEC 810 for 
GAGGCGATTCAATAAGGATCCGCTGCTAACAAAGCCCGAAAGG 
CPEC 983 rev 
GATATTCTTGCTCATGGATCCCTCCTTCAGTTTTCGTGCATAAGCACAATACGC 
CPEC 983 for 
GAGTGGAGTAGGGATCCGCTGCTAACAAAGCCCGAAAGG 
Table 8.4 Primers used to inverse PCR both operon A and B plasmids, removing the NotI site and 
adding in overlaps for each TAm. In italics and underlined is the restriction site BamHI. In bold and 
underlined is the artificial RBS used for both TAm's. The 5' of the forward primer contains a stretch 
of nucleotides homologous to the 5' flanking end of the gene that end is going to be placed next too. 
 
Table 8.5 lists the primers used on plasmid minipreps of each TAm to generate the 
fragments required for the CPEC reaction.  
 
pQR810 ChnD o/v for 
GTGCTTATGCACGAAAACTGAAGGAGGGATCCATGAGCGTCAACAACCCGCAAAC 
pQR810 vec o/v rev 
CCTTTCGGGCTTTGTTAGCAGCGGATCC TT ATT GAA TCG CCT CAA G 
pQR983 ChnD o/v for 
GTGCTTATGCACGAAAACTGAAGGAGGGATCCATGAGCAAGAATATCGATTGG 
pQR983 vec o/v rev 
CCTTTCGGGCTTTGTTAGCAGCGGATCC CTA CTC CAC TCG GAC GAG 
Table 8.5 PCR primers used on plasmid minipreps from pQR810 and pQR983 to add on a ChnD and 
vector overlap, RBS and BamHI site to each TAm. 
 
After unsuccessfully attempting to clone pQR1014 by CPEC, it was cloned by standard 
restriction cloning using AvrII and BbvCI sites into operon A only. The RBS was added 
directed after ChnD which was immediately followed by the AvrII site. The BbvCI site was 
added to the 3' end of the MLUT_00920 (sometimes identified as MLUT_RS12025).   
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The DNA sequence for MLUT_00920 (aka MLUT_RS12025) is as follows: 
ATGTCCGAGCATCAGCAGCACGTCGGCCGCCGGGACCCCCGGATCAGCGACGAGGCCATCGAGCG
GGGCCGCCGCGCCCACGAGCTCGACCGCGCGCACGTGTTCCACTCGTGGAGCGCGCAGCGCGATC
TGAATCCGATGACCATCCTCGACGCCGAGGGGTCGTGGGTGTGGGACGGTGAGGGTCGGCCCATG
GTCGACTTCAGCGGGCAGCTCGTCTTCACGAACGTCGGCCACCGCCACCCGAAGATCGTGGCCGCG
ATCCGCGAACAGGCCGAGACGCTCGCCACCGTGGCCCCGCAGCACGTCAACGACGCCCGGTCCGA
GGCAGCCCGGCTGATCACCGAGCGGCTGCCGGAGTCCATCAACCACGTGTTCTTCACGAACGCGG
GCGCGGAGGCCAACGAGCACGCGGTGCGGATGGCACGCCTGCACACGGGTCGGCACAAGGTGCT
CTCCGCGTACCTCTCGTACCACGGCGCCACGCGCCTGACCGCGAACCTGACCGGCTCCCTGCGACG
CGTGGGCTCGGACTCGGCGTCCGACGGCGTCGTGCACTTCCAGCCCGCGTACACGTACCGCTCCGC
GTTCGGCTCGGAGAGCGATGAGCAGGAGGCCGAGCGCGCGCTGGCCCACCTGCGCGACGTGATC
GAGCTCGAGGGTCCCTCCACCGTGGCCGCCGTGGTCCTCGAGGCCGTCCCCGGCACCGCGGGCAT
CTTCCTGCCGCCGCCGGGCTACATGGCCGGCGTCGGGGAGCTGTGCCGCGAGCACGGGATCCTGC
TGATCATCGACGAGGTCATGGTCGGCTTCGGCCGCGTGGGCGAGTGGTTCGGCCACCAGCTCACG
GGCGTCACCCCGGACATCGTCACGTTCGCCAAGGGGGTCAACTCCGGGTACGTGCCGTTGGGCGG
CGTCGCCATGAGCGACGACGTCTACGAGAGCTTCGCGACCACGCCCTACCCCGGCGGCCTGACCTA
CTCGGGCCACCCCCTCGCGTGCGCGGCCGCCGTCGCCGCGATCACCGCGATGGAGGAGGAGGGCA
TGGTGGCCCATGCGAAGCGCATCGGCGAGGAGGTCATCGGGCCGCGCCTGGCCGAGATCGCCGT
GGCCCATCCGAGCGTGGGCGACGTGCGCGGCGCCGGCGCGTTCTGGGCCGTCGAGCTGGTGAAG
GACCGGCAGACCCGGGAGCGGTTGGCCCCGCTCGGCCAGGTGGCGCCCGTGATGGGGCGGATGA
TGGCCGAGGCCAAGGACCGCGGGCTGCTGCTGTTCATGGCCGAGAACCGGTTCCACCTGTGCCCG
CCGCTGAACATCTCGGACGAGGACCTGCGCTTCGGCCTCGACGTGCTCGACCGGGTCCTCACCCTC
GCCGACGAGGAGGTCGCGGCCAGCTGA 
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Table 8.6 contains the primers used in the cloning of MLUT_00920 into  operon A only. The 
RBA was added onto the linearised operon A vector followed by the AvrII site. 
OPA rev  AvrII GGTTATCCTAGGCTCCTTCAGTTTTCGTGCATAAGCACAATA 
OPA for BbvCI 
ATCTAGCCTCAGCGCTGCTAACAAAGCCCGAAAGG 
1014 for (AvrII) AACTATCCTAGGATGTCCGAGCATCAGCAGCAC 
1014 rev (BbvCI) CGATTAGCTGAGGTCAGCTGGCCGCGACCTC 
Table 8.6 Primers used in the cloning of MLUT_00920 into operon A  
 
 
A.3. Individually cloning the Acinetobacter calcoaceticus NCIMB 9871 genes 
individually 
Each gene taken from Acinetobacter was cloned individually into a pET29a vector. Each 
genes stop codon was removed and the RBS from the vector as well as the his-tag was used 
for each gene. The NdeI site was positioned at the 5' end and the NotI site at the 3' end of 
the gene. The pET29a vector was linearised by double digestion with both enzymes 
followed by gel purification.  
ChnA for idvc (NdeI) ATCGTACATATGATGTCAAATAAATTCAACAATAAAG 
ChnA rev idvc (NotI) TAACTAGCGGCCGCTTTCGAGGTATATGCACC 
ChnB for idvc (NdeI) ATCGTACATATGATGTCACAAAAAATGGATTTTGATGC 
ChnB rev idvc (NotI) TAACTAGCGGCCGCGGCATTGGCAGGTTGCTT 
ChnC for idvc (NdeI) ATCGTACATATGATGAATAGCACACAAAGCAATAC   
ChnC rev idvc (NotI) TAACTAGCGGCCGC TGC TTT AAA CCA CTG C    
ChnD for idvc (NdeI) ATCGTACATATGATG CAC TGT TAC TGC GTG AC    
ChnD rev idvc (NotI) TAACTAGCGGCCGC GTT TTC GTG CAT AAG C 
Table 8.7 Primers used for individually cloning each enzyme into a pET29a 
vector for his-tag purification. 
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A.4. Assembling pQR1559: Cloning a T7-operator-ChnD-terminator sequence into 
pQR1553  
 
The addition of a second copy of ChnD regulated by its own promoter, operator and 
terminator required several rounds of iteration. The fragment called AvrII-T7-operator-
ChnD-terminator-SalI was inserted into a inverse PCR lineaerised pQR1553 plasmid at a site 
between the ROP and LacI sequences and the AvrII and SalI sites were added. The nested 
fragment of ChnD was used to generate this fragment. The two fragments were restriction 
cloned together. 
 
Step 1 Nested fragment 
AvrIT7opChnD for 
AvrII 
CTAGTCCCTAGGTAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCAAGG
AGAGATTATGCACTGTTACTG 
ChnD rev  
SalI 
TAGCTAGTCGACTCAGTTTTCGTGCATAAGCACAATACGCCCGATGACGTT GCC ATC 
Step 2 Using step 1 as a template 
T7ChnDterm rev CAA AAA ACC CCT CAA GAC CCG TTT AGA GGC CCC AAG GGG TTA TGC TAG TCA 
GTT TTC GTG CAT AAG CAC AAT AC 
AvrIT7opChnD for  
Step 3 Product of step 2 
ChnDfinalRev 
SalI 
TAGCTAGTCGACCAAAAAACCCCTCAAGACCCGTTTAGAG   
ChnDfinalFor 
AvrII 
CTAGTCCCTAGGTAATACGACTCACTATAGGGGAATTGTGAG   
  
 Inverse PCR of pQR1553 
53revAvrII ACGTTACCTAGGGTCTGCGACCTGAGCAACAACATGAATG 
53forSalI TCGATGGTCGACGTATCGGTGATTCATTCTGCTAACCAGTAAG   
Table 8.8 A list of the primers used to create pQR1559. 
    
212 
 
Appendix B 
Table 8.9 is a list of the plasmid constructs and what each contain. 
pQR1543  pET29a encoding ChnA-D under native RBS sequences 
pQR1548 pET29a encoding ChnA-D under artificial RBS sequences 
pQR1553 pQR1543 + PP5182 
pQR1554 pQR1548 + PP5182 
pQR1555 pQR1543 + DGEO_2743 
pQR1556 pQR1548 + DGEO_2743 
pQR1557 pQR1543 + MLUT_00920 
pQR1559 pQR1553 + T7-operator-ChnD-terminator 
pQR426  Pseudomonas aeruginosa PAO2, PAO132 
pQR427 Pseudomonas putida KT2440, PP0596 
QR803  Saccharopolyspora erythrea DSM40517 Sery1824 = SACE3329  
pQR804 Saccharopolyspora erythrea DSM40517 Sery1599 = SACE4673 
pQR805 Saccharopolyspora erythrea DSM40517 Sery1902 = SACE5670 
pQR808  Streptomyces coelicolor A3(2) DSM40783 Sco5655 
pQR809 Thermobifida fusca DSM43792 Tfus0278 
pQR810 Pseudomonas putida KT2440 PP5182 
pQR811 Pseudomonas putida KT2440 PP2799 
pQR812 Pseudomonas putida KT2440 PP2588 
pQR813 Pseudomonas aeruginosa PAO2 PAO221 
pQR815 Pseudomonas aeruginosa PAO2 PA5313 
CV2025 Chromobacterium violaceum DSM30191 
pQR965 Saccharopolyspora erythraea SACE_0784  
pQR966 Saccharopolyspora erythraea SACE_1875 
pQR967 Saccharopolyspora erythraea SACE_2128 
pQR972 Saccharopolyspora erythraea SACE_3766 
pQR974 Saccharopolyspora erythraea SACE_6022 
pQR979 Deinococcus geothermalis Dgeo_1219 
pQR983 Deinococcus geothermalis Dgeo_2743 
pQR985 Bacillus licheniformis BLi00474 
pQR986 Bacillus licheniformis BLi00767 
pQR987 Bacillus licheniformis BLi01183 
pQR1003 Vibrio fluvialis 
pQR1010 Klebsiella pneumoniae KPN_01493 
pQR1011 Klebsiella pneumoniae KPN_03745 
pQR1014 Microccocus luteus Mlut_00920 
pQR1015 Microccocus luteus Mlut_10360 
Table 8.9 The plasmid construct I.D and what each is encoding in a pET29a vector 
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Appendix C 
Figure 8.2 shows a typical chromatograph and spectra produced from lysed cell cultures. 
The peaks were compared to standards and quanitified using standard curves (Figure 8.3 - 
Figure 8.8). Retention times and peak separation was optimised by chanign column flow 
rate, run duration and split flow.   
 
Figure 8.2 Above is a typical chromatograph, diluted 1:2 in ethyl acetate of dried cell lysate from a 
10 mM cyclohexanol culture. Below is the spectra of the peak at 8.1 min corresponding to 6-ACA 
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Figure 8.3 Cyclohexanol standard curve and spectra 
 
 
Figure 8.4 Cyclohexanone standard curve and spectra from GC-MS 
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Figure 8.5 Caprolactone standard curve and spectra from GC-MS 
 
 
 
Figure 8.6. 2-TMS-6-hydroxyhexanoate standard curve and spectra from GC-MS 
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Figure 8.7 Adipic acid standard curve and GC-MS spectra 
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Figure 8.8. 2-TMS-6Aminocaproic acid GC-MS spectra and standard curve 
 
 
 
 
 
 
